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ABSTRACT 
Rebecca Keyser Parsons:  The Comparative Susceptibility of 
Porphyromonas gingivalis to the Killing Mechanisms of the Neutrophil 
(Under the direction of Roland R. Arnold) 
 
Neutrophils are critical in defense against periodontal pathogens such as 
Porphyromonas gingivalis, yet the mechanisms employed by neutrophils to kill this 
species are unclear.   Using a dual-color fluorescence assay, we investigated 
phagocytosis and killing of P. gingivalis by neutrophils from normally healthy human 
donors vs. subjects with either chronic granulomatous disease (CGD) or 
myeloperoxidase (MPO)-deficiency.    P. gingivalis was not killed in the absence of 
phagocytosis, and neutrophil phagocytosis required both complement and high titered 
specific antibody.    Intraphagosomal killing of P. gingivalis required a functional NADPH 
oxidase, which required the availability of oxygen, as there was no killing by CGD 
neutrophils or by normal neutrophils when NADPH oxidase was inhibited either with 
anaerobiosis or diphenyl iodonium.   Furthermore, MPO was not required for neutrophil-
mediated killing of this pathogen, as MPO-deficient neutrophils were fully competent in 
killing P. gingivalis, and MPO inhibition with 4-aminobenzoic acid hydrazide did not block 
neutrophil killing of P. gingivalis.   The relative susceptibility of P. gingivalis to the 
reactive oxygen species associated with NADPH oxidase-dependent killing was also 
investigated.    H2O2, but not superoxide, was effective in killing P. gingivalis, as killing by 
the xanthine-xanthine oxidase system was blocked by catalase, but not superoxide 
dismutase.    When delivered as a bolus, H2O2 killed P. gingivalis in a dose-, time-, and 
temperature-dependent fashion, while -OCl killed at a critical concentration, independent 
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of time or temperature.    Compared to other species tested, P. gingivalis was 
remarkably sensitive to H2O2.   Despite having very different susceptibilities to H2O2, all 
test bacteria showed similar susceptibilities to the MPO-H2O2 system and to its product,  
-OCl.   When administered to logarithmically-varied bacterial densities, H2O2 killing was 
dependent on concentration, but not target density; while -OCl killing was lost with 
increasing target density.   Together, these data support the hypothesis that -OCl is 
contact-lethal.   In contrast, the time- and temperature-dependent properties associated 
with MPO-independent H2O2-mediated killing are consistent with the conversion of H2O2 
to a more toxic product by the bacteria itself.    The involvement of hydroxyl radical in 
this bactericidal activity was suggested by the protection afforded by dimethyl sulfoxide 
against H2O2 killing and azide protection against neutrophil-mediated killing of P. 
gingivalis.    
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CHAPTER 1 
INTRODUCTION:   
LITERATURE REVIEW AND RATIONALE 
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Periodontal Health and its Relationship with the Neutrophil 
 
Multiple cell types of the innate and adaptive immune systems together provide 
an effective arsenal of host defense.    Among the white blood cell types important to 
immunity, however, a granulocytic leukocyte called the polymorphonuclear neutrophilic 
leukocyte (PMN or neutrophil) is the one invariably associated with the health of the 
periodontium.   The neutrophil is a professional phagocyte indispensible to periodontal 
defense, supported by the fact that individuals with neutrophil deficiencies, or with 
specific dysfunctions that impair certain but not all neutrophil functions, are highly 
susceptible to periodontal diseases (1) (2) (3).     
 
Periodontal Diseases as Infectious and Inflammatory Diseases 
 
The periodontal diseases are a clinically diverse group of infection-driven, 
chronic inflammatory diseases of the gums (gingiva) and the supporting structures of the 
teeth (periodontium) (4) (5).   Specific pathogens are associated with different forms of 
periodontal disease, from gingivitis, which is considered reversible if treated; to 
periodontitis, which if left untreated can result in the formation of deep periodontal 
pockets, irreversible destruction of the attachment apparatus of the teeth (periodontal 
ligament and connective tissue), resorption of supporting alveolar bone, and ultimately, 
tooth loss.   While gingivitis can progress to periodontitis in the absence of adequate oral 
hygiene, periodontitis is not an inevitable progression from gingivitis.   Additionally, 
epidemiological surveys have estimated that up to 50% of the US adult population has 
gingivitis affecting a minimum of three teeth (6), and at least  10% of the US adult 
population (30 million people in the USA alone) suffers from moderate to severe forms of 
periodontitis (7).   Periodontal diseases are therefore among the most common chronic 
infectious diseases in humans (8). 
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Periodontitis can generally be characterized by the rate (chronic or aggressive), 
extent (localized or generalized), and severity (mild, moderate, or severe) at which 
attachment and bone loss occur, and is attributed as the major cause of tooth loss in 
adults (5).   While the etiology of periodontitis is multifactorial, it is generally understood 
that the host’s immune and inflammatory responses to specific pathogenic flora are 
responsible for the periodontal tissue destruction that is the hallmark of this disease (9).   
Impacting quality of life as well as, perhaps, life expectancy, periodontitis has been 
linked to an increased risk of premature heart disease, stroke, lung infections, abnormal 
pregnancy outcomes, and septicemia (10).   Therefore, periodontitis, which affects a 
significant portion of the human population, is not just a matter of aesthetics, but can 
have a holistic impact on health and well-being (11).    
 
The Complex Flora Associated with Periodontal Health and Disease 
 
It is estimated that upward of 700 different bacterial phylotypes and species 
colonize the oral cavity of humans (12).   Colonizing both non-shedding (teeth) and 
continually-shedding (mucosal epithelium) surfaces, the bacteria in dental plaque 
colonize in a sequential fashion, forming surface-attached communities called biofilms 
(5).   The shift from periodontal health to periodontal disease is accompanied by a shift 
in the microflora of dental plaque, due to architectural changes of the gingival crevice, or 
sulcus.   Specifically, alterations in the depth of the gingival crevice (the space between 
the tooth and wall of the gingival epithelium), oxygen tension (i.e. decreased oxygen 
when the gingival crevice transitions to a deeper pocket and/or the inflammatory 
response reduces local oxygen levels), and increased gingival crevicular fluid (a serous 
exudate that fills the sulcus and bathes the surrounding tissues) flow are the conditions 
concomitant with and necessary for the microbiological progression which initiates the 
transition from gingival health to disease (12).    
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Periodontal health, defined as the absence of gingival pocket depths of 4mm or 
greater, is associated with the colonization of predominantly Gram-positive, aerobic and 
facultative anaerobic bacteria such as Actinomyces and Streptococci spp., localized 
predominantly at the gingival margin (13) (14).   The transition to gingivitis and 
periodontitis is associated with biofilm development extending beneath the gingival 
sulcus, with increased percentages of specific Gram-negative, microaerophilic and 
strictly anaerobic bacteria, such as Aggregatibacter, Campylobacter, Fusobacterium, 
Prevotella, Porphyromonas, Selenomonas, Tannerella, and Treponema spp., etc (5) (13) 
(14).   Continued development of the biofilm relies on interactions such as coaggregation 
with bacteria from the same or different genera (15), and both earlier and later colonizers 
are believed to mutually benefit each other.    It is generally thought that by providing 
critical attachment sites and by reducing oxygen tensions to levels permissive to the 
obligate anaerobic growth of these more fastidious organisms, earlier colonizers 
facilitate the colonization of later colonizers.   By stimulating inflammation and tissue 
damage, the more pathogenic later colonizers are also beneficial to the earlier colonizers 
and to the community as a whole by supplying critical nutrients, etc (9) (16) (17). 
  Socransky and Haffajee et al (18) (19) (20) categorized the microflora of 
biofilms associated with gingival health, gingivitis, and periodontitis, and assigned color 
designations to these bacteria for the convenience of discussion.   Specifically, bacteria 
were divided into clusters based on association (e.g. bacteria which occur together) and 
sequence of colonization, as well as pathogenicity or disease severity (12).   ‘Orange 
complex’ bacteria were classified as bacteria appearing together, later in biofilm 
development, and comprise species such as Fusobacterium nucleatum and Prevotella 
intermedia.   During continued maturation of the biofilm, ‘orange complex’ bacteria, 
which are associated with both gingivitis as well as mild to moderate forms of 
periodontitis, are thought to condition the subgingival environment for the subsequent 
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colonization of ‘red complex’ bacteria.  ‘Red complex’ bacteria appear with ‘orange 
complex’ bacteria, but are overt periodontal pathogens, which appear late in biofilm 
development, and are associated with more severe forms of adult periodontitis.   
Comprising only three species, these include Porphyromonas gingivalis, Treponema 
denticola, and Tannerella forsythia (12).   Individually and in combination, a plethora of 
virulence factors possessed by the ‘orange’ and ‘red complex’ pathogens elicit the host 
responses that lead to the inflammation (gingivitis and periodontitis) and tissue 
destruction (periodontitis) characteristic of periodontal diseases. 
 
The Inflammatory Cell Infiltrate of Periodontal Lesions 
 
Neutrophils are the predominant inflammatory cell type which infiltrates the 
gingival sulcus and junctional epithelium, in both health and periodontal disease (13).   
While neutrophils have been shown to make up about 90-98% of the cell infiltrate of 
periodontal lesions, around 5% of the population is also constituted by cytokine-
producing mononuclear cells such as monocytes and tissue macrophages, T and B 
lymphocytes, and plasma cells (13) (21).   While the absolute numbers of each of these 
cell types greatly increase with disease severity, the approximate ratio of 
polymorphonuclear (neutrophils) to mononuclear leukocytes has been shown to stay 
relatively constant as the degree of inflammation increases in periodontal lesions (13) 
(22) (23) (24).   However, as lesions progress, there is a shift in the predominance of 
certain lymphocytes present.   For instance, as early gingivitis develops into more 
chronic and severe gingivitis, there is a shift from T cell predominance to B cell 
predominance (13) (25) (26).   As early periodontitis develops into more chronic and 
severe periodontitis, there is a shift towards antibody-secreting plasma cells (13) (21) 
(26) (27).   Consistent with this, while all of these named cell types are presumably 
involved in defense within periodontal lesions, the neutrophil axis, in concert with 
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opsonins such as complement and antibodies, is considered the primary defense 
mechanism operational in the gingival sulcus (28) (29).   Additionally, the principal 
means by which neutrophils handle periodontal pathogens is through phagocytosis and 
killing, in a process dependent upon granule fusion with the phagosome (3) (28) (30) 
(31) (32), and both oxygen-dependent and oxygen-independent killing pathways 
operational in the neutrophil are considered important in preserving periodontal health 
(3) (33) (34).    
 
Neutrophil Development in the Bone Marrow 
 
 In a process called myelopoiesis, neutrophils develop in the bone marrow in two 
stages:  a mitotic or proliferative phase, followed by a maturation phase.   During the 
mitotic phase, which averages 7.5 days in humans (35), pluripotent stem cells are 
stimulated to become neutrophil precursors under the influence of myeloid-specific 
growth factors such as granulocyte colony stimulating factor (GCSF), and to a lesser 
extent, granulocyte monocyte colony stimulating factor (GMCSF) (36).   Stem cells 
undergo a series of divisions and first become myeloblasts, then promyelocytes, and 
next myelocytes (36).   After this stage, neutrophil precursors lose their ability to divide, 
but continue to differentiate during the maturation phase into metamyelocytes, band 
cells, and finally into morphologically mature, segmented neutrophils (33).  The 
maturation phase averages 6.5 days in humans (35).    
During both the mitotic and maturation phases in the bone marrow, neutrophil 
precursors are actively undergoing granule biosynthesis, in a process called 
granulopoiesis (37) (38).   Under normal conditions, the mature neutrophil, which by now 
has a dense, granular appearance of cytoplasm, is released from the bone marrow into 
the blood stream two days after maturation is completed, as a terminally differentiated, 
highly specialized, effector cell.    As a fully differentiated and mature granulocyte, the 
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neutrophil participates in very little de novo protein synthesis, which is consistent with 
the observation that mature neutrophils contain very few mitochondria and a poorly 
developed endoplasmic reticulum (2).    Additionally, neutrophils are considered 
anaerobic cells, as they contain a rich glycogen supply in their cytoplasm and obtain 
their energy solely from glycolysis (39).   
In a normal, healthy human adult, neutrophils account for 43-65% (normal 
reference range) of the total circulating white blood cells in peripheral blood.   
Additionally, after leaving the bone marrow, neutrophils have a short circulating lifespan 
which averages about 8 hours (13) (36) (40).    When stimulated, circulating neutrophils 
are directed into tissues, where they may remain active for between two and six days, 
functioning as professional phagocytes (36).   If unstimulated, neutrophils will become 
senescent and undergo apoptosis, and are cleared by the liver and spleen.    Studies 
have demonstrated that the average daily output of neutrophils into the circulation of a 
150 lb person is approximately 1 x 1011, which has the potential to rise by a factor of at 
least five, during a bacterial infection (35) (41).   While the bone marrow contains a 
reserve pool of between 20 and 50 times the number of neutrophils in the circulation 
(36), in order to accommodate the increased need for neutrophils during a severe 
bacterial infection, morphologically immature neutrophils may also be seen in the 
circulation during illness (35).    
 
The Hierarchy of Granulopoiesis and Degranulation 
 
The cytoplasm of a mature neutrophil is densely populated with granules, which 
contain not only an arsenal of antimicrobial and potentially cytotoxic substances for the 
destruction of microbial invaders, but also an important reservoir of membrane 
receptors, essential for neutrophil functions such as chemotaxis (the directed migration 
of neutrophils toward a site of infection in tissues) and phagocytosis (the engulfment of 
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bacteria into intracellular, membrane-enclosed compartments called phagosomes), etc 
(3) (42).   During granulopoiesis, granule proteins are synthesized sequentially, but as a 
continuum, in the presence of specific transcription factors which are turned on and off, 
at distinct stages of neutrophil development (37) (38) (43).   In general, granule 
packaging is believed to occur not by sorting, but by the fusion of different transport 
vesicles which bud off the Golgi at approximately the same time (42) (44) (45).   
Therefore, granule packaging occurs continually as proteins are synthesized, and 
granule proteins that are synthesized at the same time will localize to the same granules.   
Highly heterogeneous, granules have traditionally been categorized into subsets, based 
on the order of biosynthesis of their characteristic protein contents (37) (38) (43).    As 
such, granules are categorized into primary (or azurophilic), secondary (or specific), and 
tertiary (or gelatinase) granule subsets, named for their order of appearance during 
neutrophil development. 
While all granule subsets share some proteins such as lysozyme, which is 
synthesized continually; other proteins, which are synthesized transiently and express 
minimal overlap, serve as specific markers of particular subsets.    For example, 
‘azurophilic’ or ‘primary’ granules are synthesized and packaged first during 
granulopoiesis, in myeloblasts and promyelocytes.    Named for their affinity for the basic 
dye azure A due to their peroxidase-positive content (46), azurophilic granules are 
defined based on the presence of a specific protein/ enzyme, which serves as the 
marker for this subset, called myeloperoxidase.   While myeloperoxidase is found only in 
azurophilic granules, azurophilic granules are also divided into defensin-poor 
(synthesized early and are small) and defensin-rich (synthesized later and are larger and 
dense) granules.   Defensin-rich granules appear late in promyelocytes and continue in 
myelocytes.    ‘Specific’ or ‘secondary’ granules, which are twice as populous but half the 
size of azurophilic granules (47), are synthesized and packaged second during 
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granulopoiesis, in myelocytes and metamyelocytes, and are peroxidase-negative.    
Specific granules are defined based on the presence of the proteins, vitamin B12-binding 
protein, and in particular, lactoferrin, which serves as the main marker for this subset.   
‘Gelatinase’ or ‘tertiary’ granules are synthesized and packaged third during 
granulopoiesis, in band cells and segmented polymorphonuclear neutrophils, and are 
defined based on their high content of a proteolytic enzyme called gelatinase.   Finally, 
while considered to be a different organelle than granules, ‘secretory vesicles’ are purely 
exocytotic storage vesicles, rich in receptors, and are synthesized and packaged last 
during granulopoiesis, in segmented neutrophils (37) (38) (42) (43) (44) (45).     
All granule subsets and secretory vesicles share the feature that they are 
membrane-bound organelles, which contain both a phospholipid bilayer membrane, rich 
in receptors, and an intragranular matrix.   With the exception of secretory vesicles, the 
intragranular matrices of granules are rich in antimicrobial proteins, enzymes, and 
proteases, which serve as important mechanisms of defense, in both oxygen-dependent 
and oxygen-independent killing pathways of the neutrophil.    Both the synthesis and 
mobilization of neutrophil granules and secretory vesicles, which are highly regulated 
events, are essential components of the neutrophil-mediated immune response.   For 
instance, from initial activation and recruitment, to phagocytosis, and the destruction and 
degradation of microorganisms, degranulation of both granules and secretory vesicles is 
essential to executing every function of the neutrophil (42).    
Additionally, granules and secretory vesicles are mobilized (or degranulated) in 
the opposite order in which they were synthesized.   Therefore, while secretory vesicles 
are synthesized last, they are mobilized first upon neutrophil activation; and while 
azurophilic vesicles are synthesized first, they are generally mobilized last during 
intracellular killing and digestion.    In particular, the defensin-rich granules are generally 
considered to be the last to fuse with the phagosome and the least likely to undergo 
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exocytosis.    Furthermore, while secretory vesicles are purely exocytotic vesicles which 
fuse only with the neutrophil exterior (plasma membrane); portions of gelatinase and 
specific granules, in contrast, undergo exocytosis, as well as intracellular fusion with the 
phagosome.   In contrast to the larger specific granules, the smaller gelatinase granules 
are not as rich in antimicrobial substances, and more readily undergo exocytosis, where 
they serve primarily to supply membrane receptors and matrix-degrading enzymes 
during neutrophil extravasation and tissue migration.   Only azurophilic granules undergo 
very limited exocytosis, and are therefore primarily considered lysosomal granules, 
contributing predominantly to the killing and digestion of phagocytosed organisms (42) 
(45).    
It is also important to note that the act of granule fusion with the plasma 
membrane serves not only to deliver intragranular matrix contents to the outside 
environment of the neutrophil, but also serves to incorporate granule membrane 
components into the plasma membrane and on the exterior neutrophil surface.   
Similarly, the act of granule fusion with the phagosome membrane serves not only to 
deliver intragranular matrix contents to the interior environment of the phagosome, but 
also results in incorporation of granule membrane components into the phagosome 
membrane and on the interior phagosome surface.  
 
Neutrophil Activation, Diapedesis, and Chemotaxis 
 
 The neutrophil response to an infectious insult is a multi-step process, involving 
neutrophil activation, vascular adhesion and diapedesis, tissue migration through 
chemotaxis, phagocytosis, and finally, microbicidal activity (3).  The initial response is 
characterized by the activation, and directional recruitment of neutrophils from peripheral 
blood to sites of infection that involves a process called chemotaxis.   Primary contact 
with stimulated vascular endothelium, occurring especially in the post-capillary venules 
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adjacent to sites of infection (48), activates neutrophils and initiates a series of 
exocytotic events by secretory vesicles, which are the first and most rapidly mobilized 
subcellular constituents.   By fusion with the plasma membrane, the membrane contents 
of secretory vesicles get incorporated into the plasma membrane of the neutrophil, which 
furnishes the neutrophil’s exterior with vital adhesion molecules and receptors, which 
serve to initiate the earliest functions of the neutrophil (45).   Essential to these earliest 
activities, secretory vesicles supply the neutrophil membrane with β2-integrins 
CD11b/CD18 (Mac-1, CR3), the complement receptor 1 (CR1), receptors for formylated 
bacterial peptides (formylmethionyl-leucyl-phenylalanine (fMLP) receptors), the 
lipopolysaccharide (LPS)/lipoteichoic acid binding receptor CD14, the FcγIII receptor 
CD16, and the metalloprotease leukolysin, etc (42) (45).   Surface-surface interactions 
between selectin ligands on activated endothelial cells and integrins on activated 
neutrophils then mediate the process of neutrophil rolling, tethering, and eventual 
adhesion to the endothelium.   Neutrophils then extravasate between the junctions of 
endothelial cells into tissues, in a process known as diapedesis.    Three important 
metalloproteases (MMPs) have been identified in neutrophils which facilitate this process 
by degrading extracellular matrix components, such as collagen, fibronectin, 
proteoglycan, and laminin.   These include gelatinase (or MMP-9), which is a matrix 
component predominantly found in gelatinase granules; collagenase (MMP-8), which is 
a matrix component in specific granules; and leukolysin (MMP-25), which is a matrix 
component in both specific and gelatinase granules, as well as a membrane component 
of secretory vesicles (42).   Therefore, degranulation of secretory vesicles, followed by 
portions of gelatinase and then specific granules, is concomitant with and necessary for 
the migration of neutrophils from the vascular basement membrane into infected tissues.   
Interestingly, the multilobular nucleus of the neutrophil, which contributes to the extreme 
flexibility of the cell, is another essential feature allowing not only the migration of 
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neutrophils between the narrow spaces of endothelial cell junctions, and from the bone 
marrow sinuses into the circulation (3) (35), but also serves to help minimize capillary 
and tissue damage as neutrophils cross through these structures.   
 In the periodontium, neutrophils similarly enter the gingival crevice by diapedesis 
between the endothelial cells of gingival blood vessels and capillaries, and migration 
through the tissues of the junctional epithelium, by following chemotactic substances 
which form a gradient (13).    Neutrophils can be driven toward bacteria by several types 
of chemotactic gradients, including microbial products such as LPS and fMLP, 
complement cleavage products such as C5a, antigen-antibody complexes, pro-
inflammatory cytokines such as interleukin-8, and lipid mediators such as leukotriene 
B4– all of which are found in gingival crevicular fluid during periodontal infections (49).    
 
Neutrophil Phagocytosis and Phagolysosomal Fusion  
 
Phagocytosis is the process by which a microbe is engulfed by a phagocyte (e.g. 
a neutrophil) into an intracellular and physically sequestered, plasma membrane-lined 
enclosed compartment, called a phagosome.   In a process known as opsonization, 
phagocytosis is greatly facilitated if microbes are first coated with opsonic proteins.   The 
most important opsonins in serum are the complement fragments, C3b and C3bi, and 
immunoglobulin G (IgG), which bind to and cross-link with the complement (CR1 and 
CR3) and Fc receptors on neutrophils (31).   Antibody is not always required for 
complement activation, and phagocytosis may also occur via alternative pathways of 
complement activation independent of antibody (50), as well as by non-specific opsonins 
which may also be present in serum (3).    Receptor-ligand interactions between the 
phagocyte and the opsonin-coated microbe typically initiate the process of phagocytosis, 
where the cell membrane invaginates to form a phagosome (51).   Silverstein (52) 
observed that when a neutrophil comes in contact with a bacterium, the cytoplasm of the 
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neutrophil first extends out into long, thin pseudopodia, which then spread over and flow 
around the surface of the targeted bacterium, tightly encompassing it, in a zipper-like 
fashion.   In formation of the phagosome, Zakhireh et al (35) also observed that after 
encasement, the phagosome buds off from the cell periphery and moves centripetally 
away into the cell’s interior.   Stossel (53) identified that pseudopodia formation, 
important for both neutrophil locomotion and phagocytosis, is made possible due to 
contractile proteins, similar to those of skeletal muscles, such as actin, myosin, 
actomyosin, and actin-binding proteins.   Specifically, the polymerization and 
rearrangements of these contractile networks, located within the neutrophil cytoskeleton 
just beneath the plasma membrane, permit the neutrophil motility and formation of 
pseudopodia, required for phagocytosis (30) (35) (53).     
Just after phagocytosis (1-15 min), microbicidal activity begins with the activation 
of both oxygen-dependent and oxygen-independent killing pathways, which are 
mediated predominantly by specific and azurophilic granules, which fuse with the 
phagosome, in a process called phagolysosomal fusion.    With very little extracellular 
medium taken up during phagocytosis (47) (54), the phagosome is designed to be a very 
narrow space in which a large amount of degranulation occurs, close to the bacterial 
surface, for microbial killing and digestion (50) (55).   A complex series of events are 
responsible for these processes.    In brief, degranulation is activated by a surge of 
intracellular calcium, followed by the activation of protein tyrosine kinases, which 
phosphorylate specific phospholipases (e.g. phospholipase C).   These in turn catalyze 
the generation of specific ‘messengers’ such as inositol triphosphate and diacylglycerol 
(DAG), which release additional calcium from intracellular stores and activate protein 
kinase C (PKC), respectively (3) (42).    PKC is particularly important for its role in 
activating the NADPH oxidase, a phagosomal (90-95%) and plasma membrane (5-10%) 
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-associated enzyme complex (56), that is dormant in resting neutrophils, but rapidly 
assembled when activated. 
 
Oxygen-Dependent Killing Pathways 
 
As proposed by Klebanoff (57) (58), neutrophils have two major bactericidal 
mechanisms which can be divided broadly into oxygen-dependent and oxygen-
independent killing pathways.   While the principal oxygen-dependent pathway of the 
neutrophil is mediated by the NADPH (nicotinamide adenine dinucleotide phosphate) 
oxidase enzyme, oxygen-dependent killing may also be divided into myeloperoxidase 
(MPO)-dependent and MPO-independent mechanisms.   However, while only shown to 
occur under special circumstances, another oxygen-dependent pathway of the 
neutrophil is one mediated by an enzyme called inducible nitric oxide synthase (iNOS).    
Believed to be the major oxygen-dependent killing pathway in human macrophages (59), 
iNOS is not a principal oxygen-dependent killing pathway in human neutrophils.   Since 
iNOS has not been identified in any granule subset, its generation is believed to require 
de novo protein synthesis – which is minimal in the neutrophil as a fully differentiated 
granulocyte.   However, Webb et al (60) have shown that iNOS can be induced in 
human neutrophils in the presence of specific cytokines, including interleukin-1α, tumor 
necrosis factor-α, and interferon-γ, as well as additional stimuli from adhesion to a 
surface.   Only under these circumstances, and in the presence of oxygen and L-
arginine (O2 + L-arginine  NO. + L-citrulline), is iNOS capable of generating nitric oxide 
(NO.), a reactive nitrogen species which was discovered for its role in the control of 
vascular tone (59).     
The principal oxygen-dependent killing pathway of the neutrophil is mediated by 
the multi-component NADPH oxidase system, which is responsible for the production of 
a respiratory burst (named for the large amounts of oxygen that are rapidly consumed by 
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activated neutrophils).    Dependent on the fusion of specific (or secondary) granules 
with the phagosome, the components of the NADPH oxidase (which are referred to by 
their molecular weight (kDa) and have been given the designation phox for phagocyte 
oxidase (61)), are delivered both to the phagosome membrane and to the phagosome 
interior or cytosol.   These include two membrane-associated components, gp91phox and 
p22phox, which together comprise the cytochrome b558; as well as three cytosolic 
components, p47phox, p67phox, and p40phox.    In order to activate the NADPH oxidase, all 
five NADPH oxidase subunits (gp91phox, p22phox, p47phox, p67phox, and p40phox) with the 
cytosolic GTPase Rac2 (62) (63) must come together and assemble on the interior 
surface of the phagosome membrane to form the NADPH oxidase complex, a process 
dependent on phosphorylation of cytosolic subunits by PKC (64).   Glucose-6-phosphate 
dehydrogenase (G6PD) generates NADPH, which provides the NADPH oxidase 
complex with the electron to reduce oxygen to superoxide anion:  NADPH + 2O2 → 
NADP+ + 2O2.- H+  (30) (56) (62) (64) (65) (66) (67) (68).   The genetic deficiencies in 
phagocytes of either gp91phox, p22phox, p47phox, or p67phox, or mutations in Rac2 or G6PD, 
provide the molecular bases for all cases of chronic granulomatous disease (CGD) in 
humans (69) (70).   Neutrophils from subjects with CGD are consequently unable to 
produce superoxide or any downstream reactive oxygen species, and are considered 
respiratory burst-deficient (61) (66) (69) (70) (71) (72) (73) (74) (75).   In normal, NADPH 
oxidase-functional neutrophils, superoxide, generated through the respiratory burst, 
subsequently dismutates to hydrogen peroxide (O2.- + 2H+ → H2O2); and from these 
intermediates, other more reactive oxidants are generated, either by reacting with 
bacterial iron or with enzyme systems such as MPO, or by the products of these 
systems reacting with O2.- and/or H2O2, or with each other (47) (63) (76) (77) (78) (79) 
(80) (81) (82) (83).   It is of interest to note that hydrogen peroxide is believed to form in 
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the phagosome through the collision or interaction of two superoxide molecules, since 
there is no evidence of SOD in the phagosome (84). 
The presence of oxygen and a functional NADPH oxidase are essential in 
making numerous reactive oxygen species (ROS) within the phagosome, including 
superoxide (O2.), hydrogen peroxide (H2O2), hypochlorous acid (HOCl or H+  -OCl), and 
hydroxyl radical (OH.) (64) (76) (79) (81).    Both O2.- and H2O2 are generally regarded as 
relatively nontoxic and inert (or only mildly oxidative) (79) (85) (86) (87), though their 
roles in killing bacteria are of particular interest due to the abundance of superoxide 
dismutases (SOD), catalases, and peroxidases in bacteria (O2.- and H2O2 scavenging 
enzymes); since the oxygen consumed in the respiratory burst is first converted to O2.- 
and then to H2O2; since both are generated in close proximity to ingested bacteria; and 
due to the severe clinical consequences of their absence in CGD (34) (76) (77) (81) (88) 
(89).   Additionally, considerable evidence suggests that O2.- and/or H2O2 play direct (47) 
or indirect roles in killing ingested bacteria by participating as substrates in almost every 
known killing system in the neutrophil (76) (81) (90).   Furthermore, impaired bactericidal 
activity in CGD neutrophils, which are incapable of producing their own O2.- and H2O2, is 
restored in the laboratory by the addition of a H2O2-generating system (91) (92) (93) (94) 
(95) (96).   It is also important to note that while O2.-  has limited membrane permeability 
due its charge; H2O2, in contrast, is highly membrane permeable because it is small and 
uncharged (79).   It is likely that this membrane permeability property permits H2O2 to 
gain access to the interior of the cell, where it is converted to more reactive species in 
direct proximity to vulnerable targets. 
The principal enzyme of the neutrophil known to consume H2O2 in the 
phagosome is heme-based MPO, which catalyzes the oxidation of chloride by H2O2 to 
generate the potent oxidant, HOCl or H+  -OCl, the weak acid form of the active 
ingredient found in household bleach, Na+  -OCl.    Dependent on the fusion of 
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azurophilic (or primary) granules with the phagosome, MPO (an intragranular matrix 
component defining azurophilic granules and the most abundant protein/enzyme in 
neutrophils), is delivered to the phagosome, in close proximity to bacteria, where it is 
proposed to react with H2O2, already present (by order of degranulation, H2O2 would be 
present in the phagosome before MPO), converting H2O2 to H+  -OCl:   MPO + Cl- + H2O2 
→  H+  -OCl + H2O.   Necessary chloride has been shown to be provided via channels 
which pump chloride into the phagosome from the outside of the cell (79) (97), where it 
is present in biological fluids at concentrations higher than required (84); as well as 
supplied by fluids taken up upon phagocytosis (47).   MPO, a strongly cationic 146 kDa 
hemoprotein (98), has also been shown to coat the surfaces of some negatively-charged 
bacteria (99), which would initiate HOCl generation even closer to a bacterial surface 
(84); though most MPO is believed to react with H2O2 unbound to bacteria (47).   HOCl, 
which is a small, uncharged, non-radical, highly permeable to bacterial membranes (79), 
is believed to exert the majority of its antimicrobial activity after entering the cell.   Due to 
its membrane permeability (79), its rapid reactivity (short-lived), and its ability to 
chlorinate or otherwise modify a wide range of microbial targets, MPO-generated HOCl 
is regarded as one of the most potent microbicidal and cytotoxic mechanisms of the 
neutrophil (47) (63) (84) (100) (101) (102).   In particular, HOCl has been shown to be 
highly proficient at disrupting intracellular structures and metabolic processes in bacteria 
(50) (103) (104) (105); e.g. by cross-linking enzymes, lipids, proteins, and DNA (106); by 
interfering with DNA and protein synthesis (107); by fragmenting proteins (108); and 
chlorinating amines to chloramines (104) (109), a secondary more stable product 
proposed to enhance the toxicity of HOCl in the phagosome (68) (101) (110). 
It is also well-supported that in a reductive cellular environment (which is found in 
a metabolizing cell), H2O2 is capable of reacting with bacterial-associated iron and 
mediating a Fenton reaction, where ferrous iron (Fe2+) reduces H2O2 to the most reactive 
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(i.e. non-specific and diffusion-limited) radical known, hydroxyl radical (OH.):   Fe2+ + 
H2O2  →  Fe3+ + H2O + OH.  (78) (81) (82) (83) (85) (88) (111) (112) (113) (114) (115).   
Because OH. reacts so quickly with essentially the first molecule it meets (very short 
range of action), it would likely need to be formed in the immediate vicinity of a crucial 
target in order to become lethal (116).    Upon diffusion inside the cell, H2O2 is proposed 
to react with bacterial iron (e.g. cell-associated iron or hemes, Fe-S clusters, etc) (78) 
(83) (85) (115) (117) to generate OH.  close to DNA; and has been shown to cause DNA 
modifications and strand breaks in a variety of bacteria (79) (118).   Though extremely 
reactive with most bacterial targets, OH. is especially adept at causing lipid peroxidations 
(79), which have the potential to propagate rampantly throughout a cell in a domino-like 
fashion or chain reaction (78).    
Due to the instability of these partially reduced oxygen species (e.g. O2.-  and 
OH.), their membrane permeabilities (e.g. H2O2 and HOCl), and their rapid reactivity (e.g. 
H2O2 , HOCl, and OH.) with a wide range of bacterial targets (e.g. bacterial-associated 
iron, enzymes, proteins, lipids, cell walls, cell membranes, RNA, and DNA etc), ROS 
pose a significant threat to microorganisms, especially when generated within the 
phagosome in close proximity to a bacterium, or within a bacterium itself (69) (76) (77) 
(79).    
 
Oxygen-Independent Killing Pathways 
 
Neutrophils are also proficient at killing most bacteria in the absence of oxygen.   
Oxygen-independent killing mechanisms, by definition, do not require the presence of 
oxygen in order to function, and seem to act in both primary, combinatorial, and reserve 
capacities (35).   For instance, many organisms are susceptible to more than one 
antimicrobial pathway, and so when one is absent, as in MPO-deficiency, it may be 
handled less effectively, but adequately, by another system, such as by an oxygen-
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independent killing mechanism, which may serve as a type of back-up or compensatory 
mechanism (58).   Dozens of antimicrobial substances, which constitute the oxygen-
independent killing pathways of the neutrophil, have been isolated from the intragranular 
matrices of the three granule subsets.   Some of the most well-known examples include 
enzymes such as lysozyme, β-glucuronidase, and phospholipases; proteins such as 
defensins, lactoferrin, azurocidin, and bacterial permeability increasing protein; and the 
serine proteases, proteinase-3, elastase, and cathepsin G (42) (45) (61).   It is of interest 
to note that most of the oxygen-independent antimicrobial substances found in 
neutrophils are arginine- and/or lysine- rich (significance to be discussed).   A few of the 
best-characterized oxygen-independent killing pathways of the neutrophil have been 
selected for discussion below.   
Defensins are small (~3.5 kDa), arginine-rich cationic peptides, which are stored 
in a subset of the azurophilic granules – the defensin-rich dense granules.    Estimated 
to make up at least 5% of the total protein content of neutrophils, defensins are an 
important killing mechanism of the neutrophil, and display antimicrobial activities against 
a broad range of both Gram-positive and Gram-negative bacteria, as well as fungi, 
enveloped viruses, and protozoa (42) (119) (120).   Defensins appear to exert their 
antimicrobial effects by forming ion-permeable, hydrophobic channels or pores through 
the lipid bilayer of membranes (121) (122).   This increases the membrane permeability 
of microorganisms, which in turn enhances their susceptibility to a wide range of other 
microbicidal substances, which are now capable of penetrating.   
Bacterial permeability increasing protein (BPI) is a larger (~50 kDa), lysine-rich 
protein, which is stored in azurophilic granules.   Highly cationic, BPI is especially 
proficient at killing Gram-negative bacteria, at nanomolar concentrations (123).   By 
binding to the outer membranes of negatively-charged LPS residues, BPI appears to 
exert its antimicrobial effects by disrupting the integrity of bacterial cell membranes (e.g. 
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inducing lipid rearrangements) (63).   This in turn increases the membrane permeability 
of Gram-negative bacteria, and inhibits their growth (124) (125).    Further, by attaching 
to bacterial LPS, BPI has been shown to function also as an opsonin, facilitating 
phagocytosis by neutrophils (126). 
Serprocidins, such as proteinase-3, elastase, and cathepsin G, are serine 
proteases (~25-29 kDa) with microbicidal activities (42).   Serprocidins are arginine-rich 
polypeptides, which are stored in azurophilic granules.   As cationic and hydrolytic 
proteins, serprocidins damage and degrade bacteria, but are best known for their 
proteolytic activities against a wide range of extracellular matrix components, such as 
elastin, fibronectin, laminin, type IV collagen, and vitronectin; as well as for their roles in 
activating other antimicrobial enzymes and proteins which get delivered to the 
phagosome (42) (127).   Proteinase-3, for example, has been shown to play an 
important role in cleaving and activating the specific granule peptide, human cathelicidin 
protein-18 (hCAP-18), into the antimicrobial peptide cathelicidin LL-37 (128).    
Lysozyme, an arginine- and lysine-rich cationic antimicrobial peptide (14 kDa), 
was originally discovered by Sir Alexander Fleming and has come to be one of the most 
completely understood enzymes of the neutrophil (35).   Lysozyme is present in all three 
granule subsets, but has peak concentrations in specific granules (129).    Lysozyme is 
an endoacetyl muramidase, specific for cleaving the β-(1,4)-N-acetyl-muramyl-N-
acetylglucosamine linkages within the peptidoglycan layer of bacterial cells walls (130).   
Because the peptidoglycan layer of Gram-negative bacteria is protected by LPS, Gram-
negative bacteria are not usually susceptible to lysozyme (131).   Additionally, while long 
known for its ability to lyse certain bacteria, it appears that many pathogens, especially 
Gram-negative bacteria, are resistant to the lytic action of lysozyme unless they are 
damaged (e.g. by defensins or by BPI) or opsonized first (e.g. with antibody and 
complement) (35) (132). 
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Lactoferrin (LF), a major constituent of specific granules, is an arginine- and 
lysine- rich, non-heme iron-binding glycoprotein (78 kDa), which has been shown to 
demonstrate both bacteriostatic and bactericidal activities against a broad range of 
Gram-positive and Gram-negative bacteria (133) (134) (135) (136).    A member of the 
transferrin family of iron-binding proteins, LF was originally demonstrated to display 
bacteriostatic activities by binding and sequestering environmental iron, which leads to 
bacterial nutritional deprivation (137).   In addition to its competitive iron-binding 
capacity, LF has also been shown to cause irreversible membrane damage and cell lysis 
by binding to bacterial cell membranes via an N-terminal cationic and amphipathic α-
helical region called lactoferricin (138).    Ambruso and Johnson (139), however, 
demonstrated that LF is also capable of participating in hydroxyl radical (OH.) generation 
in human neutrophils.    Kalmar et al (140) demonstrated that the periodontal pathogen 
Aggregatibacter actinomycetemcomitans was highly susceptible to killing by LF in vitro 
(i.e. apoLF, which is an iron- and anion-free form), by a mechanism consistent with OH. 
generation.    While LF was not capable of killing the periodontal pathogen 
Porphyromonas gingivalis by a similar mechanism, Wei (141), however, discovered that 
purified apoLF does inhibit the expression of one of P. gingivalis’ most important 
virulence factors – the arginine-specific gingipains, a discrete protease of P. gingivalis, 
which specifically cleaves after arginine amino acids (more discussion on these later).    
Human LF has also been shown to bind and remove the hemoglobin receptor (HbR) 
from the cell surface of P. gingivalis, inhibiting its growth when supplied with a medium 
containing hemoglobin as its sole iron source (142).    Therefore, LF is proposed to 
function both as an oxygen-independent, as well as a possible oxygen-dependent killing 
mechanism of the neutrophil. 
It is important to note that the antimicrobial function of neutrophils depends on a 
collection of oxygen-dependent, as well as oxygen-independent killing mechanisms, 
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which operate simultaneously and work as a partnership, to kill and degrade the plethora 
of potential infecting organisms that challenge the human host.    Many antimicrobial 
mechanisms therefore exist, and some even overlap, to ensure an effective host 
defense.    While the majority of microorganisms are susceptible to multiple killing 
systems; killing of other microorganisms may depend on a select mechanism for killing.   
Due to an intrinsic resistance or due to the possession of defense mechanisms, a 
microbe may not be effectively handled when one antimicrobial pathway is absent or 
defective (such as in CGD or MPO-deficiency), if it is its critical killing mechanism and if 
there is no other killing system which compensates effectively.    This situation may 
result in an infection, which progresses to pathology (disease).    Interestingly, neutrophil 
defects in oxygen-dependent and oxygen-independent killing pathways – as well as 
quantitative defects, such as neutropenias – can be considered ‘experiments in nature’, 
helping to elucidate the host defense mechanisms which are essential for the killing of 
specific microorganisms.   It is the study of human diseases which provide insights into 
normal host defense that were not likely to have been made otherwise. 
 
Protective and Destructive Roles of Neutrophils in the Periodontium 
 
The best evidence of the importance of neutrophils in the defense of the 
periodontium is the consequence of neutropenia, which is defined as an absolute 
neutrophil count of less than 1,500 neutrophils per microliter of blood.    In addition, 
individuals with other specific defects that result in neutrophil dysfunction, such as 
leukocyte adhesion deficiency (LAD) (adherence, phagocytosis and chemotaxis 
defects), Papillon-Lefévre syndrome (chemotaxis and phagocytic defects), Chédiak-
Higashi syndrome (chemotaxis and phagolysosomal fusion defects), specific granule 
deficiency (chemotaxis and microbicidal defects due to the absence of secondary, 
tertiary, and defensin-rich granules), as well as systemic diseases which reduce 
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neutrophil function (such as diabetes and Down’s syndrome), also suffer from rapidly 
destructive forms of adult periodontitis, which manifest in children with these defects 
shortly after the teeth erupt (1) (2) (13) (33) (65) (143) (144) (145) (146) (147) (148).   
Interestingly, individuals with cyclic neutropenia, which is characterized by the cyclic 
disappearance of neutrophils from the blood and bone marrow at intervals of every few 
weeks (on average, lasts 3 to 6 days every three weeks), are usually asymptomatic and 
appear healthy without obvious infections, with the exception of symptoms consistent 
with the initiation of periodontitis, lasting for the duration of the neutropenia (33).   Once 
neutrophil counts recover in these patients, and after potential infection sources are 
removed, symptoms typically reverse with periodontal health restored (33).    It is 
important to note that in the absence of the neutrophil, as in subjects with chronic 
neutropenia or LAD for instance, there is an increased susceptibility to not only 
periodontal pathogens, but to specific other pathogens as well, in particular, 
Staphylococcus aureus and certain Streptococcus species such as Streptocococcus 
pyogenes.    Importantly, all of these neutrophil disorders associated with periodontitis 
demonstrate that the ability to recruit properly functioning neutrophils in sufficient 
number to subgingival infection sites, followed by phagocytosis and killing by 
phagolysosomal fusion, is absolutely crucial in the protection against periodontal disease 
initiation and in limiting disease progression. 
Although neutrophils play an important protective role in the periodontium; 
neutrophils, when present in chronically elevated levels, are also implicated as the main 
cell type to contribute to periodontal disease progression, due to the release of 
antimicrobial substances, reactive oxygen species, and matrix-degrading enzymes into 
tissues (‘double-edge sword’ theory) (149) (150) (151) (152) (153).   Host tissue damage 
most likely occurs unintentionally by ‘frustrated’ neutrophils, unable to clear 
phagocytosis-resistant bacteria, or when confronted by high concentrations of bacteria 
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that they are unable to handle (154).   In an attempt to control infection via extracellular 
killing of bacteria, neutrophils release more of their granule contents extracellularly than 
usual (which in these special circumstances include azurophilic granules).   The 
deployment of an overzealous host response to infection is therefore as potentially 
damaging to periodontal tissues, as when there is a breakdown in neutrophil defense 
mechanisms (28) (152).     
 
While neutrophils play both protective and destructive roles in periodontitis, and 
while the protective and destructive functions of neutrophils are not mutually exclusive in 
periodontitis; the focus of this dissertation is on the protective role of the neutrophil in 
periodontal defense – as neutrophils are the one cell type, the protective activities of 
which, are invariably associated with the health of the periodontium.    Despite the 
importance of neutrophils in the periodontium, however, relatively few studies have 
examined which killing mechanisms employed by the neutrophil are the most important 
to the suppression of periodontal pathogens.   While it is well-known that the main 
method by which neutrophils handle potential periodontal pathogens is through 
phagocytosis and killing (28) (30) (31) (50), the specific bactericidal mechanism(s) that 
neutrophils use against overt periodontal pathogens have yet to be defined.   The 
objective of this dissertation project was therefore to elucidate the mechanism(s) used 
by neutrophils to kill Porphyromonas gingivalis, the periodontal pathogen most 
associated with the etiology of both chronic and aggressive forms of severe adult 
periodontitis (4) (16) (18) (19) (155) (156).   Understanding how neutrophils kill P. 
gingivalis may offer clues about how normally healthy people are resistant to 
periodontitis; and likewise, offer clues about the underlying bases for susceptibility to 
periodontitis in others.   
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Discrete Defects in the Principal Oxygen-Dependent Killing Pathway 
 
As previously discussed, the principal oxygen-dependent killing pathway of the 
neutrophil is mediated by the NADPH oxidase, which can then be sub-divided into MPO-
independent and MPO-dependent killing mechanisms.    In order to investigate the 
importance of the NADPH oxidase and MPO in neutrophil-mediated killing of P. 
gingivalis, we examined killing of P. gingivalis by neutrophils from normally healthy 
human donors as controls that had no definable neutrophil defects, deficiencies, or 
dysfunctions vs. from subjects with chronic granulomatous disease (CGD) and from 
myeloperoxidase (MPO)-deficiency.    Both CGD and MPO-deficiency represent 
congenital defects in discrete components of oxygen-dependent killing.   The 
consequences of these deficiencies are discussed below. 
 
Myeloperoxidase-Deficiency 
When Klebanoff (157) demonstrated that MPO (a major constituent of 
neutrophils, highly conserved in all mammals) contributed to the microbicidal activity of 
leukocytes, a generation of scientists was stimulated to dissect the specific role of this 
protein in host defense.    As a result of numerous elegant studies, the antimicrobial 
action of MPO has since been attributed to its unique capacity to produce HOCl within 
the phagosome (47) (63) (79) (84) (100) (101) (102).   Since much of the oxygen 
consumed by an activated neutrophil is converted to H2O2 from O2.- (158) (159), and 
since
 
most of the H2O2 generated in the neutrophil is reported to be converted to HOCl 
by MPO (47) (63) (79) (105) (160), MPO is a prime candidate as the dominant oxygen-
dependent killing mechanism of the neutrophil.    Additionally, MPO-generated HOCl 
(also the active ingredient in household bleach) has repeatedly been shown to display 
potent microbicidal activities against a broad range of microorganisms, by chlorinating or 
otherwise modifying a wide range of microbial targets, including enzymes, proteins, 
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lipids, cell walls, membranes, RNA, and DNA, etc (47) (63) (79) (84) (100) (101) (102) 
(161) (162) (163).    
The real importance of MPO in host defense, however, is somewhat of an 
enigma.    Despite the abundance of MPO in the neutrophil, the evidence of robust HOCl 
production in the phagosome (47) (63), and its perceived importance for its potent 
antimicrobial potential; MPO-deficiency represents the most common form of neutrophil 
dysfunction in humans, with an estimated incidence of 1 in 2,000 to 4,000 individuals in 
the USA and Europe (164) (165).  Yet, these subjects are remarkably healthy and do not 
experience an increased frequency of infection (166) (167).   In fact, MPO-deficiency is 
generally considered innocuous and was recently removed as a primary immune 
deficiency disease (168) (169).   However, in ex vivo conditions, neutrophils from 
subjects with MPO-deficiency experience a significantly impaired (i.e. delayed) ability to 
kill certain targets, such as S. aureus, Escherichia coli, Serratia spp., and Candida 
albicans, etc (84) (170) (171) (172) (173) (174) (175).   Despite this, the only clinical 
complication reported in these patients is a predisposition to infections with Candida spp. 
in MPO-deficient subjects who also happen to be diabetic (69) (176).   Yet even the 
frequency of Candida infections is very low in diabetic MPO-deficient subjects (reported 
in less than 5%) (167), raising doubts of the importance of MPO in host defense (177) 
(178) (179).   MPO does, however, appear crucial when the host is challenged with high 
doses of infecting agents, as recently suggested by the studies of Aratani (180).    With 
all things taken together, however, while the significance of MPO has been questioned 
due to its apparent dispensability in humans, the prevailing current view remains that 
MPO plays an important role in killing and digestion within the phagosome and that 
MPO-sufficiency in neutrophils contributes to optimal host defense. 
 
 
27 
 
Chronic Granulomatous Disease  
CGD is a rare (estimated incidence of 1 in 200,000 to 250,000 individuals) (181), 
heterogeneous group of neutrophil disorders with genetically distinct forms, all of which 
are characterized by a deficient respiratory burst capacity in stimulated neutrophils (61).   
While caused by a wide variety of unique mutations (200 or more) in the components of 
the NADPH oxidase (e.g. substitutions, deletions, insertions, and splices) (73) (74), CGD 
is divided into an X-linked form (i.e.  gp91phox deficient), which is male-dominated, with 
females as carriers; as well as autosomal recessive forms (e.g. p22phox, p47phox, p67phox, 
and p40phox deficient), which affect both males and females.    Autosomal recessive 
forms are clinically less severe, and are usually diagnosed later in childhood, but are 
less common than the X-linked form of CGD, which comprises the majority 
(approximately two-thirds) of CGD cases (61) (74).   The p47phox form comprises the 
second most common form of CGD (approximately one-fourth of cases), and is the least 
severe autosomal recessive form (33).   In contrast, subjects with the X-linked form 
suffer the most severe clinical courses, have more frequent infections than subjects with 
the autosomal recessive forms, experience an earlier onset (are usually diagnosed 
within the first year of life), and have the highest mortality rate in children (65) (68) (74) 
(182).   However, a few CGD patients (usually the p47phox form) go undiagnosed until 
adulthood, due to less severe infections and longer intervals between infections (168) 
(183).   It is hypothesized that the CGD patients that go undiagnosed until older ages 
may have compensatory mechanisms in place (e.g. upregulated oxidases, such as 
duox, xanthine oxidase, or glucose oxidase, though upregulated iNOS is associated with 
interferon-γ treatment) (61) (184) (185); or have ‘variant’ forms of CGD, producing 
minute levels of O2.-, which suffice (61) (72) (186) (187) (188).   Interestingly, some 
carriers of X-linked CGD with only 5-10% of NADPH oxidase-functional neutrophils are 
asymptomatic.   
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In contrast to MPO-deficiency, the vast majority of subjects with CGD present 
early in life with severe, life-threatening, and recurrent opportunistic infections, as well as 
uncontrolled inflammation associated with granuloma formation (74).   Additionally, in 
contrast to MPO-deficiency, the microorganisms that are poorly killed by CGD 
neutrophils ex vivo are typically the pathogens responsible for the characteristic 
infections in CGD (79) (170) (189) (190) (191) (192).   In North America, the majority of 
infections in CGD are due to only five microorganisms, which include S. aureus, 
Burkholderia cepacia, Serratia marcescens, Norcardia, and Aspergillus (72), in tissues 
that serve as natural barriers to the environment (skin, lungs, gastrointestinal tract, and 
the lymph nodes downstream from these organs; with liver, spleen, bone, and brain 
affected as infections spread) (68) (75).    
While the lack of correlation between MPO-deficiency and morbidity from 
infection seems to imply that MPO is not important to host defense; the significant 
morbidity associated with infections secondary to CGD, in contrast, appears as a 
dramatic demonstration of the importance of the NADPH oxidase for normal host 
defense (63).   However, another explanation (in addition to potential compensatory 
mechanisms operating in MPO-deficiency) is that CGD affects a wider spectrum of cells 
(eosinophils, monocytes, and neutrophils) than MPO-deficiency (monocytes and 
neutrophils) (79); and perhaps more importantly, affects the oxidative killing pathway 
higher up (NADPH oxidase), than the more distal effects of MPO-deficiency (63).   For 
instance, in CGD, both MPO-catalyzed and MPO-independent oxidative killing 
mechanisms are absent (57), which likely explains its greater severity.   This translates 
to the inability of phagocytes to generate O2.-  and every downstream ROS dependent on 
O2.-  generation, including H2O2, HOCl, OH., ONOO.-, 1O2 etc; compared to MPO-
deficiency, where presumably only HOCl is absent.    As a result, the isolated pathogens 
in CGD are microorganisms believed to be resistant to the oxygen-independent killing 
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mechanisms of the neutrophil, and are typically catalase-positive, capable of eliminating 
their own metabolically-generated H2O2 (68).   Likewise, the microorganisms that are 
killed normally in CGD are believed to be killed either because they are catalase-
negative, and thus able to supply a source of H2O2 for their own demise (bacterial 
catalase is believed to deprive phagocytes from using bacterial-generated H2O2 for 
killing), or because non-oxidative killing mechanisms are effective (68) (193) (194).    
 
Interestingly, while subjects with neutropenia have an increased susceptibility to 
both staphylococcal and streptococcal infections (195); subjects with CGD show intact 
bactericidal activity against streptococcal species, but not to certain staphylococcal 
species such as S. aureus (170) (196).   This suggests that neutrophil function is 
important to both Staphylococcus and Streptococcus, but that NADPH oxidase activity is 
essential to the killing of certain staphylococcal species such as S. aureus, but not to 
streptococcal species.    The significant predisposition to severe periodontitis in subjects 
with quantitative (neutropenias) as well as qualitative neutrophil disorders (adherence, 
chemotaxis, phagocytosis, and microbicidal defects) also suggests that neutrophil 
function is essential to the defense against periodontal pathogens such as P. gingivalis.    
In the next three chapters, we examine the conditions, components, and mechanisms 
essential for neutrophil-mediated killing of this pathogen; and investigate how the 
susceptibility of P. gingivalis (catalase-negative) to the killing mechanisms of the 
neutrophil compares to the catalase-positive S. aureus (a pathogen in both CGD and 
neutropenia), to the catalase-negative S. pyogenes (a pathogen in neutropenia but not in 
CGD), as well as to other catalase-positive and catalase-negative species associated 
with periodontitis. 
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Bacterial Mechanisms of Resistance to Neutrophil-Mediated Killing 
 
In the course of their evolution, bacterial pathogens have developed strategies to 
resist neutrophil-mediated killing as well as other components of the immune system.   
Termed virulence factors or virulence traits, because they enhance their survival and 
pathogenicity (ability to establish an infection and cause disease) in the face of an 
immune response, these include (but in no means are limited to) the possession of 
antioxidant defenses, such as superoxide dismutases (SOD), catalases, and 
peroxidases (O2.- and H2O2 scavenging enzymes); protective outer cell structures such 
as capsule, LPS, S layers, and protoporphyrin; specialized proteases, which inactivate 
and dysregulate components of the immune system; and toxins such as endotoxins and 
leukotoxin, etc (13) (31) (197).      
Some of the most important strategies of a pathogen may therefore involve host 
defense evasion; e.g. inactivating chemotactic factors, resisting serum-mediated killing, 
resisting phagocytosis, resisting neutrophil-mediated killing (oxygen-independent and/or 
oxygen-dependent killing mechanisms), provoking inflammation while avoiding host 
recognition, and altering host immune responses.   P. gingivalis possesses all of these 
strategies, which undoubtedly contribute to its pathogenicity. 
 
Porphyromonas gingivalis 
 
Among the major human periodontal pathogens, Porphyromonas gingivalis is the 
oral pathogen most associated with the etiology of both chronic and aggressive forms of 
severe adult periodontitis (4) (16) (18) (19) (155) (156).   P. gingivalis is characterized as 
a Gram-negative, strictly anaerobic, and highly proteolytic bacterium, which obtains its 
energy by proteolysis of peptides and amino acids, and not sugars (is assacharolytic).   
P. gingivalis possesses an array of virulence factors that contribute to its pathogenic 
potential.   These include numerous proteases, antioxidant defenses, and a variety of 
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outer cell structures such as capsule, LPS, fimbriae, vesicles, and protoporphyrin, etc (4) 
(12) (13) (198) (199) (200) (201) (202).   A few of P. gingivalis’ most important virulence 
characteristics and strategies used to resist neutrophil-mediated killing have been 
selected for discussion.   
  
Proteases, Capsule, and Antioxidant Defenses  
 
P. gingivalis is a highly proteolytic bacterium, and produces and releases large 
quantities of a variety of proteases, which have all been implicated in the pathogenesis 
of periodontitis (203).   In fact, the proteolytic activities of P. gingivalis alone are 
implicated in provoking every hallmark feature of periodontitis, including neutrophil 
accumulation at infected sites, increased gingival crevicular flow, bleeding on probing, 
formation of the periodontal pocket, destruction of periodontal ligament, and bone 
resorption; as well as most of the observed deregulated inflammatory and immune 
features of this disease (4) (9) (12) (28) (200) (201) (204) (205) (206) (207) (208).    
Some of the proteases identified in P. gingivalis include collagenases, hemagglutinins, 
hemolysins, dipeptidyl peptidases, prolyl tripeptidyl peptidases, serine endopeptidases, 
periodontains, gingipains, and broad-spectrum proteases (9) (28) (201) (209).    
Of the proteases identified in P. gingivalis, however, three gingipains, encoded 
by the genes rgpA, rgpB, and kgp, are generally considered the major virulence factors 
of this periodontal pathogen, and are believed to be the main tools used by P. gingivalis 
in host defense evasion (201) (204) (210) (211).   Belonging to the cysteine and serine 
catalytic class of peptidases, the gingipains demonstrate ‘trypsin-like’ activities, though 
the arginine gingipains (HRgpA and RgpB) specifically cleave after arginine residues 
(the carboxy-terminal side peptide bond of arginine); whereas, the lysine gingipains 
(Kgp) specifically cleave after lysine residues (the carboxy-terminal side peptide bond of 
lysine) (4) (212).     
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Many of the oxygen-independent killing mechanisms of the neutrophil are highly 
cationic and rich in arginine and/or lysine residues, and would therefore seem 
susceptible to digestion by the arginine and lysine gingipains of P. gingivalis.   
Interestingly, this seems to occur as culture supernatants and whole cells of P. gingivalis 
have been shown to digest and inactivate a multitude of antimicrobial peptides, proteins, 
and enzymes found in neutrophil granules, including lactoferrin, the cathelicidin LL-37, β-
defensins, cathepsin G, elastase, and bacterial-permeability increasing factor (209) 
(213) (214) (215) (216) (217) (218) (219) (220) (221).  
Prior studies have suggested that several strains of P. gingivalis exhibit 
remarkable resistance to neutrophil phagocytosis due in part to the production of an 
extracellular polysaccharide capsule, and to the proteolytic degradation of serum 
opsonins and their receptors  (199) (201) (202) (221) (222) (223) (224) (225) (226) 
(227).   The addition of high titered antibodies (IgG) to P. gingivalis can facilitate 
phagocytosis, however, not only by specificity for the capsule, but through retardation of 
the proteolytic destruction of the opsonins C3b, C3bi, and IgG, as well as the 
complement (CR1 and CR3) and Fc receptors on the neutrophil (32) (228) (229) (230).    
This is speculated to occur by gingipain-specific antibodies at least temporarily inhibiting 
(masking) the discrete proteases of P. gingivalis, permitting increased surface deposition 
of opsonic complement and C3-IgG complexes (50) (228) (231), so that opsonization 
and neutrophil phagocytosis of P. gingivalis may occur. 
Like its mechanism of resistance to phagocytosis (228), the resistance of P. 
gingivalis to the bactericidal activity of serum has been attributed to both capsule and to 
the proteolytic degradation of complement, which together prevent the membrane attack 
complex from assembling on and penetrating the bacterial surface (227) (232) (233).   P. 
gingivalis is not only resistant to the bactericidal activity of complement components in 
serum, but also to antibody. 
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While P. gingivalis does not make catalase or peroxidase enzymes to degrade 
H2O2 (234) (235), it does make a black-pigmenting, protoporphyrin layer from 
hemoglobin (236) (237), as well as rubrerythrin (238), Dps (DNA binding protein from 
starved cells) (239), an alkyl hydroperoxide reductase (AhpFC) (240) (241), and OxyR 
(242), which have all been shown to potentially protect P. gingivalis against H2O2.    P. 
gingivalis also makes superoxide dismutases (MnSOD and FeSOD) that potentially 
protect P. gingivalis against O2.- (234) (243) (244) (245). 
 
Co-opting the Host Inflammatory Response 
 
 Besides contributing to host defense evasion, the numerous virulence factors of 
P. gingivalis contribute to its ability to evoke an aggressive inflammatory response, 
which undoubtedly serves to its benefit.    Afterall, it would seem likely that a successful 
pathogen such as P. gingivalis would avoid provoking mechanisms of host defense, 
unless the net outcome offered some survival advantage (17).   It is hypothesized that in 
early stages of infection, P. gingivalis may evade, inactivate, and dysregulate 
mechanisms of host defense (e.g.  pro-inflammatory cytokines, host receptors and 
adhesion molecules, opsonins, etc), in order to facilitate its establishment (4) (28) (201) 
(221) (246) (247); while at later stages of infection, P. gingivalis may stimulate 
inflammation (e.g. neutrophil recruitment) in order to meet its nutritional and 
environmental needs (4) (17) (28).   Increased gingival crevicular fluid (serous exudate) 
and flow (stimulated by P. gingivalis via proteolytic activation of the kallikrein/kinin 
pathways, which release bradykinin and increase vascular permeability/ edema), as well 
as tissue destruction and degradation of host proteins (by proteases of both neutrophil 
and P. gingivalis origin), provide the assacharolytic P. gingivalis with a source of 
peptides and amino acids for growth and nutrition (4) (28) (205) (206) (207).   Bleeding 
gums (stimulated by P. gingivalis via proteolytic dysregulation of the coagulation and 
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fibrinolysis pathways), followed by hemolysis of red blood cells by hemagglutinins, 
hemolysins, and gingipains of P. gingivalis provide this hemolytic bacterium with its two 
essential growth requirements, hemin (which provides both nutritional iron and 
protoporphyrin for black pigmentation, when derived from hemoglobin) and Vitamin K  
(4) (9) (200) (205) (206) (237) (248); while stimulation of the respiratory burst helps to 
reduce the subgingival environment by the consumption of oxygen, for the anaerobic 
growth of this fastidious organism.   The ability to resist several features of the immune 
system (including neutrophil phagocytosis, serum-mediated killing, arginine- and lysine- 
rich antimicrobial peptides, and pro-inflammatory cytokines, etc) undoubtedly enable P. 
gingivalis to co-opt the host inflammatory response for its survival advantage.     
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Overall Objectives, Hypothesis, and Study Design 
 
While exceptionally resistant to phagocytosis (32) (224) (225) (226) (227) (228) 
(249) (250) (251), previous studies in our laboratory have shown that normal neutrophils 
are readily capable of killing P. gingivalis, once phagocytized (32).   The overall objective 
of this study was therefore to elucidate the specific bactericidal mechanism(s) employed 
by neutrophils to kill phagocytized P. gingivalis.    Our overall hypothesis was that 
oxygen-dependent killing mechanisms are important to the killing of P. gingivalis, 
because so many of the oxygen-independent killing mechanisms of the neutrophil 
appear susceptible to the proteolytic activities of P. gingivalis (209) (213) (214) (215) 
(216) (217) (218) (219).   A second objective was to investigate how the susceptibility of 
P. gingivalis to the killing mechanisms of the neutrophil compares relative to selected 
other pathogens, in order to gauge whether its sensitivity is specific to P. gingivalis, or 
generalizable to other relevant pathogens.   The pathogens that were selected for 
comparison included the catalase-negative, anaerobic periodontal pathogens, 
Fusobacterium nucleatum and Prevotella intermedia; the catalase-positive, aerotolerant 
periodontal pathogen Aggregatibacter actinomycetemcomitans; the catalase-positive 
Staphylococcus aureus, and the catalase-negative Streptococcus pyogenes – two 
aerotolerant pathogens responsible for pathology in neutropenia as well as oral 
infections in humans.    
In order to begin to understand the mechanisms required to kill this species, we 
used a dual-color fluorescence assay to investigate under what conditions the human 
neutrophil kills P. gingivalis.   Differential interference contrast optics and the fluorescent 
dyes, DAPI (4’,6-diamidino-2-phenylindole) and PI (propidium iodide), were used to 
visualize the phagocytic and microbicidal activities of neutrophils under epi-illumination 
UV microscopy.   Bacterial killing was detected by permeability of PI, which enters the 
bacteria immediately upon loss of membrane integrity or death, at which point they 
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fluoresce red; whereas, live bacteria exclude PI and fluoresce blue, due to the 
intercalation of DAPI with DNA.   This approach allows direct visualization of both 
phagocytosis and killing, enabling a clear and straightforward interpretation:  the bacteria 
are either within the confines of the neutrophil plasma membrane or not, and are either 
alive (blue) or dead (red).   In contrast to the neutrophil lysis and plating methods 
reviewed by Decleva et al (170), which commonly overestimate killing (i.e. suggests 
normal killing when it is not) due to incomplete neutrophil lysis (fewer bacteria are 
released and plated), and due to the clumping and lysis of the bacteria themselves 
(clumped bacteria will appear as only 1 CFU); our approach using DAPI/PI affects 
neither the viability of P. gingivalis nor of neutrophils, directly measures (without over- or 
under-estimation) both the phagocytic and microbicidal activities of neutrophils, and can 
be preserved on a slide indefinitely for later review.    Killing assays to neutrophil 
products were also performed neutrophil-free, in phosphate buffered saline. 
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ABSTRACT 
Neutrophils are indispensible in the defense against periodontal pathogens such 
as Porphyromonas gingivalis.   Yet, relatively few studies have examined the 
mechanisms essential to killing this species.   Using dual color-fluorescence microscopy, 
we investigated killing of opsonized P.gingivalis by neutrophils from normally healthy 
human donors vs. from subjects with chronic granulomatous disease (CGD) or 
myeloperoxidase-deficiency.    Strikingly, no killing of P.gingivalis occurred by CGD 
neutrophils or by normal neutrophils treated with anaerobiosis or the NADPH oxidase 
inhibitor, diphenyl iodonium (DPI).   Myeloperoxidase-deficient neutrophils killed 
P.gingivalis normally, while normal and myeloperoxidase-deficient neutrophils treated 
with the classic myeloperoxidase inhibitor, sodium azide, ablated their ability to kill 
P.gingivalis.   Treatment of normal neutrophils with a more specific myeloperoxidase 
inhibitor, 4-aminobenzoic acid hydrazide (4-ABH), permitted significant, though delayed, 
killing of P.gingivalis.   In contrast, normal neutrophils treated with anaerobiosis or DPI 
were capable of near normal killing of Aggregatibacter actinomycetemcomitans, and 
reduced, but significant, killing of Fusobacterium nucleatum; while 4-ABH reduced killing 
of F.nucleatum and A.actinomycetemcomitans, similar to P.gingivalis.   Taken together, 
these studies show that neutrophil killing of P.gingivalis requires phagocytosis, oxygen, 
and a functional NADPH oxidase, but not myeloperoxidase, and suggest that 
P.gingivalis, in contrast to select other periodontopathogens, is remarkably completely 
resistant to oxygen-independent mechanisms of neutrophil killing.    
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INTRODUCTION 
The periodontal diseases are a clinically diverse group of infection-driven, 
chronic inflammatory diseases of the gums (gingiva) and the supporting structures of the 
teeth (periodontium) (1) (2).   Periodontitis is a destructive inflammatory disease of the 
periodontium, and is among the most common chronic infectious diseases in humans (3) 
(4).   It has recently been estimated that up to 30 million people in the USA alone (10% 
of the US population) suffer from moderate to severe periodontitis (5), which is 
characterized by the formation of deep periodontal pockets, irreversible destruction of 
the attachment apparatus of the teeth (periodontal ligament and connective tissue), and 
resorption of supporting alveolar bone, and is the major cause of tooth loss in adults (1) 
(2) (6).   Impacting quality of life as well as, perhaps, life expectancy, periodontitis has 
been linked to an increased risk of premature heart disease, stroke, lung infections, 
preterm low birth weight pregnancy outcomes, and septicemia (7).   Therefore, 
periodontal disease is not just a matter of aesthetics, but can have a holistic impact on 
health and well-being.    
It is well-known that neutrophils are indispensable in the defense against 
periodontal diseases and play an integral role in the maintenance of periodontal health.   
Individuals with quantitative (neutropenia) and qualitative (adherence, chemotaxis, 
phagocytosis, degranulation) neutrophil defects, as well as systemic diseases which 
reduce neutrophil function (such as diabetes and Downs syndrome), have all been found 
to carry a significant increased risk for developing severe periodontitis (8) (9) (10) (11) 
(12) (13) (14) (15) (16).   Neutrophils are essential as the front line of defense in the 
periodontium against potential periodontal pathogens, but despite their importance, 
relatively few studies have examined the mechanisms employed by neutrophils to kill 
these species.    While it is known that the main method by which neutrophils handle 
60 
 
periodontal pathogens is through phagocytosis and killing (11) (17) (18) (19) (20), the 
specific bactericidal mechanism(s) that neutrophils use against subgingival infections 
with particular organisms have yet to be defined.   The objective of this study was 
therefore to elucidate the mechanism(s) used by neutrophils to kill the periodontal 
pathogen Porphyromonas gingivalis, the oral pathogen most associated with severe 
forms of periodontitis in adults (1) (21) (22) (23) (24).  
P. gingivalis is a Gram-negative, assacharolytic, strictly anaerobic, and highly 
proteolytic bacterium, capable of hemagglutination, hemolysis, and destruction of host 
tissues (25) (26).   It possesses an array of virulence factors such as lipopolysaccharide, 
fimbriae, vesicles, broad-spectrum and discrete proteases, extracellular polysaccharide 
(capsule), and protoporphyrin, which contribute to its ability to evade the host defenses, 
provoke inflammation, and successfully establish persistent infections within subgingival 
pockets (1) (8) (27) (28) (29).   Its success as a periodontal pathogen has been linked 
with its exceptional resistance to serum-mediated, extracellular killing and to 
phagocytosis (20) (30) (31) (32) (33) (34) (35).    However, once phagocytized, normal 
neutrophils are capable of killing P. gingivalis (20).   No studies to date have defined the 
specific mechanism(s) used by neutrophils to kill P. gingivalis, once phagocytized.    
The mechanisms employed by neutrophils to kill bacteria are oxygen-dependent 
and oxygen-independent, and both are considered important in preserving periodontal 
health (11) (13) (36).   After phagocytosis, both the oxygen-dependent and oxygen-
independent killing mechanisms are dependent on cytoplasmic granule fusion with the 
phagosome (17) (37).   The granule content believed responsible for oxygen-
independent killing pathways include enzymes such as lysozyme, β-glucuronidase, and 
phospholipases; proteins such as defensins, lactoferrin, azurocidin, and bacterial 
permeability increasing protein; and the serine proteases, elastase and cathepsins (37) 
(38) (39).   The principal oxygen-dependent killing pathway of neutrophils is mediated by 
61 
 
the multi-component NADPH (nicotinamide adenine dinucleotide phosphate) oxidase 
system, which is responsible for the production of a respiratory burst (named for the 
rapid consumption of oxygen on activation).    It is also mediated by granules (secondary 
or specific granules), which deliver the subunits of the NADPH oxidase to the 
phagosome.   In this process, the NADPH oxidase subunits (gp91phox, p22phox, p47phox, 
p67phox, and p40phox) with the GTPase Rac2 assemble on the inside of the phagosome 
membrane to form the NADPH oxidase complex.   Glucose-6-phosphate dehydrogenase 
(G6PD) generates NADPH, which provides the NADPH oxidase with the electron to 
reduce oxygen to superoxide anion:  NADPH + 2O2 → NADP+ + 2O2.- + H+ (12) (17) (40) 
(41) (42) (43) (44) (45).    The genetic deficiency in phagocytes of either gp91phox, 
p22phox, p47phox, or p67phox, or mutations in Rac2 or G6PD, provides the molecular basis 
for all cases of chronic granulomatous disease (CGD) in humans, and neutrophils from 
subjects with CGD are consequently unable to produce superoxide or any downstream 
reactive oxygen species, and are considered respiratory burst-deficient (38) (41) (46) 
(47) (48) (49) (50) (51) (52).   However, in normal, NADPH oxidase-functional 
neutrophils, superoxide, generated in the respiratory burst, subsequently dismutates to 
hydrogen peroxide (O2.- + 2H+ → H2O2), and from these intermediates, other more 
reactive oxidants are generated, either by reacting with iron or with enzyme systems, or 
by the products of these systems reacting with O2.- and/or H2O2, or with each other (53) 
(54) (55) (56) (57) (58).    The best described enzyme known to consume H2O2 in the 
phagosome is the heme-based myeloperoxidase (MPO) system, which is a chloride- and 
H2O2-dependent mechanism of generating the strong oxidant, weak acid, hypochlorous 
acid (MPO + Cl- + H2O2 → HOCl), and is regarded as one of the most potent 
microbicidal and cytotoxic mechanisms of neutrophils (53) (59) (60) (61).    
In this study, a dual color-fluorescence assay was used to investigate the 
conditions that influence the ability of human neutrophils to phagocytize and kill P. 
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gingivalis.   The importance of oxygen in neutrophil killing of P. gingivalis was examined 
by comparing the influence of aerobic vs. anaerobic atmospheres on neutrophil killing of 
antibody- and complement- opsonized P. gingivalis.   In order to investigate the 
importance of the NADPH oxidase, P. gingivalis killing by neutrophils from subjects with 
CGD and by normal neutrophils treated with the classic NADPH oxidase inhibitor, 
diphenyl iodonium (DPI), was determined.   The role of the MPO system in killing was 
examined by comparing P. gingivalis killing by neutrophils from subjects with MPO-
deficiency and by normal neutrophils treated with the MPO inhibitors, sodium azide and 
4-aminobenzoic acid hydrazide (4-ABH), vs. normal neutrophils that had not been 
treated.  
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RESULTS 
 
Requirement of Antibody and Complement, but not Oxygen, for Neutrophil 
Phagocytosis of P. gingivalis.     
As in previous studies, neutrophil phagocytosis of P. gingivalis strain A7436 was 
highly dependent on both high titered specific antibody and a complement source 
(Supplemental Table A.1).   In the presence of both hyperimmune rabbit antiserum to P. 
gingivalis and human complement, there was a rapid involvement of neutrophils in 
phagocytosis at the initial time point, which progressed to effectively 100% of neutrophils 
involved in phagocytosis by two hours.   In contrast, in the presence of complement only 
(without antibody), a maximum of only 10% of neutrophils were defined as phagocytic, 
and less than 1% were phagocytic in the absence of both antibody and complement 
(data not shown), through the two hour test period.   Additionally, phagocytosis was 
independent of oxygen, as there were no differences in the rate or extent of neutrophil 
phagocytosis under aerobic vs. anaerobic atmosphere.    
 
Requirement of Phagocytosis and Oxygen for Neutrophil Killing of P. gingivalis.     
 Neutrophil killing of P. gingivalis was tested in the presence of antibody and 
complement, under aerobic vs. anaerobic atmosphere (Table 2.1).   Despite substantial 
phagocytosis, there was no evidence of neutrophil killing of P. gingivalis at initial time.   
Under aerobic conditions, the number of phagocytic neutrophils which killed three or 
more bacteria exceeded 75% by one hour and 90% by two hours.   In contrast, 
anaerobiosis completely eliminated killing of P. gingivalis, despite normal phagocytosis.   
There was no evidence of extracellular killing through two hours (data not shown).    
These data indicate an absolute dependence on phagocytosis and oxygen for normally 
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competent neutrophils to kill P. gingivalis, and a total resistance of P. gingivalis to 
oxygen-independent killing mechanisms. 
 
Requirement of a Functional NADPH Oxidase for Neutrophil Killing of  
P. gingivalis.  
 CGD and DPI-Treated Neutrophils.   The NADPH oxidase is the principal 
oxygen-dependent killing pathway of the neutrophil.    In order to determine the 
contribution of this enzyme system in neutrophil killing of P. gingivalis, neutrophils from 
subjects with CGD vs. neutrophils from normally healthy donors that were either 
untreated or treated with DPI were examined using dual color-fluorescence microscopy.   
Neutrophils from five CGD subjects were included in these studies and their inability to 
respond with a respiratory burst was confirmed by two different methods.   Refer to 
Supplemental Table A.2 and Methods text in Appendix for detailed descriptions of CGD 
subjects. 
Flow Cytometry.  The respiratory burst capacities of neutrophils from the five 
CGD subjects, compared to normally competent neutrophils from healthy donors 
(controls), were assessed by flow cytometry (DHR123 method) (Supplemental Table 
A.3).   In PMA-stimulated neutrophil controls, a significant increase in green 
fluorescence was detected by flow cytometry suggesting normal respiratory burst 
capacity (control neutrophil oxidative index (NOI) scores ranged from 167-344).  In 
contrast, neutrophils from each of the five CGD subjects were incapable of respiratory 
burst as detected by negligible fluorescence following PMA-stimulation (CGD NOI 
scores ranged from 1-6). 
Cytochrome C Reduction.  The respiratory burst capacities of neutrophils from 
four of the CGD subjects were also assessed for SOD-inhibitable, cytochrome c 
reduction capacity in response to either PMA or fMLP/cytochalasin b (Supplemental 
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Table A.3).   Consistent with total respiratory burst-deficiency, neutrophils from the CGD 
subjects tested were completely incapable of superoxide production as determined by 
an absence of cytochrome c reduction, in contrast to the robust responses of controls. 
 Phagocytosis and Killing of P. gingivalis by CGD Neutrophils.   Compared 
to competent neutrophil controls, CGD neutrophils under aerobic atmosphere were 
severely compromised in their ability to kill P. gingivalis, despite normal phagocytosis 
(Table 2.2).   These data are consistent with the inability of neutrophils to kill P. gingivalis 
under anaerobiosis (Table 2.1), and together indicate that a functional NADPH oxidase 
is essential for neutrophil killing of P. gingivalis.    
Phagocytosis and Killing of P. gingivalis by DPI-Treated Neutrophils.   DPI 
treatment of neutrophils inhibits NADPH oxidase-dependent superoxide production 
(respiratory burst) mimicking the CGD condition (62).   DPI at the concentration used in 
these studies (20µM final concentration (FC)) completely blocked SOD-inhibitable 
reduction of cytochrome c (data not shown), suggesting complete inhibition of respiratory 
burst superoxide production with DPI.   Phagocytosis and killing of opsonized P. 
gingivalis by normally competent neutrophils either untreated (control), DMSO-treated 
(DPI control), or DPI-treated were tested under aerobic atmosphere (Table 2.3).   
Untreated neutrophil controls were capable of robust phagocytosis and a clear 
progression of killing of P. gingivalis through three hours.   In contrast, treatment of 
neutrophils with DPI ablated their ability to kill P. gingivalis without influencing 
phagocytosis.   Importantly, the DMSO control was capable of normal phagocytosis and 
killing, comparable to untreated controls – a necessary confirmation of DPI’s effect, as 
DMSO (albeit at much higher concentrations) is a known scavenger of hydroxyl radicals 
(OH.) (63).   We therefore hypothesize that the mechanism used by neutrophils to kill P. 
gingivalis is both oxygen- and NADPH oxidase-dependent, and further, because the 
respiratory burst requires both oxygen and a functional NADPH oxidase, it must be the 
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products (reactive oxygen species) generated by the respiratory burst that are effective 
in killing P. gingivalis.   Which reactive oxygen species most effective in killing P. 
gingivalis was the subject of subsequent studies. 
 
MPO is Unnecessary for Neutrophil Killing of P. gingivalis. 
MPO-Deficient, Azide- and 4-ABH-Treated Neutrophils.    MPO is the most 
abundant enzyme in neutrophils, and has frequently been described as the dominant 
bactericidal mechanism of neutrophils (53) (57) (61) (64).   In order to determine the 
contribution of this enzyme system in neutrophil killing of P. gingivalis, neutrophils from 
subjects with MPO-deficiency vs. from normally healthy donors that were either 
untreated or treated with the MPO inhibitors, sodium azide or 4-ABH, were examined.    
Neutrophils from five subjects with complete or selective deficiencies in MPO were 
included in these studies and were members of one family.   Refer to Methods text in 
Appendix for detailed descriptions of MPO-deficient subjects. 
Transmission Electron Microscopy of Neutrophils from MPO-Deficient 
Subjects.   The granule contents of neutrophils from members of the test family and 
from gender- and race-matched normal donors (controls) were assessed for MPO by 
histochemical staining and for lactoferrin by immunogold labeling (Supplemental Figure 
A.1).   Compared to MPO-sufficient controls with 100% of neutrophils showing normal 
distributions of peroxidase-positive granules (Supplemental Figure A.1A), none of the 
neutrophils examined from MPO-DS (sister) (Supplemental Figure A.1B, right panel), 
MPO-DB (brother) or MPO-DF (father) (not shown) contained peroxidase-positive 
granules, consistent with complete MPO-deficiency.   MPO-PDM (mother) 
(Supplemental Figure A.1B, left panel) showed normal distributions of peroxidase-
positive granules in 90% of neutrophils and 10% having no demonstrable peroxidase-
positive granules.   MPO-PDG (maternal grandmother) (Supplemental Figure A.1C) had 
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peroxidase staining profiles consistent with partial MPO-deficiency, with approximately 
50% of neutrophils having no demonstrable peroxidase-positive granules (right panel) 
and the remainder appearing normal for peroxidase staining (left panel).    All neutrophils 
from MPO-DS, MPO-DB, MPO-DF, MPO-PDM, and MPO-PDG contained lactoferrin-
positive granules (arrows, Supplemental Figure A.1C and data not shown) and a general 
distribution of granules that were comparable in density to controls.   
 Phagocytosis and Killing of P. gingivalis by MPO-Deficient Neutrophils.   
Phagocytosis and killing of P. gingivalis under aerobic atmosphere by MPO-deficient 
neutrophils was indistinguishable from that of normal controls (Table 2.4), indicating that 
MPO is not required for neutrophil-mediated killing of P. gingivalis.  
Influence of Sodium Azide on Neutrophil Killing of P. gingivalis.   To further 
explore the potential importance of MPO in neutrophil killing of P. gingivalis, neutrophils 
were treated with the classic MPO inhibitor, sodium azide.   In accordance with the 
literature, we confirmed that azide at the concentration used in these studies (20µM FC) 
completely abolished MPO enzymatic activity (Supplemental Figure A.2).    Additionally, 
azide treatment did not influence neutrophil phagocytosis of P. gingivalis (data not 
shown), nor did it affect the viability of P. gingivalis, as determined by recoverable CFU 
and propidium iodide (PI) permeability (data not shown).    Neutrophil killing of P. 
gingivalis was tested under aerobic atmosphere, with untreated vs. azide-treated normal 
and MPO-deficient neutrophils (Table 2.5).   Interestingly, the addition of azide blocked 
the killing of P. gingivalis by both MPO-sufficient and MPO-deficient neutrophils.   These 
data are consistent with the probability that azide is blocking a mechanism – other than 
MPO – which is essential to the killing of P. gingivalis.   
Influence of 4-ABH on Neutrophil Killing of P. gingivalis.   While azide is 
indeed a potent MPO inhibitor, it also inhibits other potentially relevant metalloenzymes 
that contain heme groups (e.g. peroxidases, catalase, superoxide dismutase, 
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cytochrome oxidases, etc) (65) (66) (67), and is reported to function as a scavenger of 
hydroxyl radicals (OH.) and singlet oxygen (1O2) (68), and as a potent inhibitor of redox 
reactions (69) and reactions involving the transition of metals (70).   4-ABH, on the other 
hand, is reported to be a mechanism-based specific inhibitor of MPO, with no effects on 
other neutrophil enzymes (71) (72) (73) (74).   We confirmed that 4-ABH at the 
concentration used in these studies (4mM FC) completely abolished MPO enzymatic 
activity (Supplemental Figure A.2), and had no direct effect on the recovery (CFU) or PI 
permeability of P. gingivalis (data not shown).   Unlike the complete ablation of killing 
observed with azide, the presence of 4-ABH permitted significant, but delayed, killing of 
P. gingivalis by normally competent neutrophils (Table 2.6).   While MPO may contribute 
to the killing of P. gingivalis, these data further support that MPO is not a required 
component for neutrophil killing of this pathogen.   
 
Comparison of the Mechanisms Employed by Neutrophils to Kill P. gingivalis vs.                 
F. nucleatum and A. actinomycetemcomitans. 
 DAPI/PI Fluorescence Microscopy of Selected Periodontopathogens.   Data 
from the preceding studies suggest that P. gingivalis is completely resistant to 
neutrophil-mediated non-oxidative mechanisms of killing.   Neutrophil killing of P. 
gingivalis was determined to be absolutely dependent on a functional NADPH oxidase, 
which requires the availability of oxygen; but neutrophil killing of P. gingivalis could occur 
in the absence of functional MPO.   The purpose of the next series of experiments was 
to determine if these observations were unique for P. gingivalis.     
The micrographs shown in Supplemental Figure A.3 are representative of the 
data obtained with P. gingivalis vs. F. nucleatum and A. actinomycetemcomitans.    P. 
gingivalis (Supplemental Figures A.3A-C) and A. actinomycetemcomitans (not shown) 
are similar in appearance microscopically, while the fusiform F. nucleatum 
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(Supplemental Figures A.3D-F) is distinguished by its long, spindle-shaped rod 
morphology and unique knot-like staining of its chromatin.   Supplemental Figure A.3A 
shows four neutrophils at 0 time defined as involved in phagocytosis of P. gingivalis 
(three or more bacteria per neutrophil), with none defined as involved in killing due to the 
absence of red bacteria (all bacteria were blue).   Note: Supplemental Figures A.3B-C 
and E-F show the same microscopic field; excitation wavelengths permit visualization of 
both DAPI and PI fluorescence in B and E, whereas narrow band excitation excludes 
DAPI fluorescence in C and F.   Supplemental Figures A.3B-C show four phagocytic 
neutrophils at 60 min, three of which were involved in killing (three or more red bacteria 
per neutrophil).   Supplemental Figure A.3D shows four neutrophils at 0 time defined as 
involved in phagocytosis of F. nucleatum (three or more bacteria per neutrophil), with 
none defined as involved in killing (all bacteria were blue), and two neutrophils (arrows) 
that did not meet the definition of phagocytic.   Supplemental Figures A.3E-F show five 
phagocytic neutrophils at 60 min involved in killing, with the exception of one neutrophil 
(arrow) that would not have been counted (neutrophil was dead as determined by PI 
staining of the nucleus).   
Influence of Anaerobiosis on Neutrophil Killing, Comparing Select 
Periodontopathogens.   Neutrophil phagocytosis and killing of opsonized P. gingivalis 
vs. opsonized F. nucleatum and A. actinomycetemcomitans were tested using normally 
competent neutrophils, under aerobic vs. anaerobic atmosphere (Table 2.7).   
Phagocytosis of P. gingivalis, F. nucleatum, and A. actinomycetemcomitans was 
independent of oxygen, as there were no differences in % phagocytosis under aerobic 
vs. anaerobic conditions at 0 or 90 min.   Additionally, there was no evidence of 
extracellular or serum-mediated killing of P. gingivalis, F. nucleatum, or A. 
actinomycetemcomitans through 90 min (data not shown).   Despite substantial 
phagocytosis, there was no evidence of neutrophil killing of any of the test bacteria at 
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initial time.   By 90 min, in the presence of oxygen, however, there was a significant 
involvement of phagocytic neutrophils in the killing of all three test bacteria.   In contrast 
to the complete ablation of killing that occurs with P. gingivalis under anaerobiosis at 90 
min, there was a greatly reduced, though significant, % of neutrophils involved in killing 
F. nucleatum; and a reduced, but near normal, % of neutrophils involved in killing A. 
actinomycetemcomitans.   These data suggest that P. gingivalis is unique among the 
periodontopathogens tested in its total resistance to neutrophil-mediated non-oxidative 
mechanisms of killing.   
Influence of DPI on Neutrophil Killing, Comparing Select 
Periodontopathogens.   Neutrophil phagocytosis and killing of opsonized P. gingivalis 
vs. opsonized F. nucleatum and A. actinomycetemcomitans were tested under aerobic 
atmosphere, using untreated (control) vs. DPI-treated normally competent neutrophils 
(Table 2.8).   Untreated neutrophil controls were capable of robust phagocytosis and 
killing of P. gingivalis, F. nucleatum, and A. actinomycetemcomitans, with a clear 
progression through 180 min.   Consistent with the anaerobiosis data, in contrast to the 
complete ablation of killing that occurs with P. gingivalis with DPI-treatment of 
neutrophils over 180 min, there was a greatly reduced, though significant, % of 
neutrophils involved in killing F. nucleatum; and a reduced, but near normal, % of 
neutrophils involved in killing A. actinomycetemcomitans.    Importantly, the DMSO 
control was capable of normal phagocytosis and killing of all three test bacteria, 
comparable to untreated controls (data not shown).    These data are consistent with P. 
gingivalis having a unique relationship with neutrophils.   While F. nucleatum and A. 
actinomycetemcomitans are susceptible to killing by oxygen-independent, as well as 
DPI-insensitive mechanisms; P. gingivalis, in striking contrast, is completely resistant to 
killing when DPI-sensitive mechanisms are inhibited. 
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 Influence of 4-ABH on Neutrophil Killing, Comparing Select 
Periodontopathogens.   Neutrophil phagocytosis and killing of opsonized P. gingivalis 
vs. opsonized F. nucleatum and A. actinomycetemcomitans were tested under aerobic 
atmosphere, using untreated (control) vs. 4-ABH-treated normally competent neutrophils 
(Figure 2.1).   Addition of 4-ABH had no influence on the rate or extent of neutrophil 
phagocytosis of P. gingivalis, F. nucleatum, or A. actinomycetemcomitans, but did 
significantly retard the rate of neutrophil killing of all three test bacteria, compared to 
untreated controls.    For P. gingivalis and F. nucleatum, the effect of 4-ABH was 
significant at all time points between 30 min and three hours.    The 4-ABH effect on A. 
actinomycetemcomitans only reached significance at the 30 min time point, consistent 
with its greater susceptibility to non-oxidative killing mechanisms compared with F. 
nucleatum and P. gingivalis.   These data suggest that MPO or some other yet-to-be-
identified 4-ABH-sensitive mechanism contributes to the killing of all three 
periodontopathogens, but there are highly effective MPO-independent mechanisms 
utilized by the neutrophil for the killing of all three species.   
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DISCUSSION 
Previous studies in this laboratory using DAPI/PI have shown that P. gingivalis is 
not killed in the absence of phagocytosis, though once phagocytized, neutrophils are 
readily capable of killing P. gingivalis (20).   Additionally, prior studies have suggested 
that several strains of P. gingivalis including A7436 exhibit remarkable resistance to 
neutrophil phagocytosis due in part to the production of a capsule and to the proteolytic 
degradation of serum opsonins and their receptors  (26) (29) (31) (32) (75) (76) (77) (78) 
(79).   High titered antibodies (IgG) to P. gingivalis can facilitate phagocytosis not only by 
specificity for the capsule, but through retardation of the proteolytic destruction of the 
opsonins C3b, C3bi, and IgG, as well as the complement (CR1 and CR3) and Fc 
receptors on the neutrophil (20) (35) (80) (81).   This is speculated to occur by gingipain-
specific antibodies at least temporarily inhibiting (masking) the discrete proteases of P. 
gingivalis, permitting increased surface deposition of opsonic complement and C3-IgG 
complexes (35) (82) (83).   The current study provides further confirmation that 
neutrophil phagocytosis of P. gingivalis strain A7436 requires both complement and high 
titered specific antibodies, as there was only a small subset of neutrophils capable of 
phagocytosis in the presence of complement only (Supplemental Table A.1), and 
absolutely no phagocytosis in the absence of both of these opsonins (data not shown).   
Furthermore, there was no evidence of extracellular killing under any test condition (data 
not shown).    
In addition to phagocytosis, neutrophil killing of P. gingivalis A7436 absolutely 
requires a functional NADPH oxidase, which is dependent on the availability of oxygen, 
as there was no killing of P. gingivalis by normal neutrophils under anaerobic 
atmosphere (Table 2.1); by neutrophils from subjects with CGD (Table 2.2); or by normal 
neutrophils treated with the NADPH oxidase inhibitor, DPI (Table 2.3).   In contrast, 
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normal neutrophils were capable of reduced, though significant, killing of F. nucleatum, 
and of near normal killing of A. actinomycetemcomitans, under anaerobiosis (Table 2.7) 
and in the presence of DPI (Table 2.8).   Because even a small amount of contaminating 
oxygen proved sufficient to allow neutrophil killing of strain A7436 (unpublished 
observations), all reagents were thoroughly pre-reduced before use in anaerobic 
experiments, and neutrophil preparations required a minimum of one hour in the 
anaerobic chamber prior to the addition of opsonized bacteria.   These findings extend 
those of Odell et al (84), who previously reported an oxygen requirement for neutrophil-
mediated killing of P. gingivalis strain W83 (an encapsulated, disseminating strain, like 
strain A7436).     
These data further suggest that P. gingivalis, in contrast to select other 
periodontopathogens, is remarkably resistant to the oxygen-independent killing 
mechanisms of the neutrophil, which by definition should still be operational under 
anaerobiosis, in CGD, and in the presence of DPI.   Like its mechanism of resistance to 
phagocytosis (35), the resistance of P. gingivalis to the bactericidal activity of serum has 
been attributed to both the production of capsule and to the proteolytic degradation of 
complement, which together prevent the membrane attack complex from assembling on 
and penetrating the bacterial surface (30) (85).   Additionally, the resistance of P. 
gingivalis to the non-oxidative killing mechanisms of the neutrophil may also be 
attributed to the robust proteolytic activities of P. gingivalis, since culture supernatants 
and whole cells of P. gingivalis are able to digest and inactivate a multitude of 
antimicrobial proteins, enzymes, and peptides, including lactoferrin, the cathelicidin LL-
37, β-defensins, cathepsin G, elastase, and bacterial-permeability increasing factor (84) 
(86) (87) (88) (89) (90) (91) (92).    Interestingly, Bachrach et al (93) suggest that the 
resistance of P. gingivalis strain ATCC 33277 (a non-encapsulated, non-disseminating 
strain) to direct killing by select antimicrobial peptides, including the neutrophil peptide 
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LL-37, can be attributed more to the low affinity of these antimicrobial peptides, rather 
than to the proteolytic activities of P. gingivalis.    
Because A7436 appeared completely resistant to the oxygen-independent killing 
mechanisms of the neutrophil, we hypothesize that the success of P. gingivalis as a 
periodontal pathogen may not only be linked with its exceptional resistance to 
phagocytosis and to extracellular killing, but to its requirement for oxygen (i.e. a 
respiratory burst) in order to be killed.   Despite a large number of neutrophils; reduced 
oxygen conditions, which prevail in the periodontal pocket (94), likely explain the ability 
of this strict anaerobe to resist killing (reduces the ability of neutrophils to kill this 
pathogen), as well as to persist and multiply in active periodontitis.   Believed to parallel 
the anoxic conditions in severe periodontitis, P. gingivalis is not killed by neutrophils 
when atmospheric oxygen levels are reduced due to the inability of these neutrophils to 
mount a respiratory burst (95).   It is further hypothesized that P. gingivalis may even 
benefit from the presence of neutrophils, which would make major contributions to the 
reduction of oxygen at sites of inflammation, while contributing to the tissue destruction 
necessary to provide this fastidious, assacharolytic bacterium with a source of peptides 
and amino acids. 
Localized in the azurophilic (primary) granules, MPO is the most abundant 
enzyme in neutrophils (96) (97), and is proposed to play a central role in oxygen-
dependent killing in the phagosome by catalyzing the generation of hypochlorous acid 
(HOCl) from H2O2 (MPO + Cl- + H2O2 → HOCl) in close proximity to bacteria (59) (64).   
HOCl is regarded as one of the most potent microbicidal mechanisms of neutrophils 
because of its reactivity and ability to chlorinate or otherwise modify a wide range of 
bacterial targets, including enzymes, proteins, lipids, cell walls, membranes, RNA, and 
DNA (53) (57) (60) (61) (96) (98) (99) (100) (101).   Furthermore, since much of the 
oxygen consumed by an activated neutrophil is converted to H2O2 from O2.- (102) (103), 
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and since
 
most of the H2O2 generated in the neutrophil is reported to be converted to 
HOCl by MPO (53) (57) (61) (104) (105), MPO is a prime candidate as the dominant 
oxygen-dependent killing mechanism of the neutrophil.    Despite its abundance and 
perceived importance, however, MPO-deficiency represents the most common form of 
neutrophil dysfunction in humans, with an incidence of 1 in 2,000 to 4,000 individuals 
(106), and these subjects do not experience an increased frequency of infections 
(including periodontitis) and are remarkably healthy (107) (108).   In fact, MPO-
deficiency is generally considered innocuous and was recently removed as a primary 
immune deficiency disease (109) (110).   Despite the impaired ability of their phagocytes 
to kill certain targets, such as Staphylococcus aureus and Candida albicans (59) (111) 
(112), the only clinical complication reported in these patients is a predisposition to 
infections with Candida spp. in MPO-deficient subjects who also happen to be diabetic 
(51) (113).   However, even the frequency of Candida infections is very low (reported in 
less than 5% of MPO-deficient subjects) (108), raising doubts as to the importance of 
MPO in host defense (114) (115) (116). 
In initial experiments, MPO was found to be dispensable in the killing of A7436, 
as subjects with MPO-deficiency (partial and complete) were fully capable of killing strain 
A7436, comparable to MPO-sufficient controls (Table 2.4).   The killing of A7436 was 
next examined by neutrophils treated with the MPO inhibitors, sodium azide and 4-ABH.   
Neutrophils from normally healthy donors and from MPO-deficient subjects treated with 
the classic MPO inhibitor, sodium azide, were not capable of killing P. gingivalis strain 
A7436 (Table 2.5), while normal neutrophils treated with the more specific MPO inhibitor, 
4-ABH, were still capable of effective, though delayed, killing of P. gingivalis (Table 2.6).   
Comparable to P. gingivalis, normal neutrophils treated with 4-ABH were also delayed in 
their ability to kill F. nucleatum and A. actinomycetemcomitans (Figure 2.1).   
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 Important to the interpretation of the azide data, however, is the fact that while 
azide is a highly potent inhibitor of MPO activity (by directly attaching to the coordinate 
position of the iron in the heme moiety) (117), azide is not specific for MPO and is 
reported to also inhibit the activity of other enzymes in the neutrophil (65) (66) (67) (118), 
without affecting respiratory burst or granule release (71) (119).   Interestingly, azide is 
also reported to function as a hydroxyl radical (OH.) and singlet oxygen (1O2) scavenger 
(68), as well as a potent inhibitor of redox reactions (69) and reactions involving the 
transition of metals (70).   Therefore, azide may have protected A7436 by functioning as 
a radical scavenger or by preventing toxicity by H2O2.   For instance, by binding and 
bridging transition metals (70), azide may have prevented H2O2 from participating in a 
Fenton Reaction (Fe2+ + H2O2 →  Fe3+ + H2O + OH.), in the absence of competition with 
MPO for H2O2.   It is also conceivable that azide may have protected A7436 by shutting 
it down, since azide has been used to inhibit the metabolism of P. gingivalis (120) (121) 
(122) (123).   This is consistent with the concept presented by Imlay et al (124), who 
suggested that active bacterial metabolism is required for killing by H2O2.   In contrast to 
azide, 4-ABH is a more specific inhibitor of MPO, with no effects on other neutrophil 
enzymes (71) (72) (73) (74), so the influence of 4-ABH on neutrophil killing of A7436 is 
believed to more directly reflect the contribution of MPO in killing.   Taken together, the 
results indicate that while MPO may contribute to the oxidative killing of P. gingivalis, this 
enzyme is not necessary for neutrophil-mediated killing of this pathogen.    Furthermore, 
these data suggest that the main mechanism that normal and MPO-deficient neutrophils 
use to kill A7436 is an MPO-independent, but azide-sensitive mechanism.    Additionally, 
because neither azide nor 4-ABH affects the respiratory burst or degranulation (71) 
(119), P. gingivalis A7436 is likely killed by a mechanism subsequent to the initial 
generation of superoxide by the NADPH oxidase.  
77 
 
It is important to note that the MPO-deficient family reported in this study was 
identified in the course of clinical evaluation of the children, for recurrent pulmonary 
infections and asthma.   It seems unlikely that the MPO-deficiency was the predisposing 
factor for their clinical symptoms, especially considering that the father (MPO-DF) 
proved to be MPO-deficient and reported a normal health history.   It would be difficult to 
explain the symptoms of the daughter (MPO-DS) or son (MPO-DB) based on MPO-
deficiency, and instead are likely a reflection of a humoral immune deficiency, as their 
immunoglobulin values were low, they were non-responsive to pneumococcal vaccine, 
and symptoms responded to gamma globulin therapy (Appendix).    Neither the father 
(MPO-DF) nor the children (MPO-DS and MPO-DB) had detectable MPO in their 
neutrophils, but were capable of normal killing of P. gingivalis, at a level and kinetic that 
were not discernibly different from controls, as were the neutrophils from the partially-
deficient grandmother (MPO-PDG) and mother (MPO-PDM) (Table 2.4).     
MPO-deficiency was clearly demonstrated by histochemical intracellular staining 
of neutrophils visualized by electron microscopy, which provides the additional benefit of 
assessing functional MPO (i.e. peroxidase activity) within neutrophils (125).   This 
method also detected functionally normal eosinophils in the MPO-deficient subjects, 
which confirms the findings of Mauch et al (109), that MPO-deficient subjects retain 
functional eosinophil peroxidase.   Additionally, none of these MPO-deficient subjects 
had discernible deficiencies in lactoferrin-containing granules, and the numbers and 
distribution of non-MPO granules appeared normal (Supplemental Figures A.1B-C).    
One possible explanation of the 4-ABH data (reduced kinetics of killing of 
A7436), in light of the MPO-deficient subject data (normal killing of A7436), is that MPO-
deficient subjects may have compensatory killing mechanisms in place in the absence of 
MPO.    For instance, augmented inducible nitric oxide synthase (iNOS) expression and 
increased NO production observed in MPO-null mice during bacterial sepsis is proposed 
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to compensate for the lack of HOCl in host defense, in the absence of MPO (126).   
Another possibility is that H2O2 may build up in the absence of MPO to kill directly or 
through participation in OH. generation (57) (59) (127).   This is consistent with the 
findings of Winterbourn (128) that suggested that OH. generation is more favorable in 
MPO-deficient neutrophils due to the absence of competition with MPO for H2O2.   In 
addition, the neutrophils of MPO-deficient subjects consume more oxygen in the 
respiratory burst (65) (129), and have extended superoxide and hydrogen peroxide 
production, compared to MPO-competent neutrophils (64) (130).   It has been suggested 
that the MPO system may inactivate the respiratory burst, and consequently, the 
absence of MPO may permit a sustained burst (57) (65).   Furthermore, it is also 
possible that increased phagocytosis (131), degranulation (132), and/or enhanced non-
oxidative killing in the absence of MPO (99) (133) may compensate in MPO-deficiency.    
Alternative or upregulated MPO-independent killing mechanisms such as these may 
therefore account for greater (normal) killing of P. gingivalis by MPO-deficient 
neutrophils, compared to neutrophils treated with 4-ABH, and may explain the low 
(normal) morbidity in subjects with MPO-deficiency.    
In contrast to MPO-deficiency, subjects with CGD present early in life with 
severe, life-threatening and recurrent opportunistic infections, as well as uncontrolled 
inflammation associated with granuloma formation.   In addition, the microorganisms that 
are poorly killed by CGD neutrophils ex vivo, as well as by neutrophils in anaerobic 
conditions and in the presence of DPI, are typically the pathogens responsible for the 
characteristic infections in CGD (57) (62) (111) (134) (135) (136).   The significant 
morbidity associated with infections secondary to CGD may appear as a dramatic 
demonstration of the importance of the NADPH oxidase for normal host defense, while 
the lack of correlation between MPO-deficiency and morbidity from infection may imply 
that MPO is not important to host defense (53).   However, another explanation (in 
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addition to potential compensatory mechanisms operating in MPO-deficiency) is that 
CGD affects a wider spectrum of cells (eosinophils, monocytes, and neutrophils) than 
MPO-deficiency (monocytes and neutrophils) (57), and perhaps more importantly, 
affects the oxidative killing pathway higher up (NADPH oxidase), than MPO-deficiency 
where the defect is more distal (53).   For instance, in CGD, both MPO-catalyzed and 
MPO-independent oxidative killing mechanisms are absent (137), which likely explains 
its greater severity.   This translates to the inability of phagocytes to generate O2.-  and 
every downstream ROS dependent on O2.-  generation, including H2O2, HOCl, OH., 
ONOO.-, 1O2 etc, compared to MPO-deficiency, where presumably only HOCl is absent.    
As a result, the isolated pathogens in CGD are organisms believed to be resistant to the 
oxygen-independent killing mechanisms of the neutrophil, and are typically catalase-
positive organisms, capable of destroying their own metabolically-generated H2O2 (45).   
Likewise, the organisms that are killed normally in CGD are believed to be killed either 
because they are catalase-negative, and thus able to supply a source of H2O2 for their 
own demise (bacterial catalase is believed to deprive phagocytes from using bacterial-
generated H2O2 for killing), or because non-oxidative killing mechanisms are effective 
(45) (138) (139).   
In North America, the majority of infections in CGD are due to only five 
microorganisms, which include S. aureus, Burkholderia cepacia, Serratia marcescens, 
Norcardia, and Aspergillus (47), in tissues that serve as natural barriers to the 
environment (skin, lungs, gastrointestinal tract, and the lymph nodes downstream from 
these organs, with liver, spleen, bone, and brain affected as infections spread) (45) (50).   
In contrast, subjects with CGD are neither abnormally predisposed to periodontal 
infections (140) (141) (142) (143) nor to anaerobic bacterial infections in general (141) 
(144).   Curiously, while CGD and DPI-treated neutrophils are incapable of killing both 
the catalase-positive S. aureus (111) and the catalase-negative P. gingivalis (Tables 2.2 
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and 2.3), S. aureus, but not P. gingivalis, is a definitive pathogen in CGD.    Furthermore, 
because subjects with CGD are characteristically susceptible to Staphylococcus 
infections, we ideally wanted to include S. aureus in our neutrophil killing studies along 
with P. gingivalis.   However, in preliminary experiments, it was discovered that sub-
optimal PI concentrations killed S. aureus (as detected by immediate PI uptake and 
logarithmic reductions in CFU/mL by plating) (Supplemental Table A.4), so it was not 
possible to include this pathogen in our phagocytosis and killing studies using DAPI/PI.    
The observation that catalase-positive, but not catalase-negative microorganisms 
are infecting agents in CGD, and that subjects with CGD are capable of normal killing of 
catalase-negative microorganisms (e.g. Streptococcus species), but not catalase-
positive organisms (e.g. Staphylococcus species) (145), led to the hypothesis that CGD 
neutrophils are compensated in part by H2O2, generated by catalase-negative bacteria, 
which serves as a substrate for the MPO system after phagocytosis (138) (146).   This 
concept has been challenged in mouse models of CGD, which have shown catalase-
negative mutants of Aspergillus and S. aureus to be equally virulent to their catalase-
positive counterparts (147) (148), and due to the finding in this model that the H2O2 
produced by catalase-negative organisms was insufficient to cause significant iodination, 
a marker for chlorination (147).   However, these conclusions are confounded by the fact 
that CGD mice displayed aberrant inflammatory responses even to sterile hyphae (149), 
and developed fatal infections with normally avirulent auxotrophs (150).    
It therefore appears that the traditionally held theory remains, but that the level of 
H2O2 production may be more important than catalase production, in terms of 
susceptibility and resistance to killing by CGD neutrophils (59).   The recent work of 
Saito et al (151), which showed that H2O2 -producing strains of Streptococcus pyogenes 
are rapidly killed by CGD neutrophils, whereas H2O2-non-producing strains of S. 
pyogenes, which are killed by normal neutrophils, are resistant to killing by CGD 
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neutrophils; as well as studies with other mutant strains of H2O2-producing, catalase-
negative organisms (139) (152) (153) (154) also support this concept.   Therefore, it is 
not inconceivable that P. gingivalis is not killed by CGD neutrophils because it does not 
generate H2O2.   While P. gingivalis does not make catalase or peroxidase enzymes to 
degrade H2O2 (155) (156), it does make a protoporphyrin layer from hemoglobin (157) 
(158), as well as rubrerythrin (159), Dps (DNA binding protein from starved cells) (160), 
an alkyl hydroperoxide reductase (AhpFC) (161) (162), and OxyR (163) which have all 
been shown to potentially protect P. gingivalis against H2O2.   It is possible that a strict 
anaerobic metabolism may safeguard P. gingivalis, as it is presumed to not be 
metabolically active in the presence of oxygen. 
The question still remains as to why subjects with CGD, whose neutrophils are 
incapable of killing P. gingivalis, rarely present with periodontal or other anaerobic 
infections.   It is possible that the answer lies in the absence of the respiratory burst 
itself.   For instance, the inability to reduce the microenvironment (i.e. rid oxygen) in 
CGD, despite its inability to kill, may prevent this strict anaerobe from growing and thus 
establishing an infection in healthy, aerated periodontal tissues.   It is also well-
supported that ROS from the respiratory burst are the major contributors to the severe 
periodontal tissue destruction associated with aggressive periodontitis (141), so the 
absence of a respiratory burst in CGD may explain the absence of characteristic 
periodontal tissue damage.   This is consistent with the findings of Gronert et al (164), 
which associated locally inflamed sites in subjects with localized aggressive periodontitis 
with excessive superoxide production.    Additionally, this concept is consistent with the 
findings of Mydel et al (165), which found that the host respiratory burst paradoxically 
improved the survival of P. gingivalis in the mouse subcutaneous chamber model by 
enhancing local and systemic inflammation.   Conversely, mice without a respiratory 
burst survived and were resistant to P. gingivalis infection, while mice with an intact 
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NADPH oxidase succumbed to P. gingivalis challenge.    Excessive neutrophil-
generated inflammation in wild type mice may not only have provided reduced oxygen 
conditions, but a source of nutrients for the growth of this anaerobic and assacharolytic 
bacterium, and was shown to be completely responsible for the morbidity and mortality 
associated with P. gingivalis infection.   Another explanation which may partially account 
for the lack of predisposition to periodontitis in subjects with CGD is long-term antibiotic 
use after diagnosis with CGD.   This seems a less likely explanation, however, as 
patients with other neutrophil disorders appear highly predisposed to developing severe 
periodontitis, despite aggressive antibiotic regimens (166). 
In conclusion, we know that P. gingivalis requires phagocytosis and the 
production of a Respiratory Burst in order to be killed by neutrophils, but which NADPH 
oxidase-dependent product(s) most important in neutrophil-mediated killing of P. 
gingivalis remained unclear in these studies.   While MPO does not appear to be a 
required component for neutrophil killing of this pathogen; it does, however, appear to 
play a role by participating in the kinetics of killing P. gingivalis.   In an attempt to 
determine which ROS or oxidative mechanism(s) of the neutrophil are most effective in 
killing P. gingivalis, the susceptibility of P. gingivalis to MPO-dependent and MPO-
independent H2O2-mediated killing, in comparison to selected other organisms, was the 
subject of subsequent studies.     
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MATERIALS AND METHODS 
Bacterial Growth and Storage: 
 Strain CDC A7436 is a clinical isolate of P. gingivalis that was chosen for its 
expression of multiple virulence traits considered representative of this periodontopathic 
species.   P. gingivalis A7436 was originally isolated from a patient with aggressive 
periodontitis, and was characterized by the late V.R. Dowell (167), and by this laboratory 
(20) (33) (34) (35) (82), and others (168) (169) (170).   Its virulence characteristics have 
been studied in a variety of animal models (33) (171) (172) (173).   A7436 is 
encapsulated and exhibits a remarkable resistance to phagocytosis (20) (33) (35) (82).   
In the mouse subcutaneous chamber model, A7436 is capable of spreading and 
dissemination, producing secondary lesions away from the injection site, septicemia, and 
death (33) (34) (170).   Due to the hydrophilic nature of its extra-cellular polysaccharide 
layer (capsule), strain  A7436 does not auto-aggregate, clump, or associate with 
neutrophils (75) (81) (174).  It is a Gram-negative short rod, β-hemolytic, and readily 
forms black-pigmentation on blood-based agars.    
 P. gingivalis was grown at 36oC in a flexible film anaerobic chamber (Coy 
Laboratory Products Inc, Ann Arbor, MI) in an atmosphere of 85% N2 – 10% H2 – 5% 
CO2, in 9mL volumes of Wilkins-Chalgren (WC)  Anaerobe Broth Medium (Oxoid Ltd, 
Basingstroke, Hampshire, England) in glass test tubes, without shaking.  This broth 
medium contains tryptone, gelatin peptone, yeast extract, glucose, sodium chloride, L-
arginine, sodium pyruvate, menadione, and haemin.     For the sake of consistency and 
to minimize mutation, bacteria were freshly grown from minimally passaged, aliquoted 
frozen stocks each week before use in the phagocytosis and killing assays.   Briefly, 
100µL aliquots of P. gingivalis (grown in WC to mid-exponential phase or to ~0.5 optical 
density (Aλ660nm)) were stored in 1mL glass vials containing 0.5mL sterilized skim milk 
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(Sigma, St. Louis, MO), at -80oC until use.   Individual frozen aliquots were thawed at 
room temperature and recovered by inoculation into 9mL volumes of non-reduced WC.   
From this, 3-5 drops (using a sterile plastic transfer pipette) were inoculated into fresh 
9mL volumes of non-reduced WC, and from this, 1mL was inoculated into a second 9mL 
volume of non-reduced WC to make a 10-fold dilution, and placed into the anaerobic 
incubator for growth.   These broth cultures took approximately 60 hr to initially recover 
from frozen stock in WC.   Upon initial visible growth, broth cultures were serially diluted 
(1 drop and 10-fold from that) into fresh 9mL volumes of reduced WC.   Bacteria were 
harvested from overnight cultures (~18 hr) using the dilution that best fit early- to mid-
exponential phase with an Aλ660nm of 0.2-0.6.   The starting inoculum assured that the 
test bacteria used in all experiments had undergone a minimum of five doublings.   
Individual frozen aliquots were also checked for purity by streaking for isolation on both 
aerobic and anaerobic blood agar plates.   An absence of growth on aerobic blood agar 
plates (TSA agar with 5% sheep blood (PML Microbiologicals, Mississauga, ON, 
Canada), incubated aerobically at 36oC) and a morphologically pure culture on 
anaerobic blood agar plates (reducible Brucella blood agar (Anaerobe Systems, Morgan 
Hill, CA), incubated anaerobically at 36oC) assured purity and was confirmed by Gram 
stain (agar and broth cultures) and distinct odor.    
 F. nucleatum strain 1594 and A. actinomycetemcomitans strain CDC A7154 
(leukotoxin producing, serotype b clinical isolate) were grown and stored in an identical 
manner to P. gingivalis.    
 
Bacterial Labeling with DAPI 
One 9mL overnight culture (~18 hr) in early- to mid-exponential phase (Aλ660nm of 
0.2-0.6) was divided into six 1.7mL polypropylene centrifuge tubes (VWR International, 
West Chester, PA), and centrifuged for four min at 10,000xg.  Supernatants were 
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discarded, and bacteria were concentrated into one tube by resuspending pellets serially 
in one 1mL volume (q.s. to 1.5mL) of HBSS (Hanks Balanced Salt Solution, GIBCO, 
Grand Island, NY) without metals (calcium or magnesium) or phenol red, followed by 
DAPI (4’, 6-diamidino-2-phenylindole, Sigma Chemical Co, St. Louis, MO) labeling (45µL 
of 7.5µg/mL) for ten min at room temperature, without motion in the dark.  This was 
followed by three washes (four min at 10,000xg) in 1.5mL of fresh HBSS without metals.   
After the fourth and final spin, the pellet was resuspended in 0.75mL of HBSS with 
calcium and magnesium (with metals), and adjusted with HBSS with metals to a final 
Aλ660nm =0.2 (approximately 108 CFU/mL), using a spectrophotometer (Beckman, 
Fullerton, CA). 
 
Patient Selection  
 CGD Subjects:   Five CGD subjects included in this study were genetically typed 
(Supplemental Table A.2), and are characterized in detail in the Supplemental Methods 
text in the Appendix.    Briefly, subjects were confirmed to have no respiratory burst 
function, as determined by an absence of cytochrome c reduction (inability to produce 
superoxide) and by flow cytometry (inability to produce hydrogen peroxide) 
(Supplemental Table A.3).   
  MPO-Deficient Subjects:   Five MPO-deficient subjects included in this study 
were members of one family identified with MPO-deficiency by histochemical staining of 
granule content (Supplemental Figure A.1), and are characterized in detail in the 
Supplemental Methods text.   
 
Neutrophil Separation 
Standard venipuncture was used to collect approximately 20-30mL of peripheral 
blood in Vacutainer® collection tubes containing heparin (86 USP units) (BD, Franklin 
Lakes, NJ), from consenting healthy donors and from patients with CGD or from MPO-
86 
 
deficiency (or from minors with parental consent).   A discontinuous one-step Histopaque 
(Histopaque, density 1.077, Sigma-Aldrich, St. Louis, MO) and Mono-poly (Mono-poly 
resolving medium, density 1.114, ICN Biomedicals Inc, Aurora, OH) gradient system 
described previously (175) was used for the isolation of peripheral blood neutrophils 
from whole blood.   Briefly, Mono-poly (on bottom), Histopaque, and blood (on top) were 
carefully layered with a 3:1:5 ratio (respectively) in a sterile, 50mL polypropylene conical 
centrifuge tube.   A single centrifugation at 500xg for 40 min at room temperature 
resulted in the separation of whole blood leukocytes into two distinct leukocyte bands 
(mononuclear layer and neutrophil  layer) above an erythrocyte sediment.   The 
neutrophil layer was carefully collected with a sterile plastic Pasteur pipette, and washed 
twice with 45mL of HBSS without metals in a sterile, 50mL polypropylene tube, using 
centrifugation at 400xg for 10 min at room temperature.   After the second wash, 
neutrophils were collected by gently resuspending the pellet in 1mL of HBSS without 
metals, followed by counting neutrophils with a hemacytometer.   Viability (>99%) was 
assessed by PI exclusion, and purity (>98%) was checked by differential microscopy of 
Wright-stained cytospin slides.   Neutrophils were adjusted to 2x107 cells/mL with HBSS 
without metals. 
 
Generation of Rabbit Antiserum 
 High-titered antisera to P. gingivalis strain A7436 were produced in New 
Zealand White female rabbits based on a procedure described by Cutler (82).   Aliquots 
were stored at –80oC until use, and were thawed on ice at time of assay, and used only 
once.  
 
Human Complement 
 
 Normal human serum from a single healthy adult male donor (AB positive) was 
used as a complement source.    This serum had no detectable antibodies to P. 
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gingivalis A7436, as determined by ELISA and by Western blots of outer membrane 
proteins or of purified lipopolysaccharide.   This serum was not opsonic for A7436 with 
normal human neutrophils at any concentration tested including undiluted, nor was this 
serum bactericidal for A7436, F. nucleatum strain 1594, or A. actinomycetemcomitans 
strain A7154.   Unlike with P. gingivalis and A. actinomycetemcomitans, the opsonic 
conditions for F. nucleatum do not require the addition of an antibody source (just active 
complement).    Aliquots were stored at –80oC until use, and were thawed on ice at time 
of assay, and used only once.  
 
Localized Juvenile Periodontitis (LJP) Serum 
 Previous studies in this laboratory have characterized the phagocytosis and 
killing requirements for A. actinomycetemcomitans (176).   In addition to active 
complement, LJP serum (serotype b reactive) is required as an antibody source to not 
only neutralize A. actinomycetemcomitans leukotoxin but to optimize phagocytosis.    
Sera obtained from LJP subjects were pooled and frozen in aliquots at -80oC until use.   
Aliquots were thawed on ice at time of assay, and used only once.    
 
Phagocytosis and Killing Assay 
The dual-color fluorescence phagocytosis and killing assay using DAPI/PI first 
described by Kalmar et al (176) and modified by Cutler et al (20) (82) was used to 
assess neutrophil phagocytosis and killing of P. gingivalis, as well as F. nucleatum and 
A. actinomycetemcomitans in select experiments.   DAPI is a vital stain, which binds to 
A/T-rich regions of double-stranded DNA, and forms a highly fluorescent complex (blue 
color) when bacteria are alive (177).  PI is a red fluorescing viability dye, which is 
excluded by the cytoplasmic membranes of live bacteria and enters the bacteria upon 
loss of membrane potential, associated with death (178).   Using the combination of 
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DAPI and PI allows monitoring of phagocytosis and killing of bacteria, discrimination of 
intra- and extra-cellular bacterial killing, and determination of phagocyte death.   Two 
independent observers, each calibrated in the assay, viewed coded slides without the 
bias of knowing the nature of the samples.   At least 100 neutrophils were counted by 
each observer and averaged to obtain values for % phagocytosis and killing.   The final 
estimated ratio of bacteria to neutrophils was ~20:1. 
Phagocytosis was expressed as the percentage of total neutrophils involved in 
phagocytosis, defined as having three or more bacteria (alive or dead) clearly contained 
within the neutrophil, confirmed using differential interference contrast optics.    Killing 
was expressed as the percentage of phagocytic neutrophils involved in killing, defined as 
containing three or more red or dead bacteria.   (For examples of data collection, see 
Supplemental Figure A.3).     
For aerobic assays, all reagents were equilibrated to room temperature in 
ambient atmosphere for at least one hr, and phagocytosis and killing assays were 
performed in a 37oC Fisher Isotemp dry bath (Fisher Scientific Company, Fairlawn, NJ), 
without rocking.   For anaerobic assays, all reagents were equilibrated to ambient 
temperature in the anaerobic chamber (atmosphere of 5% CO2/10% H2/85% N2) for at 
least one hr, and phagocytosis and killing assays were performed in a 37oC incubator 
inside the anaerobic chamber, without rocking.   Efforts were made to fully reduce the 
reagents used for anaerobic experiments, including neutrophil preparations, because 
any amount of oxygen introduced into the chamber (e.g. through ice or by acclimation for 
less than one hr) proved sufficient to allow neutrophil killing of P. gingivalis.   It also was 
necessary to refresh the catalyst prior to each experiment.  Anaerobiosis of the chamber 
was assured with methylene blue indicators.   
In summary, DAPI-labeled P. gingivalis (100µL at Aλ660nm =0.2) were opsonized 
(and gently mixed) with human complement (12.5µL) and hyperimmune rabbit antiserum 
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(12.5µL), in a 1.7mL polypropylene centrifuge tube (VWR International) for 10 min at 
37oC, with rocking.   DAPI-labeled A. actinomycetemcomitans and F. nucleatum were 
opsonized with the same source of human complement (12.5µL) as P. gingivalis, but 
with either 12.5µL of LJP serum for A. actinomycetemcomitans, or with 12.5µL of heat-
inactivated (at 56oC for 30 min just prior to use) human complement for F. nucleatum.   
After opsonization, PI (10µL of 7.5µg/mL) and purified neutrophils (125µL at 2x107 
cells/mL) were added and gently resuspended, immediately initiating the start of the 
experiment (time 0).   In selected experiments, the classic NADPH oxidase inhibitor, DPI 
(Sigma; 20µM FC, in less than 0.3mM FC DMSO); the classic MPO inhibitor, sodium 
azide (Sigma; 20µM FC); or the more specific MPO inhibitor, 4-ABH (Sigma; 4mM FC), 
was added to neutrophil suspensions (pre-incubated together for one min prior to the 
addition of PI and opsonized bacteria), in order to examine DPI-, azide-, and 4-ABH- 
inhibitable killing of test bacteria.    At the prescribed intervals, 30µL aliquots were 
removed (after gently resuspending) and cytospun (Shandon Inc., Sewickley, PA) for 3 
min at 850rpm onto pre-cleaned microscope slides (VWR International).   Once dried (≤1 
min after spin finished), glass cover slips (VWR) were mounted with cyanoacrylate 
(Krazy Glue™), and slides were examined by epi-illumination UV microscopy with oil 
immersion (63x) on a Zeiss Axioskop to access phagocytosis and killing by neutrophils.   
Approximate fluorescence excitation/ emission maxima for DAPI and PI, when bound to 
DNA, were 358/461 and 535/617, respectively.  
 
Statistical Analysis 
 As appropriate, the data are expressed as means and standard deviations.   
Differences in means between normally distributed data sets were tested for significance 
using the paired Student’s t test with confidence set at p<0.05. 
 
90 
 
Acknowledgements 
 This work was supported in part by Public Health Service awards R01-DE08671 
and K16-DE00165 from the National Institutes of Health.   We are grateful to Sara 
Sparks, UNC Hospital, for her excellent technical assistance in flow cytometry.   
 
 
 
 
 
 
 
 
 
 
 
  
91 
 
Table 2.1.  Influence of Anaerobiosis on Neutrophil Killing of Opsonized  
P. gingivalis  
Aerobic Atmosphere Anaerobic Atmosphere 
Time % Phagocytosis % Killing % Phagocytosis % Killing 
0 hr 71 (5) 1 (1) 72 (6) 1 (1) 
1 hr 97 (5) 76 (14) 96 (4) *1 (1) 
2 hr 98 (3) 92 (5) 98 (3) *1 (2) 
 
Results are expressed as the % of total neutrophils involved in phagocytosis (three or 
more alive or dead bacteria per neutrophil), and the % of phagocytic neutrophils involved 
in killing (three or more dead bacteria per neutrophil).   Experiments were performed at 
37oC under aerobic vs. anaerobic atmosphere, using normally competent neutrophils 
from healthy donors.    Phagocytosis and killing (%) values are the means from three or 
more independent experiments, and values in parentheses are the standard deviations 
of those means.    Asterisks indicate that the difference, compared to aerobic controls, is 
statistically significant (p<0.05). 
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Table 2.2.  CGD vs. Normal Neutrophil Killing of Opsonized P. gingivalis at 1 hr  
Subject % Phagocytosis % Killing 
CGD 1 97 3 
CGD 2 98 2 
CGD 3 75 7 
CGD 4 90 2 
CGD 5 95 0 
Controls 96 (2) 73 (12) 
 
Experiments were performed under aerobic atmosphere.   Control values are the means 
from normally competent neutrophils from five different healthy donors, and values in 
parentheses are the standard deviations of those means.   Values for CGD Subjects 1-5 
represent data obtained from a single sample.    
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Table 2.3.  Influence of DPI on Neutrophil Killing of Opsonized P. gingivalis  
Control  DMSO Control DPI-Treated  
Time 
% 
Phagocytosis 
%  
Killing 
% 
Phagocytosis 
%  
Killing 
% 
Phagocytosis 
% 
Killing 
0 hr 71 (5) 1 (1) 70 (6) 1 (1) 68 (1) 1 (1) 
1 hr 97 (5) 76 (14) 97 (5) 80 (6) 97 (5) *1 (1) 
2 hr 98 (3) 92 (5) 99 (4) 87 (9) 99 (2) *1 (2) 
3 hr 100 (1) 98 (3) 100 (1) 97 (3) 99 (1) *1 (1) 
 
Experiments were performed under aerobic atmosphere using normally competent 
neutrophils.   Neutrophils were either untreated (control) or treated with DPI (20µM FC in 
less than 0.3mM final FC DMSO).    Phagocytosis and killing (%) values are the means 
from three or more independent experiments, and values in parentheses are the 
standard deviations of those means.    Asterisks indicate that the difference, compared 
to untreated controls, is statistically significant (p<0.05). 
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Table 2.4.  Normal vs. MPO-Deficient Neutrophil Killing of Opsonized P. gingivalis  
 
 40 min 60 min 
Subject 
% 
Phagocytosis 
%  
Killing 
% 
Phagocytosis 
%  
Killing 
Controls 95 (2) 59 (18) 97 (5) 76 (14) 
MPO-DS 93 61 99 85 
MPO-DB 96 67 98 78 
MPO-DF 93 44 97 63 
MPO-PDM 96 41 99 66 
MPO-PDG 95 68 93 88 
 
Experiments were performed under aerobic atmosphere.   Control values are the means 
from normally competent neutrophils from five different healthy donors, and values in 
parentheses are the standard deviations of those means.   MPO-sufficient controls 
showed normal distributions of peroxidase-positive granules in 100% of neutrophils.    
MPO-DS and MPO-DB were siblings whose neutrophils were devoid of MPO-positive 
granules, as were those of the father, MPO-DF.    MPO-PDM was the mother of MPO-
DS and MPO-DB, and showed normal distributions of peroxidase-positive granules in 
90% of neutrophils, with 10% having no demonstrable peroxidase-positive granules.    
MPO-PDG was the maternal grandmother with 50% of neutrophils devoid of MPO-
positive granules.   Values for MPO-deficient subjects represent data obtained from a 
single sample. 
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Table 2.5.  Influence of Sodium Azide (NaN3) on Normal vs. MPO-Deficient Neutrophil 
Killing of Opsonized P. gingivalis  
 40 min  
 
% Killing 
60 min  
 
% Killing 
Subject - NaN3 + NaN3 - NaN3 + NaN3 
 
Controls 
 
59 (18) 
 
*5 (5) 
 
76 (14) 
 
*7 (8) 
 
MPO-DB 
 
67 
 
7 
 
78 
 
11 
 
 
MPO-DF 
 
44 
 
3 
 
63 
 
9 
 
MPO-PDG 
 
 
68 
 
3 
 
88 
 
8 
 
MPO-PDM 
 
 
41 
 
0 
 
66 
 
6 
 
Experiments were performed under aerobic atmosphere.   Neutrophils were either 
untreated (- NaN3) or treated with 20µM FC NaN3 (+ NaN3).    Control values are the 
means from normally competent neutrophils from four different healthy donors, and 
values in parentheses are the standard deviations of those means.    Asterisks indicate 
that the difference, compared to untreated controls, is statistically significant (p<0.05).    
Values for MPO-deficient subjects represent data obtained from a single sample.    
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Table 2.6.  Influence of 4-ABH on Neutrophil Killing of Opsonized P. gingivalis  
 
Control 4-ABH Treated 
Time % Phagocytosis % Killing % Phagocytosis % Killing 
0 min 71 (5) 1 (3) 72 (5) 1 (1) 
30 min 87 (5) 75 (5) 85 (6) *43 (4) 
1 hr 97 (5) 87 (6) 97 (4) *61 (5) 
2 hr 98 (3) 94 (5) 98 (3) *76 (4) 
3 hr 100 (2) 98 (2) 99 (2) *80 (5) 
 
Experiments were performed under aerobic conditions using normally competent 
neutrophils.   Neutrophils were either untreated (control) or treated with 4-ABH (4mM 
FC).   Phagocytosis and killing (%) values are the means from three or more 
independent experiments, and values in parentheses are the standard deviations of 
those means.   Asterisks indicate a significant difference from untreated controls 
(p<0.05). 
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Table 2.7.  Influence of Anaerobiosis on Neutrophil Killing of Opsonized  
P. gingivalis, F. nucleatum, and A. actinomycetemcomitans  
 
 
P. gingivalis 
 
F. nucleatum 
 
A. actinomycetem-
comitans 
 
 
Time Atm. 
% 
Phagocytosis 
% 
Killing 
% 
Phagocytosis 
% 
Killing 
% 
Phagocytosis 
%  
Killing 
 
0 
min Aerobic  71 (4) 1 (1) 70 (6) 1 (1) 80 (8) 2 (1) 
 
Anaerobic  72 (6) 1 (1) 72 (8) 1 (1) 81 (9) 1 (1) 
 
  
90 
min Aerobic  94 (5) 81 (9) 80 (6) 82 (8) 98 (1) 90 (5) 
 
Anaerobic  95 (4) *1 (1) 81 (7) *10 (1) 99 (1) *70 (5) 
 
Experiments were performed under aerobic vs. anaerobic atmosphere, using normally 
competent neutrophils.   Phagocytosis and killing (%) values are the means from three 
or more independent experiments, and values in parentheses are the standard 
deviations of those means.    All bacteria were tested at the same time using aliquots of 
the same neutrophil populations.    Asterisks indicate a significant difference compared 
to aerobic atmosphere.    The % killing values of F. nucleatum and A. 
actinomycetemcomitans at 90 min under anaerobiosis were significantly different from 
that of P. gingivalis and from each other (p<0.05).  
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Table 2.8.   Influence of DPI on Neutrophil Killing of Opsonized P. gingivalis,               
F. nucleatum, and A. actinomycetemcomitans  
Control P. gingivalis  F. nucleatum 
A. actinomycetem-
comitans 
Time 
(min) 
% 
Phagocytosis 
% 
Killing 
% 
Phagocytosis 
%  
Killing 
%  
Phagocytosis 
%  
Killing 
0  72 (4) 1 (1) 67 (9) 1 (1) 85 (4) 2 (1) 
30  92 (6) 77 (9) 74 (8) 78 (9) 96 (3) 92 (4) 
60  97 (3) 85 (5) 78 (8) 85 (5) 99 (1) 96 (6) 
120  99 (1) 91 (4) 82 (8) 91 (9) 100 (1) 99 (1) 
180  100 (1) 92 (4) 83 (6) 92 (9) 100 (1) 100 (1) 
 
DPI-
Treated P. gingivalis  F. nucleatum 
A. actinomycetem-
comitans 
Time 
(min) 
% 
Phagocytosis 
% 
Killing 
% 
Phagocytosis 
%  
Killing 
%  
Phagocytosis 
%  
Killing 
0 70 (5) 1 (1) 65 (5) 1 (1) 85 (4) 2 (1) 
60  95 (3) *1 (1) 76 (7) *13 (4) 98 (2) *81 (5) 
120 98 (1) *1 (1) 81 (5) *16 (3) 100 (1) *90 (4) 
180  99 (1) *1 (1) 82 (6) *19 (3) 100 (1) *91 (3) 
 
Experiments were performed under aerobic atmosphere using normally competent 
neutrophils.   Neutrophils were either untreated (control) or treated with 20µM FC DPI.   
Phagocytosis and killing (%) values are the means from three or more independent 
experiments, and values in parentheses are the standard deviations of those means.   
All bacteria were tested at the same time using aliquots of the same neutrophil 
populations.    Asterisks indicate a significant difference from the results obtained from 
untreated controls at the same time point.   The % killing values of F. nucleatum and A. 
actinomycetemcomitans with DPI-treated neutrophils were significantly different from 
that of P. gingivalis and from each other at the same time points (p<0.05). 
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Figure 2.1.  Influence of 4-ABH on Neutrophil Killing of Opsonized P. gingivalis,                          
F. nucleatum, and A. actinomycetemcomitans 
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ABSTRACT 
 Porphyromonas gingivalis is an overt periodontal pathogen associated with the 
etiology of chronic and aggressive forms of adult periodontitis.   It was previously shown 
that human neutrophils require a functional NADPH oxidase to kill P. gingivalis.   This 
report examines the relative susceptibilities of P. gingivalis to the principal reactive 
oxygen species associated with NADPH oxidase-dependent, neutrophil-mediated killing.    
P. gingivalis was killed by both the xanthine- xanthine oxidase and glucose- glucose 
oxidase systems.    Killing by the xanthine- xanthine oxidase system was blocked by 
catalase, but not by superoxide dismutase.    When delivered as a bolus, H2O2 killed P. 
gingivalis in a time- and dose- dependent fashion.   Compared to other strictly anaerobic 
periodontal pathogens, all strains of P. gingivalis independent of capsule or virulence 
type were consistently more susceptible to low concentrations of H2O2.   In contrast, 
aerotolerant pathogens independent of catalase production were highly resistant to 
H2O2.   The addition of myeloperoxidase protected P. gingivalis and Fusobacterium 
nucleatum against bactericidal concentrations of H2O2, but enhanced killing of all test 
bacteria including P. gingivalis and F. nucleatum at concentrations between 1 and 10µM 
H2O2, with an optimum at 5µM.   The MPO enzymatic inhibitor 4-aminobenzoic acid 
hydrazide completely abolished this activity.   There was no killing by the 
myeloperoxidase system when H2O2 concentrations exceeded 10µM.   These data 
suggest that P. gingivalis and possibly other H2O2-sensitive bacteria may be killed in the 
phagosome by H2O2 alone, and that phagosomal concentrations of H2O2 must be tightly 
regulated for MPO to function as a bactericidal constituent.  
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INTRODUCTION 
Porphyromonas gingivalis is an overt periodontal pathogen associated with the 
etiology of chronic and aggressive forms of adult periodontitis (1) (2) (3) (4) (5).   P. 
gingivalis is characterized as a strictly anaerobic, Gram-negative short rod, which is β-
hemolytic and readily forms black-pigmentation on blood-based agars.   Several studies 
have shown that different isolates of P. gingivalis express discrete virulence traits in 
animal models that may reflect distinct clinical presentations (6) (7) (8) (9) (10) (11) (12).    
One virulence type in animal infection models is represented by strains including A7436, 
W83, and W50, which are encapsulated, highly resistant to phagocytosis, hydrophilic 
and non-clumping, and demonstrate spreading and dissemination from sequestered 
infection sites.    Another virulence type is represented by strains including 381, ATCC 
33277, and HG405, which, in contrast, are non-encapsulated, more readily 
phagocytosed, hydrophobic and auto-aggregating, and demonstrate local persistent 
inflammation that can progress to abscess formation, but does not disseminate or 
spread from sequestered infection sites. 
Previous studies have suggested that several strains of P. gingivalis including 
A7436 exhibit remarkable resistance to neutrophil phagocytosis due in part to the 
production of a capsule, but also due to the proteolytic degradation of serum opsonins 
and their receptors (13) (14) (15) (16) (17) (18) (19) (20) (21) (22).   However, 
phagocytosis-resistant strains of P. gingivalis including A7436 are readily phagocytized 
in the presence of serum containing complement and high titered specific antibody (23) 
(24).   Additionally, P. gingivalis is not killed in the absence of phagocytosis, though P. 
gingivalis is readily killed by normal neutrophils once phagocytized (23) (24).     
It was previously reported in this laboratory that in addition to phagocytosis, 
neutrophil killing of P. gingivalis A7436 absolutely requires a functional NADPH oxidase, 
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which is dependent on the availability of oxygen, as there was no killing of P. gingivalis 
by neutrophils from subjects with chronic granulomatous disease (CGD); by normally 
competent neutrophils treated with the NADPH oxidase inhibitor, diphenyleneiodonium 
(DPI); or by normally competent neutrophils under anaerobic atmosphere (24).   In all 
three cases, the NADPH oxidase was inhibited, superoxide was not generated, and 
there was no killing of P. gingivalis, despite normal phagocytosis, even after several 
hours.   In contrast, competent neutrophils treated with either anaerobiosis or DPI were 
capable of near normal killing of Aggregatibacter actinomycetemcomitans; and 
significant, though substantially reduced, killing of Fusobacterium nucleatum.    
Compared to these periodontal pathogens, P. gingivalis was remarkably resistant to the 
non-oxidative killing mechanisms of the neutrophil, which by definition, should still be 
operational under anaerobiosis, in the presence of DPI, and in CGD; and was instead 
completely dependent on an NADPH oxidase- dependent mechanism for killing. 
Not surprisingly, the pathogens responsible for the characteristic infections in 
CGD are killed poorly by CGD neutrophils ex vivo, as well as by neutrophils under 
anaerobic conditions and in the presence of DPI (25) (26) (27) (28) (29) (30) (31).   
Additionally, the common pathogens in CGD are catalase-positive organisms resistant to 
the non-oxidative killing mechanisms of the neutrophil (32).   Conversely, the organisms 
that are killed normally in CGD are believed to be killed either because non-oxidative 
killing mechanisms are effective; or because they are catalase-negative, and 
consequently contribute the missing H2O2 to the phagosome environment through their 
own metabolism (32) (33) (34).    Predictably, the neutrophils of subjects with CGD show 
intact bactericidal activity against catalase-negative organisms such as streptococcal 
species (31), but not against certain catalase-positive organisms such as 
Staphylococcus aureus (27) (31).   Therefore, subjects with CGD show an increased 
susceptibility to S. aureus, but not to streptococcal infections.    However, while DPI-
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treated, anaerobic, and CGD neutrophils are incapable of killing both the catalase-
positive S. aureus (27) (29) and the catalase-negative P. gingivalis (24); S. aureus, but 
not P. gingivalis, is a recognized pathogen in CGD.    In fact, subjects with CGD are 
neither abnormally predisposed to periodontal infections (35) (36) (37) (38), nor to 
anaerobic bacterial infections in general (36) (39).   In contrast, subjects with 
neutropenia have an increased susceptibility to both S. aureus and to certain 
streptococcal species such as Streptococcus pyogenes (40), as well as to a variety of 
species associated with periodontitis (35) (41) (42) (43), including F. nucleatum, 
Prevotella intermedia, and P. gingivalis.    Periodontitis is a mixed flora infectious and 
inflammatory disease, the pathology of which is associated with a relatively small group 
of specific periodontal pathogens. 
While P. gingivalis does not make catalase or peroxidase enzymes to degrade 
H2O2 (44) (45), it does make a protoporphyrin layer from hemoglobin, which accounts for 
its ability to form black-pigmentation on blood-based agars (46) (47), as well as 
rubrerythrin (48), Dps (DNA binding protein from starved cells) (49), an alkyl 
hydroperoxide reductase (AhpFC) (50) (51), and OxyR (52), which have all been shown 
to potentially protect P. gingivalis against H2O2.    P. gingivalis also makes superoxide 
dismutases (MnSOD and FeSOD) (44) (53) (54) (55), which potentially protect P. 
gingivalis against O2.-.    
In addition to capsule, which contributes to its resistance to both neutrophil 
phagocytosis and to serum-mediated killing (22) (56) (57); P. gingivalis produces a 
variety of proteases (e.g. gingipains), which have been shown to digest and inactivate a 
multitude of antimicrobial peptides, proteins, and enzymes found in neutrophil granules, 
when combined with culture supernatants or whole cells of P. gingivalis (18) (58) (59) 
(60) (61) (62) (63) (64) (65) (66).   While many of these non-oxidative killing mechanisms 
of the neutrophil are highly cationic and rich in arginine and lysine residues, and would 
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therefore seem susceptible to digestion by the arginine and lysine gingipains of P. 
gingivalis, its mechanism of resistance to the non-oxidative killing mechanisms of the 
neutrophils remains unknown.  Interestingly, Bachrach et al (67) suggested that the 
resistance of P. gingivalis strain ATCC 33277 (a non-encapsulated, non-disseminating 
strain) to direct killing by select antimicrobial peptides, including the neutrophil peptide 
LL-37, can be attributed more to the low affinity of these antimicrobial peptides, rather 
than to the proteolytic activities of P. gingivalis.     
The principal oxygen-dependent killing pathway of the neutrophil is mediated by 
the multi-component NADPH oxidase system, which consumes large amounts of oxygen 
from which it directly generates superoxide anion:  NADPH + 2O2 → NADP+ + 2O2.- + H+ 
(32) (68) (69) (70) (71).   Dependent on the fusion of specific (or secondary) granules 
with the phagosome, the components of the NADPH oxidase are delivered both to the 
phagosome membrane and to the cytosol.   These include two membrane-associated 
components, gp91phox and p22phox, which together comprise the cytochrome b558; as well 
as three cytosolic components, p47phox, p67phox, and p40phox.    In order to activate the 
NADPH oxidase, all five NADPH oxidase subunits (gp91phox, p22phox, p47phox, p67phox, 
and p40phox) with the cytosolic GTPase Rac2 (72) (73) must come together and 
assemble on the interior surface of the phagosome membrane to form the NADPH 
oxidase complex.    Superoxide subsequently dismutates to hydrogen peroxide:  O2.- + 
2H+ → H2O2, and from these intermediates, other more reactive oxidants are generated, 
either by reacting with enzyme systems such as myeloperoxidase (MPO) or with 
bacterial iron, or by the products of these systems reacting with O2.- and/or H2O2, or with 
each other (25) (73) (74) (75) (76) (77) (78) (79) (80) (81).    It is important to note that 
the oxidative killing mechanisms of the neutrophil do not operate alone, as there are 
multiple antimicrobial protein constituents and enzymes which also get delivered upon 
gelatinase, specific, and then azurophilic granule fusion with the phagosome. 
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While both superoxide (O2.-) and hydrogen peroxide (H2O2) are generally 
regarded as relatively nontoxic and inert (or only mildly oxidative) (82) (83) (84) (85), 
their roles in killing microbial pathogens are of particular interest due to the abundant 
production of enzymes dedicated to the neutralization of these two species, including 
superoxide dismutases (SOD), catalases, and peroxidases (O2.- and H2O2 scavenging 
enzymes) in bacteria.    Furthermore, the neutrophil responds to phagocytic targets by 
consuming oxygen in the respiratory burst, which is first converted to O2.- then to H2O2, 
in close proximity to ingested bacteria.    The importance of these species to phagocyte-
mediated clearance of potential pathogens is most evident in the severe clinical 
consequences of their absence in CGD (74) (75) (76) (86) (87) (88).   Additionally, 
considerable evidence suggests that O2.- and/or H2O2 play direct or indirect roles in 
killing ingested microorganisms by participating as substrates in almost every known 
killing system in the neutrophil (74) (75) (79) (89).   In addition, impaired bactericidal 
activity in CGD or DPI-treated neutrophils, which are incapable of producing their own 
O2.- and H2O2, is restored by the addition of a H2O2-generating system (90) (91)  (92) (93) 
(94) (95).   It was therefore valuable to assess the potential contributions of both 
superoxide and hydrogen peroxide in the killing of P. gingivalis in this study. 
The principal enzyme constituent of the neutrophil antimicrobial armament is 
heme-based MPO, which utilizes H2O2 to generate the strong oxidant, weak acid, 
hypochlorite (H+ -OCl or HOCl), also known as bleach:  MPO + Cl- + H2O2 → H+ -OCl 
(96) (97).    Localized in the azurophilic (primary) granules, MPO is the most abundant 
enzyme in neutrophils (98) (99), and is delivered to the phagosome in high concentration 
and in close proximity to microbial targets, following the initiation of the respiratory burst 
by specific granule fusion with the phagosome (73) (79) (100).    MPO-generated -OCl 
displays potent microbicidal activities against a broad range of microorganisms, by 
chlorinating or otherwise modifying a wide range of microbial targets, including enzymes, 
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proteins, lipids, cell walls, membranes, RNA, and DNA, etc (73) (79) (96) (97) (98) (99) 
(101) (100) (102) (103).   Since much of the oxygen consumed by an activated 
neutrophil is converted to H2O2 from O2.- (104) (105), and since most of the H2O2 
generated in the neutrophil is reported to be converted to the bactericidal -OCl by MPO 
(25) (73) (79) (106) (107), MPO is proposed to play a central role in oxygen-dependent 
killing in the phagosome.    However, the true contribution of MPO in bactericidal 
function within the neutrophil has been questioned as MPO-deficient subjects are 
remarkably healthy and do not experience an increased frequency of infection (108) 
(109).   Yet, in ex vivo conditions, neutrophils from subjects with MPO-deficiency 
demonstrate an impaired ability to kill certain targets, such as S. aureus (27) (110) (111) 
(112) (113).   This led to the question as to whether MPO-deficient neutrophils were 
capable of killing P. gingivalis.    
While sodium azide totally blocked the killing of phagocytized P. gingivalis by 
MPO-competent neutrophils, neutrophils from subjects with MPO-deficiency were not 
compromised in their ability to kill P. gingivalis (24).   Furthermore, in contrast to the total 
inhibition of killing found with azide, competent neutrophils were capable of highly 
efficient phagocytic killing of P. gingivalis in the presence of the more specific inhibitor, 
4-aminobenzoic acid hydrazide (4-ABH) (24).    Neither azide nor 4-ABH affects the 
respiratory burst of stimulated neutrophils (114) (115).   These data therefore suggest 
that the killing of phagocytized P. gingivalis is dependent on the reduced oxygen species 
of a functioning NADPH oxidase system.    Further, this killing occurs independent of 
MPO, but by an azide-sensitive mechanism. 
As suggested from preceding studies, P. gingivalis A7436 is completely resistant 
to the non-oxidative killing mechanisms of the neutrophil, and is instead completely 
dependent on a functional NADPH oxidase for killing (24).   However, which reactive 
oxygen species (ROS) or NADPH oxidase-dependent product(s) central to neutrophil-
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mediated killing of P. gingivalis remained unclear.   The objective of the current study 
was therefore to examine the susceptibility of P. gingivalis to the principal NADPH 
oxidase-dependent products (ROS) of the neutrophil, in an attempt to determine which 
oxidative mechanism(s) or ROS are most important to killing P. gingivalis.   To begin to 
address this, the killing potentials of the two initial products of the NADPH oxidase, 
superoxide and hydrogen peroxide, were examined in a cell-free system of killing and in 
the absence of other neutrophil products such as MPO.   The xanthine (X) – xanthine 
oxidase (XO) system was chosen for the enzymatic generation of both exogenous 
superoxide and hydrogen peroxide.    The individual contributions of these ROS were 
distinguished by the inclusion of superoxide dismutase (SOD) and/or catalase, and by 
the glucose (G) – glucose oxidase (GO) system for the generation of hydrogen peroxide 
free of superoxide.    As MPO is a principal constituent of the phagosome environment, 
the in vitro influences of MPO activity on the interactions of H2O2 with P. gingivalis were 
also examined.   
The distinct effects of anaerobiosis and DPI-treatment on neutrophil-mediated 
killing of P. gingivalis and F. nucleatum vs. that of A. actinomycetemcomitans, as well as 
the subtle differences in the ability of neutrophils to kill these three bacteria with 4-ABH-
treatment (24), suggested there may be insights to be gained by comparing their relative 
susceptibilities to the NADPH oxidase-dependent ROS.    Likewise, an expansion to 
other logical pathogens for comparison with P. gingivalis was included, in order to create 
a hierarchical ranking of bacterial susceptibilities to the principal NADPH oxidase-
dependent ROS.     
S. aureus is a catalase-positive, aerotolerant, Gram-positive bacterium, and is 
the prototypic pathogen in CGD and an important pathogen in neutropenia.    
Conversely, S. pyogenes is also an aerotolerant, Gram-positive bacterium, but is 
catalase-negative, and is an important pathogen in neutropenia but is not considered a 
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pathogen in CGD.   These observations suggest that, like P. gingivalis, the neutrophil is 
important to host defense against both of these pathogens, but that the mechanisms 
employed by the neutrophil to kill each are distinct.     
The catalase-negative, anaerobic, Gram-negative, and non-pigmenting F. 
nucleatum was included in the previous studies (24), and was found to be readily 
phagocytized and killed by neutrophils.   Both DPI and anaerobiosis dramatically 
reduced, but did not eliminate, the killing of this species (24).    P. intermedia, like F. 
nucleatum, is considered an important member of the mixed anaerobic population that 
constitutes a periodontopathic flora of the subgingival biofilm (116) (117) (118).   P. 
intermedia is closely related to P. gingivalis evolutionarily and, like P. gingivalis, makes a 
black-pigmenting, protoporphyrin layer on blood-based media (119), and is a catalase-
negative, Gram-negative, strict anaerobe. 
A. actinomycetemcomitans is also a Gram-negative periodontal pathogen but, 
unlike the others, is catalase-positive and capable of growth in the presence of oxygen 
(120) (121).    It is an etiologic agent in certain forms of aggressive periodontitis, where it 
can be isolated in high numbers in relatively pure form from active disease sites (122).    
It makes a carbohydrate capsule and produces a leukotoxin that is potent against human 
neutrophils (123) (124) (125) (126) (127) (128) (129).   Susceptibility to A. 
actinomycetemcomitans has been associated with discrete neutrophil dysfunctions (126) 
(130) (131).    In contrast to P. gingivalis, A. actinomycetemcomitans is readily killed by 
normally competent neutrophils treated with DPI and by normally competent neutrophils 
under anaerobic atmosphere (24). 
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MATERIALS AND METHODS 
Bacterial Growth and Storage: 
 Strain CDC A7436 is a clinical isolate of P. gingivalis that was chosen for its 
expression of multiple virulence traits considered representative of this periodontopathic 
species.   P. gingivalis A7436 was originally isolated from a patient with aggressive 
periodontitis, and was characterized by the late V.R. Dowell (132), and by this laboratory 
(8) (23) (133) (134) (135), and others (9) (136) (137).  Its virulence characteristics have 
been studied in a variety of animal models (133) (138) (139) (140).   A7436 is 
encapsulated and exhibits a remarkable resistance to phagocytosis (23) (133) (134) 
(135).   In the mouse subcutaneous chamber model, A7436 is capable of spreading and 
dissemination, producing secondary lesions away from the injection site, septicemia, and 
death (8) (9) (133).   Due to the hydrophilic nature of its extra-cellular polysaccharide 
layer (capsule), strain  A7436 does not auto-aggregate, clump, or associate with 
neutrophils (11) (13) (141).  It is a Gram-negative short rod, β-hemolytic, and readily 
forms black-pigmentation on blood-based agars.    
 P. gingivalis was grown at 36oC in a flexible film anaerobic chamber (Coy 
Laboratory Products Inc, Ann Arbor, MI) in an atmosphere of 85% N2 – 10% H2 – 5% 
CO2, in 9mL volumes of Wilkins-Chalgren (WC)  Anaerobe Broth Medium (Oxoid Ltd, 
Basingstroke, Hampshire, England) in glass test tubes, without shaking.  This broth 
medium contains tryptone, gelatin peptone, yeast extract, glucose, sodium chloride, L-
arginine, sodium pyruvate, menadione, and haemin.     For the sake of consistency and 
to minimize mutation, bacteria were freshly grown from minimally passaged, aliquoted 
frozen stocks each week before use in the killing assays.   Briefly, 100µL aliquots of P. 
gingivalis (grown in WC to mid-exponential phase or to ~0.5 optical density (OD) at 
Aλ660nm) were stored in 1mL glass vials containing 0.5mL sterilized skim milk (Sigma, St. 
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Louis, MO), at -80oC until use.   Individual frozen aliquots were thawed at room 
temperature (RT) and recovered by inoculation into 9mL volumes of non-reduced WC.   
From this, 3-5 drops (using a sterile plastic transfer pipette) were inoculated into fresh 
9mL volumes of non-reduced WC, and from this, 1mL was inoculated into a second 9mL 
volume of non-reduced WC to make a 10-fold dilution, and placed into the anaerobic 
incubator for growth.   These broth cultures took approximately 60 hr to initially recover 
from frozen stock in WC.   Upon initial visible growth, broth cultures were serially diluted 
(1 drop and 10-fold from that) into fresh 9mL volumes of reduced WC.   Bacteria were 
harvested from overnight cultures (~18 hr) using the dilution that best fit early- to mid-
exponential phase with an Aλ660nm of 0.2-0.6.    The starting inoculum assured that the 
test bacteria used in all experiments had undergone a minimum of five doublings.   
Individual frozen aliquots were also checked for purity by streaking for isolation on both 
aerobic and anaerobic blood agar plates.   An absence of growth on aerobic blood agar 
plates (TSA agar with 5% sheep blood (PML Microbiologicals, Mississauga, ON, 
Canada), incubated aerobically at 36oC) and a morphologically pure culture on 
anaerobic blood agar plates (reducible Brucella blood agar (Anaerobe Systems, Morgan 
Hill, CA), incubated anaerobically at 36oC) assured purity and was confirmed by Gram 
stain (agar and broth cultures) and distinct odor.    
 Prevotella intermedia ATCC 25611, Fusobacterium nucleatum 1594, and 
Aggregatibacter actinomycetemcomitans CDC A7154 (leukotoxin-producing, serotype b 
clinical isolate), as well as P. gingivalis strains HG405, FDC 381, and ATCC 33277 used 
in select experiments, were grown and stored in an identical manner to P. gingivalis 
strain CDC A7436.  Staphylococcus aureus ATCC 25923 and Streptococcus pyogenes 
ATCC 19615 were grown in WC broth at 36oC in ambient atmosphere.  
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Cell-free Killing Assays 
All killing assays were performed in vitro, in cell-free, aerobic conditions, in 1X 
sterile filtered phosphate buffered saline (PBS) (0.0067 PO4) without calcium or 
magnesium (HyClone Laboratories, Thermo Scientific, Logan, Utah).   All reagents were 
freshly prepared just prior to the start of experiments, and were equilibrated to RT in 
ambient atmosphere before use.   Bacteria were prepared last (after reagents) to 
maximize their viability.    
Briefly, bacteria were harvested from ~18 hr overnight cultures (grown either 
anaerobically or aerobically in WC, depending on species; see above), using the broth 
culture that best fit early- to mid-exponential phase with an OD of 0.2-0.6 at Aλ660nm (see 
above).   All bacteria were adjusted in aerobic conditions with non-reduced WC to a final 
Aλ660nm = 0.1, using a spectrophotometer (Beckman, Fullerton, CA).   Bacteria were then 
serially diluted in PBS (non-reduced) by performing three 10-fold dilutions, and then 
diluted by one-half after the addition of reagents in experiments.  Done this way, the final 
bacterial density in experiments was consistently between 4.5-5.2 log10 CFU/mL.   All 
killing assays were set up at RT in 1mL final volumes (FV) in 1.7mL polypropylene 
centrifuge tubes (VWR International, West Chester, PA).   Following set-up and initial 
plating (0 time), tubes were placed in a 37oC Fisher isotemp dry bath (Fisher Scientific 
Company, Fairlawn, NJ) without shaking, until subsequent time points.    
At each time point, samples were briefly vortexed (<1 s) and spiral plated (Spiral 
Systems, Bethesda, MD) to the surface of non-reduced WC agar (Oxoid Ltd), for growth 
and bacterial enumeration.   The spiral plating system delivers 49µL of liquid sample in 
an Archimedes spiral pattern onto the surface of a rotating agar plate.  The dispensing 
stylus deposits logarithmically decreasing volumes of sample as it moves from the 
center of the plate outwards, and because of this unique plating action, samples that 
normally require several serial dilutions prior to plating can be plated directly without 
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dilution.   After the growth of countable colonies, plates were enumerated by an 
automatic colony counter with computer software (ProtoCOL, Synbiosis USA, Frederick, 
MD) specifically programmed for determining spiral plated counts.   Results were 
represented as recoverable log10 CFU/mL.    Logarithmic reductions in recoverable 
CFU/mL were considered significant; i.e. ≥1 log reduction which equated to a ≥90% 
reduction in CFU/mL was considered significant, while <1 log reduction was not 
considered significant.   The lower limit of detection in samples enumerated by the spiral 
plate method was 1.31 log10 CFU/mL.   Samples were plated at least in duplicate, and 
colony counts were averaged.   Data are representative of three or more independent 
experiments using overlapping concentrations of test reagents and progressive 
refinement of the dilutions around the effective concentrations. 
After plating, agar surfaces were briefly allowed to dry in ambient air (dried within 
5 min of plating), and were quickly placed into the anaerobic chamber incubator (for P. 
gingivalis, P. intermedia, F. nucleatum, and A. actinomycetemcomitans) or aerobic 
incubator (for S. aureus and S. pyogenes) for growth.   Plates were incubated at 36oC, 
and recoverable CFU were countable after 4-6 days for P. gingivalis and P. intermedia; 
after 2-3 days for F. nucleatum, A. actinomycetemcomitans, and S. pyogenes; and after 
1 day for S. aureus.   It is noteworthy that various conditions (e.g. low humidity or mild 
oxygen contamination) impacted the recovery time of CFU of the strict anaerobes such 
as P. gingivalis in experiments.    Inhibitory concentrations of hydrogen peroxide with 
any bacterial species often resulted in recoverable CFU that were smaller or took longer 
to grow than controls. 
 
Xanthine (X) – Xanthine Oxidase (XO) Killing Assays 
The xanthine (X) – xanthine oxidase (XO) system was used to enzymatically 
generate exogenous superoxide and/or hydrogen peroxide in a cell-free system of killing 
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(Figure 3.1).    Xanthine is a catabolic product of purine nucleotide metabolism, and 
generates both superoxide and hydrogen peroxide when used as the substrate for XO 
(by definition, 1U of XO will convert 1µmole of xanthine to uric acid/min at pH 7.5 at 
25oC).   Since urate is a byproduct of the X-XO system, it remained present in the assay 
+/- superoxide dismutase (SOD) and catalase, but was not found to contribute to either 
protection or enhancement of killing.    Xanthine (Sigma-Aldrich, St. Louis, MO) was 
freshly prepared as a 100mM stock in 1M NaOH, and then serially diluted in PBS and 
added to experiments at a final concentration (FC) of 100µM.   XO (Sigma, from 
buttermilk) was freshly prepared as a 1U/mL stock in PBS, and then diluted in PBS and 
added to experiments at a FC of 15mU/mL.   SOD (Boehringer Mannheim, Mannheim, 
Germany, from bovine erythrocytes) was used to eliminate superoxide in the X-XO 
system, by catalyzing the dismutation of superoxide radicals to hydrogen peroxide and 
oxygen.  SOD was freshly prepared as a 1mg/mL stock in PBS, and added to 
experiments at a FC of 0.1mg/mL.   Catalase (Sigma, from bovine liver) was used to 
eliminate hydrogen peroxide in the X-XO system, by converting hydrogen peroxide to 
oxygen and water (by definition, 1U of catalase decomposes 1µmole H2O2/min at pH 7 
at 25oC).  Catalase was freshly prepared as a 5,000U/mL stock in PBS, and then diluted 
in PBS and added to experiments at a FC of 125mU/mL.     
Preliminary experiments that titered xanthine and XO led to the selection of 
100µM xanthine and 15mU/mL XO as optimal for use in these experiments.   125mU/mL 
catalase and 0.1mg/mL SOD were also chosen as optimal in preliminary assays.   
Reagents were added quickly with consistent timing to reaction tubes, with brief 
vortexing (<1 s) after each addition.  In order to set up the X-XO system in favor of 
radical generation (or inhibition of discrete ROS) before challenge with P. gingivalis, the 
following order of addition was used:  1st: 100µL of XO, 2nd: 100µL of catalase (or 100µL 
of PBS), 3rd: 100µL of SOD (or 100µL of PBS), 4th: 100µL of xanthine, 5th: 600µL of 
129 
 
bacteria (final bacterial density per tube approximately 4.5 log10 CFU/mL in 1mL FV).   
After all reagents were combined, vortexing following the addition of bacteria started the 
experiment (0 time).   All samples were spiral plated. 
 
Cytochrome C Reduction/ Oxidation Assay  
 The ability of SOD and catalase to eliminate superoxide and hydrogen peroxide 
(respectively) in the X-XO system was confirmed by cytochrome c oxidation in the 
presence of SOD, and cytochrome c reduction in the presence of catalase (data not 
shown), using a microtiter spectrophotometric assay, based on the SOD-inhibitable 
reduction of cytochrome c used to measure neutrophil oxidative burst function 
(superoxide production) upon stimulation with PMA (132) (142).    Briefly, cytochrome c 
reduction/ oxidation were assessed by measuring the change in OD at Aλ550nm every 10 s 
for 30 min in a Vmax kinetic microplate reader (Molecular Devices, Menlo Park, CA) at 
RT.   Agitation was applied immediately prior to each reading using the auto-mixing 
feature of the instrument.   The microplate reader was connected to a PC with Softmax 
software (Molecular Devices) allowing Vmax estimates, OD change measurement, and 
curve fittings.   Cytochrome c (Sigma), SOD, catalase, xanthine, and XO were freshly 
made using PBS (see above methods), and test wells contained a FC of 0.11µM 
cytochrome c, 125mU/mL catalase or 0.1mg/mL SOD, 100µM xanthine, and 15mU/mL 
XO, in a FV of 100µL.    A positive slope correlated with cytochrome c reduction by 
superoxide in the presence of X-XO + CAT, while a negative slope correlated with 
cytochrome c oxidation by hydrogen peroxide in the presence of X-XO + SOD.    An 
absence of cytochrome c reduction or oxidation, as demonstrated by a Vmax of zero, 
and a negligible OD change over 30 min, was observed in samples with X-XO + SOD 
and CAT.   
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Glucose (G) – Glucose Oxidase (GO) Killing Assays 
 The glucose (G) – glucose oxidase (GO) system was used to enzymatically 
generate exogenous hydrogen peroxide in a cell-free system of killing (Figure 3.2).   
When β-D-glucose is used as the substrate for GO, GO catalyzes the oxidation of β-D-
glucose to D-gluconolactone and hydrogen peroxide (by definition, 1U of GO will oxidize 
1µM of β-D-glucose to D-gluconolactone and hydrogen peroxide/min at pH 5.1 at 35oC).    
GO (Sigma, from Aspergillus niger, type VII) was freshly prepared as a 1,000U/mL stock 
in PBS, and then titered in experiments using PBS so that the FC of GO started at 
1U/mL, and decreased 10-fold from this.  β-D-glucose (EM Science, Gibbstown, NJ) was 
freshly prepared in PBS and added to experiments at a FC of 160mM, which allowed 
glucose to be in excess and GO to be the limiting reagent upon titration.    
Reagents were added quickly with consistent timing to reaction tubes, with brief 
vortexing (<1 s) after each addition.  In order to set up the G-GO system in favor of 
hydrogen peroxide generation before challenge with P. gingivalis, the following order of 
addition was used:  1st: 250µL of GO (or 250µL of PBS), 2nd: 250µL of glucose (or 250µL 
of PBS), 3rd: 500µL of bacteria (final bacterial density per tube approximately 4.5 log10 
CFU/mL in 1mL FV).  After all reagents were combined, vortexing following the addition 
of bacteria started the experiment (0 time).   All samples were spiral plated. 
 
Hydrogen Peroxide (H2O2) Killing Assays  
H2O2 was delivered as a bolus (non-enzymatic delivery of H2O2) to P. gingivalis, 
in order to determine the killing kinetics of P. gingivalis with H2O2 over time (Figure 3.3); 
and to P. intermedia, F. nucleatum, A. actinomycetemcomitans, S. aureus, and to S. 
pyogenes (Figure 3.4), in order to determine how the susceptibility of P. gingivalis to 
H2O2 compares with these selected bacteria.   Dilutions of H2O2 were freshly prepared in 
PBS before each experiment from a 30% w/w stock solution (Sigma), and molar 
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concentrations (c) were determined using the Beer’s Law formula, A = cbε, where A was 
the OD of the H2O2 dilution in PBS at Aλ230nm in a quartz cuvette,  ε was an 81 cm-1M-1 
extinction coefficient, and b equaled 1.   Known concentrations of H2O2 were then titered 
in PBS and are reported as approximate FC.   500µL of bacteria (final bacterial density 
approximately 5.0 log10 CFU/mL) were added to 500µL of hydrogen peroxide (or 500µL 
of PBS), and samples were spiral plated (see above) at specific time points in order to 
discern killing curves.   Initial experiments tested the killing activity of ten-fold dilutions of 
H2O2.   Subsequent experiments progressed from five-fold and then two-fold dilutions 
around the effective concentration of the preceding experiment to refine the titration. 
 
Myeloperoxidase (MPO) – Hydrogen Peroxide (H2O2) Killing Assays  
The MPO-H2O2 system was used to enzymatically generate exogenous 
hypochlorous acid (HOCl or bleach) in a cell-free system of killing (Figures 3.5 and 3.6).  
Human neutrophil MPO (Athens Research and Technology Inc, Athens, GA) was 
prepared in 50mM sodium acetate pH 6 + 100mM NaCl as a 20,000mU/mL stock, and 
frozen as 30µL aliquots at -20oC until use.   MPO was thawed on ice and dilutions were 
prepared in PBS just before experiments.   Dilutions of H2O2 were also freshly prepared 
in PBS from a 30% w/w H2O2 stock solution (Sigma), and molar concentrations were 
determined spectrophotometrically using the Beer’s Law formula (see above).    The 
source of chloride in the MPO-H2O2 system of generating HOCl (Cl- + H2O2 + H+ + MPO 
→ HOCl + H2O) was derived from PBS (HyClone Laboratories, Thermo Scientific), which 
contained 0.15M NaCl.   This concentration provided an excess of chloride, and as a 
result, chloride was not a rate-limiting reagent in the MPO-H2O2 system.    In order to set 
up the MPO- H2O2 system in favor of HOCl generation before challenge with bacteria, 
MPO and H2O2 were incubated together for exactly 20 s before the addition of bacteria.  
Hence, reagents were added in the following order, with brief vortexing (<1 s) after each 
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addition:  1st: 250µL of MPO (or 250µL of PBS), 2nd: 250µL of H2O2 (or 250µL of PBS), 
3rd:  500µL of bacteria (final bacterial density approximately 4.5 - 5.0 log10 CFU/mL).  
After all reagents were combined, vortexing following the addition of bacteria started the 
experiment (0 time).   All samples were spiral plated. 
In 4-aminobenzoic acid hydrazide (4-ABH) studies (Figure 3.6), the effect of 4-
ABH (an inhibitor of MPO enzymatic activity) on bacterial killing by the MPO- H2O2 
system was examined.   4-ABH (Sigma) was prepared as a 100mM stock in 10mM HCl, 
and then diluted in PBS and added at a FC of 4mM (chosen as an optimal concentration 
in preliminary experiments to inhibit MPO peroxidatic activity).   In order to favor the 
activity of 4-ABH, MPO and 4-ABH were incubated together for exactly 10 s before the 
addition of H2O2.  Next, in order to set up the MPO- H2O2 system in favor of HOCl 
generation before bacterial challenge, H2O2 plus MPO +/- 4-ABH were incubated 
together for an additional 20 s before the addition of bacteria.  Hence, reagents were 
added in the following order, with brief vortexing (<1 s) after each addition:  1st: 225µL of 
MPO (or 225µL of PBS), 2nd: 25µL of 4-ABH (or 25µL of PBS), 3rd: 250µL of H2O2 (or 
250µL of PBS), 3rd:  500µL of bacteria (final bacterial density approximately 4.5 - 5.0 
log10 CFU/mL).   After all reagents were combined, vortexing following the addition of 
bacteria started the experiment (0 time).   All samples were spiral plated. 
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RESULTS 
Catalase, but not SOD, blocks X-XO Killing of P. gingivalis  
 The X-XO system was used to enzymatically generate both exogenous 
superoxide and hydrogen peroxide in a cell-free system of killing (Figure 3.1).   Catalase 
(CAT) and/or superoxide dismutase (SOD) were used with this system, in order to 
determine the susceptibility of P. gingivalis to these individual ROS.   The X-XO system 
is proposed to resemble the NADPH oxidase in the phagosome, by generating 
superoxide first, which subsequently dismutates to hydrogen peroxide (143) (144).   
Additionally analogous, the X-XO system enzymatically generates these species in a 
continual or sustained fashion (provided there is enough substrate), as opposed to 
delivering them all at once to bacteria, as a bolus.   Non-recoverable, logarithmic 
reductions in CFU/mL were interpreted as killing.   
 In order to examine the effect of both superoxide and hydrogen peroxide 
generation on P. gingivalis, A7436 was challenged with X (100µM FC) and XO 
(15mU/mL FC), and killing was compared to controls, which contained no X or XO.   
Significant killing did not occur in the control (no X or XO) over the two hour test period.   
However, X-XO killed P. gingivalis in a time-dependent manner:   Killing did not occur at 
0 time, though significant killing had occurred by one hour (>2 log reductions or >99% 
reduction in log10 CFU/mL), with additional and complete killing (no detectable CFU) by 
two hours.   Sensitivity to X-XO suggested that P. gingivalis is susceptible to any or all of 
the components generated by this system (superoxide, hydrogen peroxide, and urate).    
However, the addition of SOD + CAT to X-XO (which eliminated both superoxide and 
hydrogen peroxide, but not urate) resulted in complete protection from killing, 
comparable to controls.   Additionally, no killing occurred in controls with SOD alone 
(without X or XO) or CAT alone (without X or XO), or in controls with SOD + CAT alone 
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(without X or XO).   These data support that the killing which occurred in the X-XO 
system is due to the ROS generated by the X-XO system:  superoxide and/or hydrogen 
peroxide, but not urate.  
In order to discern the susceptibility of P. gingivalis to superoxide individually, 
A7436 was challenged with X-XO plus CAT.   Under these conditions, superoxide was 
generated as determined by cytochrome c reduction, and there was no discernible killing 
of A7436.  In contrast, when challenged with X-XO plus SOD, A7436 killing was 
equivalent to that of X-XO alone.   Under these conditions, hydrogen peroxide was 
generated as determined by cytochrome c oxidation.    These data indicate that 
hydrogen peroxide alone can kill A7436, and that superoxide under the conditions of 
these experiments has no effect on P. gingivalis A7436.   
 
P. gingivalis is Killed by G-GO 
 The G-GO system was next used to enzymatically generate exogenous 
hydrogen peroxide in a cell-free system of killing (Figure 3.2).   The G-GO system also 
generates hydrogen peroxide in a sustained fashion (145), but unlike X-XO and the 
NADPH oxidase, the G-GO system does not generate superoxide first, but directly 
generates hydrogen peroxide.    GO was titered in the presence of excess glucose (FC 
of 160mM), which varied the rate of hydrogen peroxide generation.       
The G-GO system killed P. gingivalis A7436 in a time- and rate- dependent 
manner.   There was no evidence of killing at the initial plating (0 time) with any of the 
GO concentrations tested.   There was no killing through two hours with 100µU/mL GO 
(0.0001U/mL GO), but a ten-fold increase in GO (0.001U/mL GO) resulted in killing by 
one hour and total killing by two hours.   Higher concentrations of GO (≥0.01U/mL GO) 
resulted in total killing by one hour.   This GO-dependent killing of P. gingivalis A7436 
was completely blocked by the addition of 125mU/mL catalase (data not shown), which 
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supports that the killing which occurred in the G-GO system is due to hydrogen peroxide 
alone.     
 
Killing of P. gingivalis by H2O2 Requires Time 
 Data from the X-XO (Figure 3.1) and G-GO systems (Figure 3.2) suggest that P. 
gingivalis is susceptible to hydrogen peroxide without exogenous co-factors, and that 
superoxide has no influence on A7436 under these conditions.   Furthermore, the effect 
of GO titration suggests there is a threshold concentration of H2O2 necessary to kill P. 
gingivalis.   The fact that there was no detectable reduction in recoverable CFU/mL at 
the initial time point, regardless of the concentration of GO tested, also suggests a time-
dependent kinetic of killing by H2O2.   In order to validate the H2O2-sensitivity of P. 
gingivalis and to address the killing kinetic of P. gingivalis by H2O2, the bactericidal 
activity of H2O2 delivered as a bolus (non-enzymatic delivery of H2O2) was next 
examined. 
 In initial experiments, the bactericidal activity of H2O2 on P. gingivalis A7436 was 
titrated from 10mM H2O2 using ten-fold dilutions to determine approximate sensitivity 
(data not shown).   Figure 3.3 represents the data from a two-fold titration from 100µM 
H2O2, which was spiral plated at select times through three hours.   As suggested in 
Figure 3.3, H2O2, delivered as a bolus, killed P. gingivalis in a time-and dose-dependent 
fashion.   There was no reduction in recoverable CFU/mL upon initial plating, despite 
concentrations of H2O2 as high as 10mM (data not shown).   This suggests that the 
process of plating neutralizes any additional bactericidal activity of H2O2 that may have 
occurred on the plate, and that the killing events occur in the reaction volume only.   
Additionally, there was a concentration-dependent, logarithmic killing progression over 
the three hour test period with all H2O2 concentrations tested, including 6.25µM H2O2. 
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P. gingivalis is Remarkably Susceptible to H2O2, compared with Select Pathogens 
These data indicate that low, micromolar concentrations of H2O2 are capable of 
killing P. gingivalis in the absence of exogenous co-factors.   The next series of 
experiments were designed to determine if this H2O2-sensitivity is unique to this strain of 
P. gingivalis and/or to this species.   In Figure 3.4, the sensitivity of P. gingivalis to H2O2 
was compared with other periodontal pathogens, including P. intermedia, F. nucleatum, 
and A. actinomycetemcomitans, as well as with other important human pathogens 
associated with neutrophil dysfunctions, including S. aureus and S. pyogenes.    Four P. 
gingivalis strains (A7436, HG405, 381, and 33277) were also included.   The killing of all 
test bacteria by H2O2 was a time-dependent event (data not shown).    At 60 min, there 
were logarithmic reductions in recoverable CFU/mL of all four P. gingivalis strains with 
20µM H2O2 (Figures 3.4A and B).   At 60 min, P. intermedia required 100µM H2O2 
(Figure 3.4B), while F. nucleatum required >300µM H2O2 (Figure 3.4A), in order to 
achieve logarithmic reductions.   In contrast, the three species that are capable of 
growing in an aerobic environment, A. actinomycetemcomitans, S. aureus, and S. 
pyogenes, required >1,250µM, >2,500µM, and >5,000µM H2O2, respectively, to achieve 
logarithmic reductions at 60 min (Figures 3.4A and B).   
 
Influence of MPO on the Bactericidal Activity of H2O2 with P. gingivalis and  
F. nucleatum 
 In initial experiments to determine the influence of MPO on the bactericidal 
activity of H2O2, H2O2 was titrated using two-fold dilutions from 1,600µM, in the presence 
of 2mU/mL MPO with both P. gingivalis A7436 (data not shown) and F. nucleatum 
(Figure 3.5A).  This concentration of MPO totally protected both bacteria against the 
bactericidal activity of even the highest concentrations of H2O2.   In subsequent 
experiments, H2O2 was titrated from 40µM with increased concentrations of MPO 
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(Figures 3.5B and C).    In Figure 3.5B, again the bactericidal activity of H2O2 against P. 
gingivalis was eliminated by the addition of MPO.   However, at sub-lethal 
concentrations of H2O2, there was a dose-dependent killing of P. gingivalis in the 
presence of 12mU/mL MPO (Figure 3.5B).   This killing activity peaked at 5µM H2O2, 
lessened at 10µM H2O2, and was lost with greater H2O2 concentrations (Figure 3.5B).   
Over the same range of H2O2 concentrations, the MPO system resulted in a strikingly 
similar pattern of killing with F. nucleatum (Figure 3.5C), despite its logarithmically 
greater resistance to MPO-independent killing by H2O2.   
 
Relative Sensitivities of the different target bacteria to the MPO System 
These data are consistent with a bactericidal mechanism involving the generation 
of HOCl by the peroxidatic activity of MPO, which occurs over a discrete range of H2O2 
concentrations from 0.6µM to 10µM, with an optimum at 5µM H2O2.   Also, this 
bactericidal activity and/or the peroxidatic generation of HOCl by MPO appears to be a 
time-dependent event (Figures 3.5B and C).   Higher concentrations of H2O2 apparently 
interfere with this peroxidatic activity, and the presence of MPO limits the activity and/or 
availability of bactericidal concentrations of H2O2 (Figure 3.5).    
The next series of experiments (Figure 3.6) was designed to compare the relative 
patterns of sensitivities to MPO-dependent killing of H2O2-resistant species compared to 
that of the more H2O2-sensitive species.   Each of the six target bacteria were treated 
with a titration of H2O2 through 5µM, in the presence of MPO ranging in concentration 
from 0 to 24mU/mL.  As can be seen, there was a variable requirement of the MPO 
concentration required to enhance killing by H2O2, depending on the target bacterium.  
The two catalase-producing species (Figures 3.6D and E) required the highest 
concentration of MPO (12-24mU/mL) to achieve logarithmic killing by the system; 
whereas F. nucleatum (Figure 3.6C) showed logarithmic killing with the lowest 
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concentration/ activity of MPO (3-6mU/mL).   Surprisingly, all of the test bacteria were 
sensitive to the same optimum concentration of H2O2, provided there was sufficient 
MPO.   All killing activity was inhibited by 4-ABH (Figure 3.6), which is a potent, 
mechanism-based inhibitor of MPO peroxidatic activity (146).   The ablation of killing with 
4-ABH supports that the killing in this system is due to the peroxidatic generation of 
HOCl by MPO.    Neither sub-optimal nor optimal MPO concentrations alone, or 4-ABH 
(at 4mM FC) alone, demonstrated any bactericidal activity with any of the species tested 
(Figure 3.6).  
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DISCUSSION 
Since human neutrophils require a functional NADPH oxidase in order to kill 
phagocytosed P. gingivalis (24), it was important to examine the roles of the principal 
products of the NADPH oxidase (O2.-, H2O2, and MPO-generated -OCl) in this killing 
process.   In preliminary experiments, XO was titrated in the presence of excess 
xanthine in PBS to screen for any bactericidal activity against P. gingivalis and to 
determine a concentration that yielded a definable killing kinetic and was capable of 
SOD-inhibitable reduction and catalase-inhibitable oxidation of cytochrome c (data not 
shown).   The XO enzyme system was found capable of potent killing of P. gingivalis 
with an activity yielded by 15mU/mL in a reaction mixture containing 100µM xanthine.   
This combination resulted in significant, but not total, killing at one hour (Figure 3.1).   
This activity would be estimated to generate approximately 30nmoles/min of O2.-/H2O2, 
for a total of 1.8µmoles over the initial one hour treatment period.   These data 
suggested that either, both, or the combination of O2.-  and H2O2, without the possible co-
factors of the phagosome environment, was capable of killing P. gingivalis.   Catalase, 
but not SOD, was capable of total protection of P. gingivalis against this bactericidal 
activity, suggesting that H2O2 was solely responsible for killing (Figure 3.1).   
The catalase-inhibitable bactericidal activity of the GO system provided further 
evidence for the direct bactericidal activity of H2O2 against P. gingivalis in the absence of 
O2.-  (Figure 3.2).   The titration of GO in the presence of excess glucose in PBS yielded 
total killing by one hour with an activity of 0.01U/mL; while an activity of 0.001U/mL GO 
yielded a less than one log reduction in recoverable CFU/mL by one hour, but total killing 
after two hours of treatment.   This is consistent with a bactericidal rate of H2O2 
generation of between 10nmoles and 100nmoles/min, strikingly similar to the 
30nmoles/min estimated with XO.   These data clearly implicate H2O2 as the sole active 
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agent in both enzyme systems.   The absence of demonstrable bactericidal activity by 
O2.- with the XO system would be consistent with its lack of diffusibility across a 
membrane (79) (82).   In support of inaccessibility to lethal targets, unpublished studies 
in this laboratory found that P. gingivalis was killed by paraquat, a toxic agent thought to 
act via the endogenous generation of O2.- within a cell (147).   P. gingivalis sensitivity to 
H2O2 but not to O2.-  is also consistent with P. gingivalis possessing SOD (MnSOD and 
FeSOD), but not catalase or peroxidase enzymes (45).   It is also possible that the rate 
of exogenous O2.-  generated under the conditions employed was insufficient for killing.     
Treatment of P. gingivalis with a single bolus of discrete concentrations of H2O2, 
as opposed to the enzymatic generation of uniformly increasing concentrations, 
permitted discrimination of the rate of H2O2 killing, from that of the enzyme generating 
systems (Figure 3.3).   From these studies, it is clear that there is a dose-dependent 
progression of killing by H2O2.   There was no evidence of killing at the initial time point 
with any of the concentrations tested, including much higher levels (data not shown).   
With the highest treatment doses, logarithmic killing was evident within 30 min; and with 
the lower concentrations, killing continued through three hours.   These data collectively 
suggest that the effects of a bolus of H2O2 are continuous through three hours and are 
not neutralized in the reaction volume.    In contrast, the conditions associated with spiral 
plating do appear to block the progression of killing on a plate, permitting colony 
formation with ultimately lethal concentrations of H2O2, possibly through repair of 
damage.   There was evidence of delayed appearance (requiring longer incubation 
times) and smaller colonies with the intermediate doses (data not shown), which may 
reflect such repair activities.     
Interestingly, to achieve the same level of killing in the same period of time (60 
min) as that with the enzyme- generated systems, a bolus of H2O2 at a concentration 
between 25 and 50µmoles/mL was required (Figure 3.3) vs. the 30nmoles estimated to 
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be generated in the first minute and the 1,800nmoles generated in the first hour in the 
XO system (Figure 3.1).   This would suggest that a sustained rate of H2O2 generation, 
as would be found in the phagosome, would be highly efficient at killing.    
The level of susceptibility of strain A7436 was apparently reflective of a species 
characteristic, as the other strains of P. gingivalis tested were similarly sensitive to direct 
killing by H2O2 (Figure 3.4B), despite differences in virulence properties such as capsule 
production.    Furthermore, this level of susceptibility of P. gingivalis to the direct 
bactericidal effects of H2O2 would be well within the range of the H2O2 concentrations 
(2µM) modeled by Winterbourn et al (79), sustained in the phagosome environment 
post- delivery of MPO.    As MPO is considered to be the primary consumer of H2O2 in 
the phagosome (25) (73) (79) (106) (107), the concentrations of NADPH oxidase 
products that the phagocytized bacterium would be exposed to before delivery of MPO 
would be in great excess of bactericidal concentrations. 
Like P. gingivalis, P. intermedia is also a strict anaerobe, which synthesizes an 
extracellular protoporphyrin layer from the heme constituent of hemoglobin that results in 
black pigmentation of colonies grown on blood-based media (119).   Because of their 
many similarities, these two bacteria were originally classified as subspecies of the same 
species, Bacteroides melaninogenicus (148).    It was, therefore, not surprising that its 
sensitivity to the bactericidal activity of H2O2 proved similar to that of the P. gingivalis 
strains (Figure 3.4B).   P. intermedia was not included for comparison with P. gingivalis 
in the neutrophil killing studies (24) that lead to the current studies, as it was not readily 
phagocytized.    It is not known whether it would show a similar dependence on NADPH 
oxidase activity.    
In contrast, F. nucleatum was readily phagocytized and killed by human 
neutrophils, without a requirement of an exogenous antibody source for opsonization 
(24).   Its neutrophil-associated killing was significantly depressed when the activity of 
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the NADPH oxidase was inhibited, either through oxygen limitation (anaerobiosis) or by 
chemical (DPI) inhibition (24), indicating an importance of the respiratory burst in 
neutrophil killing of F. nucleatum.   Unlike the complete ablation of killing with P. 
gingivalis, there remained a significant level of killing of F. nucleatum under these 
conditions, suggesting a sensitivity to oxygen-independent mechanisms, or an increased 
sensitivity to low levels of residual ROS.  In the current studies, however, F. nucleatum 
was found to be relatively more resistant to direct killing by H2O2 (Figures 3.4A and B), 
which may be consistent with its reported ability to grow in the presence of low levels of 
oxygen (up to 6%) and its apparently less fastidious requirements for establishing 
infection (149).     
The neutrophil-mediated killing of A. actinomycetemcomitans, unlike that of P. 
gingivalis and F. nucleatum, was relatively insensitive to inhibition of NADPH oxidase 
activity (24), supporting this bacterium’s sensitivity to oxygen-independent killing 
mechanisms, as previously reported by others (150) (151) (152).   Unlike the strict 
anaerobes included in this study, A. actinomycetemcomitans characteristically produces 
catalase and can grow in the presence of atmospheric oxygen (120) (121).   It was also 
predictably more resistant to the direct bactericidal activity of H2O2, than was F. 
nucleatum (Figure 3.4A). 
The relative susceptibility of P. gingivalis to H2O2 was also compared to that of 
the catalase-positive, aerotolerant S. aureus, a pathogen in CGD and in neutropenia; 
and to that of the catalase-negative, aerotolerant S. pyogenes, a pathogen in 
neutropenia but not in CGD.   Unfortunately, neither of these species could be included 
in the comparative studies of neutrophil phagocytosis and killing (24), as they were 
highly sensitive to the fluorescent dyes used to visualize these cell processes (S. 
pyogenes was killed by DAPI, and S. aureus was killed by PI) (Table A.4 and described 
in text of Appendix).    Other studies, however, have demonstrated the importance of a 
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functioning respiratory burst for optimal killing of S. aureus by human neutrophils (26) 
(27) (28) (29) (32) (33).   It has been suggested that the differences in susceptibility of 
CGD patients to these two species relate to the inability of S. pyogenes and other non-
catalase- producing bacteria to clear bacterially-generated H2O2 in the phagosome (33) 
(153).   However, both of these species were relatively resistant to direct killing by H2O2 
(Figures 3.4A and B).   Moreover, the catalase-negative S. pyogenes proved even more 
resistant than the catalase-positive S. aureus (Figure 3.4B), challenging this traditionally 
held theory.    The greater resistance of streptococcal species than S. aureus to H2O2 
has previously been ascribed to its abundant possession of cytosolic peroxidases (154).   
MPO is the major protein constituent of azurophilic (or primary) granules and is 
the most abundant enzyme in neutrophils (98) (99).    The hierarchy of granule fusion 
would dictate that the components of the NADPH oxidase system would already be 
assembled and functioning on the phagosome membrane, by the time MPO is delivered 
(25) (73).    Based on the results of a variety of studies, MPO is considered the major 
consumer of H2O2 in the phagosome as modeled in (79).    
MPO is a heme-containing oxidoreductase that undergoes a series of redox 
reactions that involve interconversions of the relevant intermediates:  ferric and ferrous 
peroxidase, compound I, compound II, and compound III (155).   Depending on 
substrate availability, MPO can path through the halogenation cycle and/or the 
peroxidase cycle, and/or can act as a pseudo-catalase (155).     The antimicrobial 
activity of MPO, however, has been attributed to the peroxidatic oxidation of chloride to 
the potent bactericidal agent, H+ -OCl, within the phagosome (73) (79) (82) (96) (100) 
(102) (103).   Of the mammalian peroxidases, only MPO is capable of oxidizing chloride 
at a reasonable rate (156).   Despite the attractiveness of the antimicrobial properties of 
this product, however, the actual contributions of MPO to the bactericidal activities in the 
phagosome environment are unclear and may depend on the ratios of substrate 
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availability (79).    Kettle and Winterbourne (157) suggested that MPO possesses true 
catalase activity, the extent of which is so important, compared to other peroxidases, 
that MPO should be considered as a catalase/peroxidase.   
The current studies were therefore designed to first examine the possibility that 
MPO provides protection against the direct bactericidal activity of H2O2.   H2O2 was 
titrated to cover a range of concentrations to include levels that far exceeded that which 
is necessary for minimal bactericidal activity, with relatively low concentrations of MPO in 
order to minimize protein effect.   MPO clearly afforded protection against the direct 
bactericidal activity of H2O2 for both F. nucleatum and P. gingivalis (Figures 3.5A and B).   
The extremely low concentration of protein required for this level of activity and the 
relatively high levels of H2O2 that MPO protected against, would suggest that this 
inhibition is due to the enzymatic properties of MPO, rather than to competitive 
inactivation or to a protein effect.    
During the course of titration of H2O2, there were suggestions of killing with low 
levels of H2O2 in the presence of MPO, as was evident with F. nucleatum treated with 
12.5µM H2O2, in the presence of 2mU/mL MPO, in Figure 3.5A.   This MPO-dependent 
killing appeared to be more consistent with higher concentrations of MPO.   The 
titrations of H2O2 and MPO were therefore refined to yield a clearer picture of this 
bactericidal activity of the MPO system.   The chloride was assumed to be in substrate 
excess, at the 150mM concentration in PBS.    Both P. gingivalis and F. nucleatum were 
killed optimally when treated with a concentration of H2O2 of 5µM, and killing was 
diminished at 10µM and lost at 20µM (Figures 3.5B and C).    
There was a requirement for higher concentrations of MPO with P. gingivalis than 
with F. nucleatum (Figures 3.5B and C, and Figures 3.6A and C).   This MPO- and H2O2- 
dependent killing extended to all of the other target bacteria, provided that MPO was 
present in sufficient quantity (Figures 3.6B, D, E and F).   The surprising observation 
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was that 5µM H2O2 proved optimal for the killing of all target bacteria, which suggested 
that an optimally lethal concentration of what is presumed to be HOCl was achieved at 
this concentration, and that all of the species were equally susceptible to this product, 
independent of their relative susceptibilities to MPO-independent H2O2.   
The requirement for different concentrations of MPO is interesting from several 
perspectives.    P. gingivalis is highly resistant to the non-oxidative mechanisms of 
neutrophil killing, presumably through proteolytic inactivation of the bactericidal proteins 
and peptides of granules (18) (58) (59) (60) (61) (62) (63) (64) (65) (66).   These granule 
constituents are rich in arginines and/or lysines, which are evidently the targets of the 
gingipains that define this pathogen (1).   MPO is also especially rich in arginines, and its 
structure includes critical lysines (158).   It therefore would not have been a surprise if P. 
gingivalis was highly resistant to any MPO-dependent activities.   This could have been 
an explanation for the apparent independence of MPO for neutrophil-mediated killing of 
this pathogen (24).   While P. gingivalis required more MPO than did F. nucleatum to 
demonstrate MPO-dependent killing; the ability to produce catalase (Figures 3.6D and 
E) or some other H2O2 competitor, appears to offer a more likely explanation for the 
species-dependent requirements for higher concentrations of MPO for activity.   While 
cytosolic peroxidases may afford better protection against the toxicity of MPO-
independent H2O2 (154), which diffuses into the cell; surface-associated catalase may 
afford better protection against the MPO-dependent effects of H2O2.   Competition with 
MPO for H2O2 by an extracellular protoporphyrin is also suggested by the similarity of 
MPO requirements for P. gingivalis (46) (47) and P. intermedia (119) vs. that of the non-
pigmented F. nucleatum.   
If antagonistic interactions occur in the phagosome between MPO and 
bactericidal concentrations of H2O2, it is unclear what role MPO plays in the phagosome.   
The data in this study suggest that P. gingivalis and possibly other H2O2-sensitive 
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bacteria may be directly killed in the phagosome by low micromolar concentrations of 
H2O2, which are suggested to remain steady state in the phagosome after MPO delivery 
(79), and that phagosomal concentrations of H2O2 must be tightly regulated in order for 
MPO to function as a bactericidal constituent.    As proposed by Reeves et al (159), it is 
possible that MPO has an alternative role in the phagosome such as H2O2 scavenging, 
which may serve to dampen the toxicity of the neutrophil against high concentrations of 
H2O2 and by cytotoxic enzymes.   This is consistent with the observation that the 
majority of chlorinated proteins in the phagosome are of host origin (160).    
Killing by H2O2 could be a likely mechanism of killing P. gingivalis within the 
phagosome, before MPO is delivered, due to its unusually high susceptibility to H2O2.   
H2O2 is hypothesized to kill by diffusion inside the bacterial cell, where it reacts with 
bacterial-associated iron, mediating a Fenton reaction, where ferrous iron (Fe2+) reduces 
H2O2 to the most reactive (i.e. non-specific and diffusion-limited) radical known, hydroxyl 
radical (OH.)  (75) (77) (80) (81) (83) (87) (161) (162) (163) (164) (165) (166).   This 
scenario appears consistent with the fact that H2O2-mediated killing of P. gingivalis does 
not occur instantly, but that P. gingivalis and H2O2 (generated enzymatically at a 
sufficient rate or delivered as a bolus at a sufficient dose) need time together in order for 
H2O2 to become lethal – a mechanism consistent with requiring time in order for H2O2 to 
enter the bacteria, find and react with bacterial-associated iron, generate something 
more toxic (e.g. OH.), and cause a lethal, irreparable hit (e.g. damage to DNA).     
It is therefore suggested from these studies that in order to kill P. gingivalis, MPO 
is an unnecessary co-factor, because H2O2 at a minimal dose is a highly effective 
mechanism of killing P. gingivalis.   The fact that the specific granules are delivered to 
the phagosome before the primary granules assures that the NADPH oxidase system is 
delivering ROS to the bacterial target for a period of time in the absence of MPO (25) 
(167).    This would presumably allow at least transient MPO-independent H2O2 activity 
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in the phagosome at levels that would exceed bactericidal concentrations.  The 
differential susceptibility to very low doses of H2O2, compounded with the observation 
that the MPO-H2O2 system works only within a narrow range, and that MPO activity is 
highly susceptible to neutralization, makes H2O2 a highly desirable candidate as the 
effector mechanism of killing P. gingivalis.  
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Figure 3.1.  Catalase, but not Superoxide Dismutase, blocks Xanthine – Xanthine 
Oxidase Killing of P. gingivalis.   Results are expressed as recoverable log10 CFU/mL.  
Samples were spiral plated (limit of detection: 1.31 log10 CFU/mL), and logarithmic 
differences in recoverable CFU/mL were considered significant.  Samples were plated at 
least in duplicate, and colony counts were averaged.   Data are representative of three 
or more independent experiments.   Experiments were performed at 37oC.   
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Figure 3.2.  Titration of Glucose Oxidase- Dependent Killing of P. gingivalis.   
System contained 160mM FC glucose as enzyme substrate.   Results are expressed as 
recoverable log10 CFU/mL.  Samples were spiral plated (limit of detection: 1.31 log10 
CFU/mL), and logarithmic differences in recoverable CFU/mL were considered 
significant.   Samples were plated at least in duplicate, and colony counts were 
averaged.   Data are representative of three or more independent experiments.    
Experiments were performed at 37oC.   
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Figure 3.3.  Kinetics of P. gingivalis Killing by Hydrogen Peroxide.   Results are 
expressed as recoverable log10 CFU/mL.   Samples were spiral plated (limit of detection:  
1.31 log10 CFU/mL), and logarithmic differences in recoverable CFU/mL were 
considered significant.    Samples were plated at least in duplicate, and colony counts 
were averaged.   Data are representative of three or more independent experiments.   
Experiments were performed at 37oC.   
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Figure 3.4.   Titration of H2O2-Mediated Bactericidal Activity against P. gingivalis,       
P. intermedia, F. nucleatum, A. actinomycetemcomitans, S. aureus and  
S. pyogenes.  H2O2 was delivered as a bolus to bacterial targets in PBS, in order to 
compare susceptibilities to H2O2 at 60 min.  Results are expressed as recoverable log10 
CFU/mL.  Samples were spiral plated (limit of detection: 1.31 LOG CFU/mL), and 
logarithmic reductions (≥1 log reductions) in recoverable CFU/mL were considered 
significant.  Samples were plated at least in duplicate, and colony counts were averaged.  
Data are representative of three or more independent experiments.  Experiments were 
performed at 37oC. 
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Figure 3.5.  MPO Inhibition of H2O2 Killing and MPO-Dependent H2O2 Killing of            
F. nucleatum and P. gingivalis.    H2O2 was titrated in the presence of varying 
concentrations of MPO as indicated.  Results are expressed as recoverable log10 
CFU/mL after incubation in PBS at 37oC for 60 min.   Samples were spiral plated (limit of 
detection:  1.31 log10 CFU/mL), and logarithmic differences in recoverable CFU/mL were 
considered significant.    Samples were plated at least in duplicate, and colony counts 
were averaged.   Data are representative of three or more independent experiments.   
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Figure 3.6.   4-ABH-Inhibitable Killing of Various Bacterial Species by the MPO 
System.    H2O2 was titrated from 0-5µM in the presence of varying concentrations of 
MPO as indicated.  Target bacteria include P. gingivalis A7436 (A); P. intermedia (B);  
F. nucleatum (C); A. actinomycetemcomitans (D); S. aureus (E); and S. pyogenes (F).   
The final concentration of 4-ABH in the reaction mixtures was 4mM where indicated.  
Results are expressed as recoverable log10 CFU/mL after incubation in PBS at 37oC for 
60 min.  Samples were spiral plated (limit of detection: 1.31 log10 CFU/mL), and 
logarithmic differences in recoverable CFU/mL were considered significant.  Samples 
were plated at least in duplicate, and colony counts were averaged.   Data are 
representative of three or more independent experiments.   
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ABSTRACT 
Previous studies designed to determine the NADPH oxidase-dependent, 
neutrophil-mediated mechanisms of killing Porphyromonas gingivalis, an overt 
periodontopathogen, demonstrated both MPO-dependent and MPO-independent 
bactericidal activity with H2O2, effective against P. gingivalis and all other bacterial 
species tested.   While P. gingivalis proved exceptionally sensitive to MPO-independent 
H2O2 bactericidal activity, all test species were susceptible to the same concentrations of 
H2O2 in the presence of optimal MPO activity.   The aim of the current study was to 
investigate the differential mechanisms of killing by H2O2 vs. that of the presumed 
bactericidal product of MPO, hypochlorite (bleach).    While the bactericidal activity of 
H2O2 was time- and concentration-dependent, bleach killed immediately without 
temporal progression.   Despite having very different susceptibilities to H2O2, all test 
bacteria showed identical susceptibilities to bleach.   The bactericidal activity of H2O2 
was also temperature-dependent, with intermediate killing at room temperature and no 
killing on ice.   In striking contrast, the bactericidal activity of bleach was temperature-
independent.   When the bacterial target numbers were varied relative to fixed 
concentrations of H2O2, the highest bacterial densities were killed exponentially better 
than the lower bacterial densities.   In contrast, the bactericidal activity of bleach was lost 
as the bacterial target densities increased.    Dimethyl sulfoxide competitively inhibited 
the bactericidal activity of H2O2 with all test species, suggesting a role for hydroxyl 
radical (OH.).   These data are consistent with a mechanism that requires bacterial 
conversion of H2O2 to the more reactive OH., proximal to a susceptible vital target, in 
contrast to the direct bactericidal activity of the MPO product, hypochlorite. 
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INTRODUCTION 
The principal oxygen-dependent killing pathway of the neutrophil is mediated by 
the multi-component NADPH oxidase system, which is responsible for the production of 
a respiratory burst, where large amounts of oxygen are consumed in the enzymatic 
generation of superoxide anion:  NADPH + 2O2 → NADP+ + 2O2.- + H+ (1) (2) (3) (4) (5).   
Once generated, superoxide subsequently dismutates to hydrogen peroxide (O2.- + 2H+ 
→ H2O2), and from these intermediates, which are generally considered relatively 
nontoxic and inert (or only mildly oxidative) (6) (7) (8), other more reactive oxidants are 
generated, either by reacting with enzyme systems or with bacterial iron, or by the 
products of these systems reacting with O2.- and/or H2O2, or with each other (6) (9) (10) 
(11) (12) (13) (14) (15) (16) (17).    
The best described enzyme known to consume H2O2 in the phagosome is the 
heme-based myeloperoxidase (MPO) system, which is a H2O2-dependent mechanism of 
generating the strong oxidant, weak acid, hypochlorous acid (HOCl):  MPO + Cl- + H2O2 
→ HOCl.    Due to its reactivity and ability to chlorinate or otherwise modify a wide range 
of bacterial targets, MPO-generated HOCl is regarded as one of the most potent 
microbicidal and cytotoxic mechanisms of the neutrophil (6) (11) (15) (18) (19) (20) (21).    
It is also well-supported that in a reductive cellular environment, as found in a 
metabolizing cell, the toxicity of H2O2 can be enhanced by reacting with bacterial-
associated iron and mediating a Fenton reaction, where ferrous iron (Fe2+) reduces H2O2 
to the most reactive (i.e. non-specific and diffusion-limited) radical known, hydroxyl 
radical (OH.):   Fe2+ + H2O2 → Fe3+ + H2O + OH.  (7) (10) (13) (16) (17) (22) (23) (24) (25) 
(26) (27).   H2O2 is membrane permeable, and upon diffusion inside the cell, is believed 
to react with bacterial iron to generate OH.  close to DNA.   Like the membrane-
permeable HOCl, OH.  is capable of powerful oxidative damage, which if not repaired, 
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leads to lethality (6) (28).   The instability of these partially reduced oxygen species, their 
membrane permeabilities, and their rapid reactivity with a wide range of bacterial targets 
(e.g. cell- associated iron or hemes, Fe-S clusters, enzymes, proteins, lipids, cell walls, 
membranes, RNA, and DNA etc) pose a significant threat to microorganisms, and when 
generated within the phagosome in close proximity to bacteria, are important for 
microbial killing and digestion (6) (9) (12) (29) (30).    
From preceding studies, the MPO-independent bactericidal activity of H2O2, 
effective against Porphyromonas gingivalis and all other species tested, was 
demonstrated to be both time- and dose- dependent (31).    A significant range of 
susceptibilities to H2O2 was demonstrated among the various species tested.   Of all the 
species tested, all strains of the periodontal pathogen P. gingivalis were consistently 
more susceptible to low concentrations of H2O2, and experienced logarithmic killing with 
≥20µM H2O2 at one hour.   In comparison, other anaerobic periodontal pathogens, 
Prevotella intermedia and Fusobacterium nucleatum, required approximately 5- and 15-
fold, respectively, higher concentrations of H2O2 to be killed logarithmically at one hour.   
In contrast, the aerotolerant pathogens Aggregatibacter actinomycetemcomitans, 
Staphylococcus aureus, and Streptococcus pyogenes required approximately 100-,  
150-, and 250- fold, respectively, higher concentrations of H2O2 to be killed 
logarithmically at one hour.    Interestingly, however, while there were major differences 
in the susceptibilities of these bacteria to MPO-independent H2O2, there were no 
differences in the susceptibilities of these bacteria to the H2O2 required for MPO-
dependent killing.    As long as there was optimum MPO activity available (to 
presumably exceed the ability of the catalase- producing bacteria to scavenge 
exogenous H2O2), there was no difference in the amount of H2O2 required to kill with 
MPO.    This seemed to suggest that these test bacteria were not different in their 
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susceptibility to the product of the MPO-H2O2 system (HOCl), despite having very 
different susceptibilities to H2O2. 
The objective of the current study was therefore to investigate the differential 
killing mechanisms of H2O2 vs. bleach, in an attempt to better understand how these 
oxidative killing mechanisms may operate in the neutrophil with various bacteria.   To 
begin to address this, select bacteria were challenged with either a bolus of H2O2 or 
sodium hypochlorite (Na+ OCl-, which is the salt form of HOCl generated by the MPO-
H2O2 system in the neutrophil), in order to compare the killing kinetics of H2O2 vs. 
bleach.   The effects of varying temperature and bacterial density on H2O2- vs. bleach- 
mediated killing were also assessed.    Finally, the ability of the hydroxyl radical 
scavenger, dimethyl sulfoxide (DMSO), to protect against H2O2-mediated killing of these 
bacteria was examined.    
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MATERIALS AND METHODS 
 
Bacterial Growth and Storage: 
 Strain A7436 was an original clinical isolate of P. gingivalis, and was chosen for 
its expression of multiple virulence traits considered representative of this 
periodontopathic species.   P. gingivalis A7436 was originally isolated from a patient with 
aggressive periodontitis, and was characterized by the late V.R. Dowell (32), and by this 
laboratory (33) (34) (35) (36) (37), and others (38) (39) (40).   Its virulence 
characteristics have been studied in a variety of animal models (34) (41) (42) (43).   
A7436 is encapsulated and exhibits a remarkable resistance to phagocytosis (33) (34) 
(36) (37).   In the mouse subcutaneous chamber model, A7436 is capable of spreading 
and dissemination, producing secondary lesions away from the injection site, septicemia, 
and death (34) (35) (40).   Due to the hydrophilic nature of its extra-cellular 
polysaccharide layer (capsule), strain  A7436 does not auto-aggregate, clump, or 
associate with neutrophils (44) (45) (46).  It is a Gram-negative short rod, β-hemolytic, 
and readily forms black-pigmentation on blood-based agars.    
 P. gingivalis was grown at 36oC in a flexible film anaerobic chamber (Coy 
Laboratory Products Inc, Ann Arbor, MI) in an atmosphere of 85% N2 – 10% H2 – 5% 
CO2, in 9mL volumes of Wilkins-Chalgren (WC)  Anaerobe Broth Medium (Oxoid Ltd, 
Basingstroke, Hampshire, England) in glass test tubes, without shaking.    For the sake 
of consistency and to minimize mutation, bacteria were freshly grown from minimally 
passaged, aliquoted frozen stocks each week before use in the killing assays.   Briefly, 
100µL aliquots of P. gingivalis (grown in WC to mid-exponential phase or to ~0.5 optical 
density (OD) at Aλ660nm) were stored in 1mL glass vials containing 0.5mL sterilized skim 
milk (Sigma, St. Louis, MO), at -80oC until use.   Individual frozen aliquots were thawed 
at room temperature (RT) and recovered by inoculation into 9mL volumes of non-
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reduced WC.   From this, 3-5 drops (using a sterile plastic transfer pipette) were 
inoculated into fresh 9mL volumes of non-reduced WC, and from this, 1mL was 
inoculated into a second 9mL volume of non-reduced WC to make a 10-fold dilution, and 
placed into the anaerobic incubator for growth.   These broth cultures took approximately 
60 hr to initially recover from frozen stock in WC.   Upon initial visible growth, broth 
cultures were serially diluted (1 drop and 10-fold from that) into fresh 9mL volumes of 
reduced WC.   Bacteria were harvested from overnight cultures (~18 hr) using the 
dilution that best fit early- to mid-exponential phase with an Aλ660nm of 0.2-0.6.   The 
starting inoculum assured that the test bacteria used in all experiments had undergone a 
minimum of five doublings.   Individual frozen aliquots were also checked for purity by 
streaking for isolation on both aerobic and anaerobic blood agar plates.   An absence of 
growth on aerobic blood agar plates (TSA agar with 5% sheep blood (PML 
Microbiologicals, Mississauga, ON, Canada), incubated aerobically at 36oC) and a 
morphologically pure culture on anaerobic blood agar plates (reducible Brucella blood 
agar (Anaerobe Systems, Morgan Hill, CA), incubated anaerobically at 36oC) assured 
purity and was confirmed by Gram stain (agar and broth cultures) and distinct odor.    
The pathogens that were selected for comparison with the catalase-negative, 
strictly anaerobic periodontal pathogen, P. gingivalis, include the catalase-negative, 
microaerophilic periodontal pathogen, Fusobacterium nucleatum; the catalase-positive, 
aerotolerant periodontal pathogen, Aggregatibacter actinomycetemcomitans; the 
catalase-positive, aerotolerant pathogen, Staphylococcus aureus; and the catalase-
negative, but peroxidase-positive, aerotolerant pathogen, Streptococcus pyogenes (both 
S. aureus and S. pyogenes are pathogens in subjects with neutrophil dysfunctions).    
Fusobacterium nucleatum strain 1594, and Aggregatibacter actinomycetemcomitans 
strain A7154 (leukotoxin-producing, serotype b clinical isolate) were grown and stored in 
an identical manner to P. gingivalis strain A7436.   Staphylococcus aureus strain 25923 
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and Streptococcus pyogenes strain 19615 were also grown in WC broth at 36oC, but in 
ambient atmosphere.  
 
Cell-Free Killing Assays 
All killing assays were performed in vitro, in cell-free, aerobic conditions, in 1X 
sterile filtered phosphate buffered saline (PBS) (0.0067 PO4) without calcium or 
magnesium (HyClone Laboratories, Thermo Scientific, Logan, Utah).   All reagents were 
freshly prepared just prior to the start of experiments, and were equilibrated to RT 
(unless otherwise stated) in ambient atmosphere before use.   Bacteria were prepared 
last (after reagents) to maximize their viability.     
Briefly, bacteria were harvested from ~18 hr overnight cultures (grown in WC at 
36oC, either anaerobically or aerobically, depending on species; see above), using the 
broth culture that best fit early- to mid-exponential phase with an OD of 0.2-0.6 at Aλ660nm 
(see above).   All bacteria were adjusted in aerobic conditions with non-reduced WC to a 
final Aλ660nm = 0.1, using a spectrophotometer (Beckman, Fullerton, CA).   Bacteria were 
then serially diluted in PBS (non-reduced) by performing three 10-fold dilutions, and then 
diluted by one-half after the addition of reagents in experiments.   Done this way, the 
final bacterial densities in experiments was consistently between 4.2-5.2 log10 CFU/mL.   
All killing assays were set up at RT (unless otherwise stated) in 1mL final volumes (FV) 
in 1.7mL polypropylene centrifuge tubes (VWR International, West Chester, PA).   
Following set-up and initial plating (0 time), tubes were placed in a 37oC Fisher isotemp 
dry bath (Fisher Scientific Company, Fairlawn, NJ) (unless otherwise stated) without 
shaking, until subsequent time points.    
At each time point, samples were briefly vortexed (<1 s) and either spiral plated 
(Spiral Systems, Bethesda, MD) or plated by delivering 10µL of sample (spot assayed) 
to the surface of non-reduced WC agar (Oxoid Ltd), for growth and bacterial 
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enumeration.   In some experiments, detection of logarithmic differences in recoverable 
CFU was sufficient, so samples plated by the spot assay method (10µL of sample 
delivered as a localized drop or spot to the surface of an agar plate) was more practical 
because it allowed dozens of samples to be compared side by side on the same plate, 
capturing more data on one plate and conserving materials and time, with the additional 
benefit that it allowed easy detection of logarithmic differences in recoverable CFU 
between samples.   Logarithmic reductions in bacterial densities per spot were estimated 
by comparison to calibration standard controls, which were serially diluted 10-fold.   
Results in these experiments were approximated to the nearest log and were reported 
as either % recoverable log10 CFU/mL (Table 4.1) or recoverable log10 CFU/mL (Table 
4.3).   All other data reported (Figures 4.1 and 4.2 and Table 4.2) were quantitated by 
spiral plating and were reported as recoverable log10 CFU/mL.    The densities of the 
bacterial suspensions permitted direct spiral plating without dilution.   After the growth of 
countable colonies, plates were enumerated by an automatic colony counter with 
computer software (ProtoCOL, Synbiosis USA, Frederick, MD) specifically programmed 
for determining spiral plated counts.   Logarithmic reductions in recoverable CFU/mL 
were considered significant.   The lower limit of detection in samples enumerated by the 
spot assay method was 2.0 log10 CFU/mL, and the limit of detection in samples 
enumerated by the spiral plate method was 1.31 log10 CFU/mL.   Samples plated both 
ways were plated at least in duplicate, and colony counts were averaged.   Data are 
representative of three or more independent experiments using overlapping 
concentrations of test reagents and progressive refinement of the dilutions around the 
effective concentrations. 
After plating, agar surfaces were briefly allowed to dry in ambient air (dried within 
5 min of plating), and were quickly placed into the anaerobic chamber incubator (for P. 
gingivalis, F. nucleatum, and A. actinomycetemcomitans) or aerobic incubator (for S. 
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aureus and S. pyogenes) for growth.   Plates were incubated at 36oC, and recoverable 
CFU were countable after 4-6 days for P. gingivalis; after 2-3 days for F. nucleatum, A. 
actinomycetemcomitans, and S. pyogenes; and after 1 day for S. aureus.   Inhibitory 
concentrations of hydrogen peroxide or bleach with any bacterial species often resulted 
in recoverable CFU that were smaller or took longer to grow than controls. 
 
Hydrogen Peroxide (H2O2) Killing Assays  
Dilutions of H2O2 were freshly prepared in PBS before each experiment from a 
30% w/w stock solution (Sigma), and molar concentrations (c) were determined using 
the Beer’s Law formula, A = cbε, where A was the OD of the H2O2 dilution in PBS at 
Aλ230nm in a quartz cuvette,  ε was an 81 cm-1M-1 extinction coefficient, and b equaled 1.   
Known concentrations of H2O2 were then titrated in PBS.   500µL of bacteria were added 
to 500µL of H2O2 (or 500µL of PBS), and samples were either spot or spiral plated (see 
above) over time in order to discern killing kinetics. 
In temperature studies (Figure 4.1), the effect of varying temperature on H2O2-
mediated killing of P. gingivalis was examined.    Small volumes of P. gingivalis (~3.5mL) 
and the various H2O2 dilutions (~1mL each), separately contained in 5mL polypropylene 
culture tubes (VWR International), were either pre-incubated in an ice water bath (1oC), 
in a water bath at RT, or in a water bath maintained at 37oC, for at least 15 min for 
equilibration to these temperatures.   After 15 min of equilibration and just prior to being 
combined (the start of the experiment), bacteria and H2O2 were briefly vortexed.   Empty 
reaction tubes (1.7mL polypropylene centrifuge tubes, VWR) were also pre-equilibrated 
in the various temperature baths, and experiments were completely set-up and 
performed in the various water baths in which they were equilibrated (ice, RT, 37oC).  
For instance, bacteria and H2O2 that had been chilled on ice for 15 min were combined 
on ice in reaction tubes that had also been chilled on ice.   500µL of bacteria (final 
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bacterial density approximately 5.0 log10 CFU/mL) were added to 500µL of H2O2 (titrated 
using 2-fold dilutions from 100µM, final concentration (FC)) (or 500µL of PBS) in the 
three test temperature conditions.   Samples were incubated in their respective 
temperature baths for the duration of the experiment, with the exception of brief 
vortexing and spiral plating at initial time and at 60 min. 
In bacterial density studies (Table 4.3), the effect of varying bacterial density on 
H2O2-mediated killing of P. gingivalis and S. aureus was examined.    P. gingivalis and S. 
aureus were titrated 10-fold, so that final bacterial densities varied logarithmically from 
8.0 – 3.0 log10 CFU/mL after the addition of hydrogen peroxide (FC listed in µM).    
Samples were spot assayed (see above), in order to discern logarithmic differences in 
recoverable CFU/mL between samples.   Since the limit of detection was 2.0 log10 
CFU/mL, a maximum of one log reduction could be detected in samples containing a 
bacterial density of 103 CFU/mL, and a maximum of six log reductions could be detected 
in samples containing a bacterial density of 108 CFU/mL.   Note:  Results denoted as <2 
recoverable log10 CFU/mL indicates no recoverable CFU on replicate plating.   Results 
denoted as 8 recoverable log10 CFU/mL, for instance, in samples with a starting 
inoculum of 108 CFU/mL, indicate no logarithmic reductions detected, and so on.    
In the dimethyl sulfoxide (DMSO) studies (Figure 4.2), the effect of DMSO on 
H2O2-mediated killing was examined with select bacteria.   DMSO (Pierce, Rockford, IL) 
was diluted in PBS and titrated using 10-fold dilutions from 100mM.  H2O2 was also 
titrated in PBS (FC listed in µM).  
 
 Reagents were added quickly with consistent timing 
to reaction tubes, with brief vortexing (<1 s) after each addition.  In order to favor the 
activity of DMSO, DMSO was present with the bacteria before challenge with H2O2.   
Hence, reagents were added in the following order:  1st: 250µL of DMSO (or 250µL of 
PBS), 2nd: 500µL of bacteria, 3rd: 250µL of H2O2 (or 250µL of PBS).   After all reagents 
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were combined, vortexing following the addition of H2O2 started the experiment (0 time), 
and all samples were spiral plated at 0 and 60 min. 
 
Bleach Killing Assays  
 Dilutions of sodium hypochlorite (bleach) were freshly prepared in PBS before 
each experiment from a stock solution of 6.15% vol/vol Na+ OCl- (Clorox Bleach, 
Oakland, CA) that was opened for the first time.    Sodium hypochlorite concentrations 
were titrated using either 2- or 10-fold dilutions, starting from different initial 
concentrations based on the progression of the outcome of experiments, and are 
expressed as % FC, vol/vol.    Each repetition included overlapping concentrations. 
In temperature studies (Table 4.1), the effects of varying temperature on sodium 
hypochlorite-mediated killing of P. gingivalis were examined.   Small volumes of P. 
gingivalis (~4mL) and the various dilutions of bleach (~0.5mL each), separately 
contained in 5mL polypropylene culture tubes (VWR International), were either pre-
incubated in an ice water bath (1oC) or in a water bath maintained at 37oC, for at least 15 
min for equilibration to these temperatures.    After 15 min of equilibration and just prior 
to being combined (the start of the experiment), bacteria and the bleach dilutions were 
briefly vortexed.   Empty reaction tubes (1.7mL polypropylene centrifuge tubes, VWR) 
were also pre-equilibrated in the temperature baths, and experiments were completely 
set-up and performed in the water bath in which they were equilibrated (ice or 37oC).   
500µL of bacteria (final bacterial density 5.0 log10 CFU/mL ) were added to 500µL of 
bleach (or 500µL of PBS).   Samples were incubated in either ice or at 37oC for the 
duration of the experiment, with the exception of brief vortexing and plating (spot 
method) at 0, 1, and 2 hr.    
In Table 2, the killing kinetics of select bacteria with sodium hypochlorite were 
compared at 37oC.   500µL of bacteria (starting inoculums between 4.4 – 4.8 log10 
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CFU/mL, final bacterial densities) were added to 500µL of bleach (or 500µL of PBS).   
Samples were incubated at 37oC in a Fisher isotemp dry bath for the duration of the 
experiment, with the exception of brief vortexing and spiral plating at 0 and 60 min.  
In bacterial density studies (Table 4.3), the effects of varying bacterial density on 
sodium hypochlorite-mediated killing of P. gingivalis and S. aureus were examined.    P. 
gingivalis and S. aureus were titrated using 10-fold dilutions, so that final bacterial 
densities varied logarithmically from 8.0 – 3.0 log10 CFU/mL after the addition of bleach.   
Bleach was titrated using 10-fold dilutions from 1% v/v.  
 
Samples were spot assayed 
(see above), in order to discern logarithmic differences in recoverable CFU/mL between 
samples.   Since the limit of detection was 2.0 log10 CFU/mL, a maximum of one log 
reduction could be detected in samples containing a bacterial density of 103 CFU/mL, 
and a maximum of six log reductions could be detected in samples containing a bacterial 
density of 108 CFU/mL.   Note:  Results denoted as <2 recoverable log10 CFU/mL 
indicates no recoverable CFU on replicate plating.   Results denoted as 8 recoverable 
log10 CFU/mL, for instance, in samples with a starting inoculum of 108 CFU/mL indicates 
no logarithmic reductions detected, and so on.    
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RESULTS 
 
H2O2-Mediated Killing is Temperature- Dependent 
The effects of varying temperature on H2O2-mediated killing of P. gingivalis were 
examined after 60 min of incubation (Figure 4.1).   As was seen in previous studies (31), 
concentrations of H2O2 in excess of 12.5µM resulted in exponential killing of P. gingivalis 
at 60 min and at 37oC.   There was a significant reduction in the effectiveness of H2O2 at 
room temperature (100µM was required for logarithmic reduction), and killing was totally 
eliminated when the reaction mixture was maintained on ice.   This protection on ice was 
evident for P. gingivalis even with H2O2 concentrations 100-times higher than the 
minimal bactericidal concentration (data not shown).    Ice also protected S. aureus from 
bactericidal concentrations of H2O2 (data not shown). 
 
Sodium Hypochlorite-Mediated Killing is Time- and Temperature- Independent 
As can be seen in Table 4.1, the bactericidal activity of sodium hypochlorite 
(bleach) was dose-dependent and was evident upon initial plating, suggesting that killing 
with bleach resulted on contact.   Unlike the activity of H2O2, there was no temporal 
progression of killing with bleach.   Furthermore, there was no influence of temperature, 
as treatment on ice resulted in killing activity equivalent to that at 37oC.   Likewise, the 
killing of S. aureus with bleach was equivalent at 37oC and on ice (data not shown). 
Previous studies have indicated that there is a range of susceptibilities among 
the various species tested to MPO-independent H2O2 bactericidal activity; however, P. 
gingivalis is consistently the most sensitive species to H2O2 in the absence of MPO (31).    
In contrast, these same species were susceptible to the same H2O2 concentrations in 
the MPO system (31).   To extend this comparison, the susceptibilities of these species 
to bleach, as well as the killing kinetics with bleach, were determined in comparison to 
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that of P. gingivalis (Table 4.2).   Consistent with the bactericidal activity in the MPO 
system (31), the susceptibilities of F. nucleatum, S. aureus, and S. pyogenes to bleach 
were strikingly similar to that found with P. gingivalis (Table 4.2).   Furthermore, with all 
bactericidal concentrations of bleach, there were immediate logarithmic reductions in 
recoverable CFU/mL with each of the target bacteria, and very little evidence of killing 
progression over time in the presence of bleach.   Identical susceptibilities to bleach 
were also observed with other tested bacteria, including P. intermedia and A. 
actinomycetemcomitans (data not shown).  
 
The Effects of Bacterial Density on H2O2- vs. Sodium Hypochlorite-Mediated 
Killing  
In the next series of experiments (Table 4.3), the densities of P. gingivalis and S. 
aureus were varied relative to titrated concentrations of either H2O2 or bleach, in order to 
determine the influence of varying target to bactericidal agent ratios, on outcome.   Again 
there was no evidence of bacterial killing at the initial time point with H2O2, despite its 
relative increase in concentration to target ratio.   This means that not only did the 
bacteria survive initial contact, but that there was no continued effect after plating.   
These experiments were done as spot assays so there were none of the dilution effects 
characteristic of spiral plating.   Additionally, the non-lethal concentrations of 6.25µM 
H2O2 and 600µM H2O2 for 105 CFU/mL of P. gingivalis and S. aureus, respectively, were 
insufficient doses to kill any bacterial density, after 60 min of treatment.   As in previous 
experiments (31), treatment of 105 CFU/mL of P. gingivalis or S. aureus with either 
12.5µM or 2000µM H2O2, respectively, resulted in one logarithmic reduction in 
recoverable CFU/mL by 60 min (Table 4.3).   Furthermore, these concentrations resulted 
in one logarithmic reduction despite increasing the target bacterial density 1,000-fold, or 
187 
 
decreasing the target bacterial density 100-fold.   Two-fold increases in H2O2 generally 
resulted in logarithmic increases in killing regardless of bacterial density.     
 In contrast to H2O2, bleach killed P. gingivalis and S. aureus at initial time (0 min), 
when challenged with a sufficient (lethal) dose (≥0.001% Na+ OCl- v/v), and showed only 
a hint of killing progression over time with certain concentrations of bleach, unlike H2O2 
(Table 4.3).   Additionally, in contrast to H2O2, bleach (at 0.001% and 0.01% Na+ OCl- 
v/v) killed the lower bacterial densities of P. gingivalis and S. aureus better than the 
higher bacterial densities, at 0 and 60 min.   In fact, 0.001% Na+ OCl- v/v killed the lower 
densities of P. gingivalis and S. aureus (≤105 CFU/mL) completely at 60 min, while there 
was no evidence of killing at the higher bacterial densities (≥106 CFU/mL) with this same 
concentration of bleach.    Similarly, 0.01% Na+ OCl- v/v killed the lower densities of P. 
gingivalis and S. aureus (≤107 CFU/mL) at 60 min, while the highest bacterial density 
(108 CFU/mL) of P. gingivalis and S. aureus was not killed at all.   With the next 
logarithmically higher bleach concentrations (0.1% and 1% Na+ OCl- v/v), however, 
every bacterial density of P. gingivalis and S. aureus was killed completely at 0 and 60 
min.   
 
Effect of DMSO on H2O2-Mediated Killing 
 The killing kinetics, temperature requirements, and the effects of bacterial density 
on the bactericidal activities of H2O2 were consistent with a requirement for bacterial 
conversion of H2O2 to a lethal product.   The possible nature of this product was 
examined with the hydroxyl radical scavenger, DMSO (47), as a competitor of H2O2-
mediated killing of P. gingivalis, F. nucleatum, A. actinomycetemcomitans, and S. aureus 
(Figure 4.2).    DMSO was titrated in 10-fold increments, starting from 100mM FC.   The 
outcome measure was recovery of log10 CFU/mL by spiral plating.  Logarithmic 
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protection from killing (≥1 log increases in recoverable CFU/mL) in the presence of 
DMSO was considered significant.   
 As was previously determined, there was a broad range of susceptibilities to 
H2O2 for these selected bacterial species and the titrated concentrations were varied 
accordingly to allow the expression of bactericidal activity against each species (Figure 
4.2).   There was dose-dependent protection with DMSO against the bactericidal 
activities of H2O2 with all four species.   With all four species, there was significant 
protection with 100mM DMSO and no effect with 0.1mM DMSO.   The protective effects 
of DMSO were most evident with the most H2O2-resistant species tested, S. aureus.   
These data support hydroxyl radical as the effector mechanism of H2O2-mediated killing 
of P. gingivalis, F. nucleatum, A. actinomycetemcomitans, and S. aureus.   
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DISCUSSION 
In previous studies, it was determined that the overt periodontopathogen, P. 
gingivalis, was remarkably resistant to killing by oxygen-independent mechanisms 
operating in the phagolysosome of a neutrophil, as there was no evidence of killing by 
normally competent neutrophils equilibrated in an anaerobic environment (48).  This was 
in striking contrast to the highly efficient, though reduced, phagolysosome killing of the 
aerotolerant periodontopathogen, A. actinomycetemcomitans, under anaerobic 
conditions.   Neutrophil-dependent killing of a second anaerobic periodontal bacterium, 
F. nucleatum, was also dramatically reduced in the absence of oxygen, but unlike with P. 
gingivalis, there was evidence of significant, though markedly delayed, killing, 
suggesting that this species shows some degree of sensitivity to oxygen-independent 
killing.  Chemical (DPI) inhibition of the NADPH oxidase of the neutrophil also totally 
ablated killing of P. gingivalis, consistent with the inability of the NADPH oxidase-
dysfunctional neutrophils of chronic granulomatous disease (CGD) patients to kill this 
pathogen (48).   In contrast, DPI minimally reduced neutrophil killing of A. 
actinomycetemcomitans, and had substantial, but not total, inhibitory effects on the 
killing of F. nucleatum (48).    These data were consistent with the relative sensitivities of 
these three pathogens to MPO-independent H2O2-mediated killing (31). 
Myeloperoxidase-deficient neutrophils demonstrated efficient killing of P. 
gingivalis that was indistinguishable from that of MPO-sufficient control neutrophils (48).   
In contrast, selective inhibition of MPO with 4-ABH significantly delayed the killing 
progression of P. gingivalis by otherwise competent neutrophils in atmospheric oxygen 
(48).   Subsequent studies determined that H2O2 was capable of MPO-independent 
killing that was actually totally blocked in the presence of MPO (31).  The species, P. 
gingivalis, proved to be exceptionally sensitive to H2O2, compared to a range of 
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resistances for other species (31).  In contrast, an MPO-dependent killing was 
demonstrable with sub-cidal concentrations of H2O2.   All species, independent of their 
relative differences in sensitivities to H2O2, were killed by the same optimal concentration 
of H2O2 in the MPO-dependent system (31).   These studies do not resolve what is 
actually happening in the phagosome and how this might differ from one target species 
to another.   
The current studies clearly indicate that the principal purported bactericidal 
product of the MPO system, hypochlorite, is capable of potent killing of a range of target 
species.   Surprisingly, these species were all killed by the same concentration of 
hypochlorite, if adjusted to the same number of target colony forming units (Table 4.2).  
This activity was energy-independent (no temperature effect) and the killing event was 
initiated on contact, as there was no significant progression of killing beyond the initial 
plating (time 0) (Table 4.1).  These data suggest that a critical concentration of 
hypochlorite, generated in proximity to any of the target species, would result in an 
immediate lethal hit.   If hypochlorite is responsible for the lethal outcome in the MPO-
dependent killing of the previous studies (31), then the time required to kill must relate to 
the enzymatic kinetics necessary to reach critical lethal concentrations.   
Our previous data would also suggest that hypochlorite is only generated by 
MPO across a very limited range of H2O2 concentrations in the presence of non-limiting 
concentrations of chloride (31).  The maximum concentration of hypochlorite achievable 
at optimal H2O2 concentrations would be at 5µM (31).   The 1% (v/v) treatment solution 
of the bleach reagent used in these experiments is estimated to contain ~70µM NaOCl.   
Dilutions to 0.001% (~70nM) were effective at killing 105 CFU/mL of target bacteria, but 
ten-fold more (~700nM) was required to affect killing of 106 CFU/mL and to give the first 
evidence of a temporal requirement with 107 CFU/mL, with both P. gingivalis and S. 
aureus (Table 4.3).  Micromolar concentrations of hypochlorite were required to kill 108 
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CFU/mL.   It is likely that at concentrations of <0.001%, the bleach is effectively 
neutralized by the reaction environment, as there was no evidence of killing with 
0.0001% bleach, even with a 100-fold reduction in target bacteria density (Table 4.3).  It 
is therefore estimated that a maximum of 90% of the bleach would be available for 
interaction with the bacteria in the 0.001% treatment mixture.     
From this it can be estimated that a maximum of 60pmoles of reactive 
hypochlorite would be available in a one mL volume, resulting in a ratio of 106 molecules 
of NaOCl/ CFU of target bacteria.   The best estimate for the minimum lethal number of 
molecules of hypochlorite would best be derived from the 0.01% treatment of 107 
CFU/mL, as the delay in evident killing was apparent at this ratio of agent to target 
(Table 4.3).   This would suggest that treatment conditions containing a minimum of 105 
molecules of hypochlorite per target CFU would be required to achieve a lethal hit.  The 
Winterbourn model (15) of ROS reactions in the neutrophil phagosome estimates that 
HOCl would be generated at the rate of 134mM/min in the phagosome volume.   This 
would result in concentrations orders of magnitude greater than that necessary to affect 
a lethal hit based on the observations in the current study.   This excess quantity may be 
necessary to overcome the competition from the protein- rich environment of the 
phagosome.    
An assumption of the Winterbourn model (15) is that O2.- and H2O2 are generated 
initially in the presence of optimal concentrations of MPO.   In this model (15), H2O2 is 
consumed by MPO as rapidly as it is derived from the dismutation of O2.-  to yield a 
steady state concentration of H2O2 in the low micromolar range.   In contrast to this 
model, however, the NADPH oxidase is assembled in active form on the phagosome 
membrane surface, primarily from fusion with the secretory specific granule, prior to the 
delivery of MPO-containing lysosomal primary granules (1) (2) (3) (4) (5) (11).  This 
would result in the generation of 5.2mM/sec of O2.- and dismutation to H2O2 in immediate 
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proximity and in high concentration to the bacterial target, at least initially in the absence 
of the influence of MPO.   It therefore is of importance to consider the nature of the 
interactions of H2O2 that lead to the lethal events previously described (15). 
Unlike hypochlorite, exposure of target bacteria to lethal concentrations of MPO-
independent H2O2 resulted in a progressive loss of recoverable CFU, with no killing 
evident on initial contact, even at concentrations in great excess of that necessary to 
totally kill (Table 4.3) (31).   Reducing the treatment concentrations of H2O2 lengthened 
the time it took to observe killing (31).  It is important to note that in order to achieve 
logarithmic reductions in CFU of P. gingivalis by 60 min, a concentration of ~20µM H2O2 
was required; while even 6.25µM was bactericidal if the treatment was allowed to 
continue to 180 min (31).   All concentrations killed better the longer treatment was 
continued.   This is in striking contrast to the all-or-none activity of NaOCl (Tables 4.1-3).   
Further insight into the action of H2O2 can be gained from examining the 
influence of altering the target densities of the bacteria, relative to the treatment 
concentrations of H2O2 (Table 4.3).  Consistent with all previous observations with P. 
gingivalis (31), there was a logarithmic reduction in the population density of 105 
CFU/mL, after 60 min of treatment with 12.5µM, and no detectable reduction at 6.25µM 
(Table 4.3).   Unlike with bleach, this concentration (12.5µM) also affected logarithmic 
reductions with each of the higher densities including 108 CFU/mL.   Conversely, this 
concentration resulted in logarithmic, but not total, killing of the lower densities of 
bacteria, and these reductions in bacterial density did not permit lower concentrations of 
H2O2 to kill.  Each two-fold increase in H2O2 concentration resulted in a logarithmic 
increase in killing of P. gingivalis through 100µM (Table 4.3).   As previously determined 
(31), the concentration of H2O2 required to affect logarithmic reductions in S. aureus 
were exponentially higher, but the killing properties were affected in the same way by 
altering target density as with P. gingivalis (Table 4.3).  In contrast, 0.001% NaOCl 
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resulted in a three log reduction in the 105 CFU/mL suspensions of both P. gingivalis and 
S. aureus at 60 min, but failed to kill ≥106 CFU/mL, while totally killing ≤105 CFU/mL 
(Table 4.3).  Increasing the concentration of NaOCl directly increased the number of 
bacteria that were killed.   Despite the increased resistance of S. aureus to H2O2, the 
susceptible target densities as CFU/mL for NaOCl were identical for P. gingivalis and S. 
aureus (Tables 4.3). 
These data are consistent with the hypothesis that bleach is directly and 
immediately toxic; whereas, H2O2 requires conversion to something else in order to kill.  
The fact that the bactericidal activity was concentration-dependent, but independent of 
target density, is consistent with each target bacterium acting on the H2O2 in its 
immediate vicinity, and converting it to a more reactive lethal product.   H2O2 is freely 
diffusible and relatively non-reactive (6) (7) (8).   In the presence of exogenous H2O2, a 
bacterium would likely achieve a critical bactericidal concentration of H2O2 within the 
periplasmic membrane that is then converted to more reactive ROS in proximity to vital 
targets such as DNA.   This reaction is likely energy-dependent and possibly dependent 
on the metabolism of the target bacteria (17).   This would explain the temperature-
dependence for H2O2 toxicity and the kinetics of killing (Figure 4.1).   If the lethal hit is 
delivered to the interior of each target, then this would explain the varied concentration 
requirements of the treatment environment, but the lack of influence by changing 
bacterial density (Table 4.3).   Bacteria that are able to reduce the environmental 
concentrations of H2O2 (e.g. the catalase- producers such as S. aureus and A. 
actinomycetemcomitans) would require greater concentrations to raise the internal H2O2 
to lethal levels.   Likewise, bacteria that are capable of converting H2O2 post-diffusion to 
more innocuous products (e.g. the cytosolic peroxidases of streptococci) would also 
require higher exogenous concentrations.    
194 
 
It is clear that H2O2 in the presence of a suitable transition metal can be 
converted to the highly reactive and potentially toxic product, OH., through the Fenton 
reaction (7) (10) (13) (16) (17) (22) (23) (24) (25) (26) (27), though there is controversy 
regarding whether this ROS plays any role in the bactericidal activity in the phagosome 
due to competition of H2O2 with MPO (49).  In our previous studies with human 
neutrophils, we reported that sodium azide totally inhibited phagosome killing of P. 
gingivalis, not only in normally competent neutrophils, but also with MPO-deficient 
neutrophils (48).  These observations, plus the lack of similar effect using 4-ABH 
treatment, suggested that P. gingivalis was being killed by an azide-inhibitable, MPO-
independent mechanism (48).   In addition to a number of other properties, azide is 
reported to scavenge OH. (50).   In an attempt to determine if OH. was contributing to the 
toxicity of MPO-independent H2O2 bactericidal activity, the highly specific OH. scavenger 
(47), DMSO, was examined to determine its ability to inhibit H2O2-mediated killing of the 
various target bacteria (Figure 4.2).   These data indicate that killing of each of the 
bacteria, regardless of their H2O2 requirements for killing, could be significantly reduced 
with DMSO.   Given the reactive nature of OH. (6) (7) (10) (13) (16) (17) (22) (23) (24) 
(25) (26) (27), and the presumed proximity to the susceptible target that this ROS must 
be generated, any protective effect by DMSO is highly suggestive of the involvement of 
OH. in killing.   
These studies suggest that if bacteria are exposed to levels of H2O2 sufficient to 
reach critical lethal concentrations inside the cell, then this could be an effective vehicle 
for delivery of OH..  In previous studies, it was reported that the presence of low 
concentrations of MPO would subvert this bactericidal activity (31).  Inhibition by MPO 
assumes that it has access to H2O2 on the outside of the cell before it has had a chance 
to diffuse to the target sites.  Once within the bacterial membrane, MPO would be 
ineffective at neutralizing the bactericidal progression of H2O2.   During the process of 
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encountering an opsonized target, there is a hierarchical delivery of discrete granule 
subsets through fusion with the plasma membrane and the developing phagosome (1) 
(2) (3) (4) (5) (11).  This results in an ordered delivery of the granule defining 
constituents contained in both the milieu of the matrix and in the granule membrane.  
This process results in prescribed progressive exposure of the phagocytized target to a 
discretely changing environment.    
In particular consideration for the studies reported here, the first granules and 
subcellular membrane vesicles shown to be delivered are those containing the 
membrane constituent components of NADPH oxidase, followed quickly by the 
mobilization of the cytosolic constituents, resulting in an active enzyme complex that 
rapidly consumes oxygen to generate O2.-  at a rate estimated to approach 5.2mM/sec, 
delivering both O2.- and H2O2 to the surface of the bacteria in the initial absence of MPO.   
This high level of NADPH oxidase products in the small volume of the phagosome could 
quickly result in critical concentrations of H2O2 within the interior of the bacteria that may 
even be facilitated by the production of superoxide dismutase, but not catalase or 
peroxidase by the bacteria, as would be the case with P. gingivalis.   This could even be 
true for the mM concentrations of H2O2 necessary to kill the more resistant target 
bacteria.  The MPO would then be delivered by the later arriving azurophilic granules 
(11) that presumably would subvert the NADPH oxidase products away from H2O2 to 
mM concentrations of HOCl, and a steady state of O2.- and low levels of H2O2 that would 
preserve the peroxidatic activity of the enzyme.   This suggests that both MPO-
independent and MPO-dependent mechanisms of H2O2-mediated killing may be 
progressively functioning in the phagosome.   
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Figure 4.1.  Effects of Temperature on Hydrogen Peroxide-Mediated Killing of             
P. gingivalis at 60 min.  Results are expressed as recoverable log10 CFU/mL.  Samples 
were spiral plated (limit of detection: 1.31 log10 CFU/mL), and logarithmic differences in 
recoverable CFU/mL were considered significant.   Samples were plated at least in 
duplicate, and colony counts were averaged.   Data are representative of three 
independent experiments.   Experiments were performed in water baths either with ice, 
at room temperature (RT), or at 37oC.   Bacteria and H2O2 were equilibrated for at least 
15 minutes on ice, at RT, or at 37oC before the start of these experiments.  Asterisks 
indicate significant differences from the 37oC treatment values.  
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Table 4.1.  Effects of Time and Temperature on Sodium Hypochlorite-Mediated 
Killing of P. gingivalis.  Sodium hypochlorite (bleach) concentrations are expressed as 
% final concentrations, vol /vol.  Treatment volumes contained a final density of ~105 
CFU/mL of P. gingivalis.   Since the limit of detection was 2.0 log10 CFU/mL, a maximum 
of three log reductions could be detected.   Killing was expressed as % recoverable log10 
CFU/mL, where 100% recoverable CFU/mL indicates no logarithmic reductions detected 
(no killing) and <0.1% recoverable CFU/mL indicates there were no recoverable CFU.  
Samples were plated at least in duplicate.   Data are representative of three independent 
experiments.   Experiments were performed in water baths either at 37oC or with ice.  
Bacteria and H2O2 were equilibrated for at least 15 minutes at 37oC or on ice before the 
start of these experiments. 
 
37oC % Recoverable CFU/mL Ice % Recoverable CFU/mL 
% Bleach t = 0 hr t = 1 hr t = 2 hr % Bleach t = 0 hr t = 1 hr t = 2 hr 
0 100 100 100 0 100 100 100 
10-6 100 100 100 10-6 100 100 100 
10-5 100 100 100 10-5 100 100 100 
10-4 100 100 100 10-4 100 100 100 
10-3 1 <0.1 <0.1 10-3 1 <0.1 <0.1 
10-2 <0.1 <0.1 <0.1 10-2 <0.1 <0.1 <0.1 
10-1 <0.1 <0.1 <0.1 10-1 <0.1 <0.1 <0.1 
1 <0.1 <0.1 <0.1 1 <0.1 <0.1 <0.1 
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Table 4.2.   Killing Kinetics of P. gingivalis, F. nucleatum, S. aureus, and  
S. pyogenes with Sodium Hypochlorite at 37oC at 0 and 60 min.    Sodium 
hypochlorite (bleach) concentrations are expressed as % final concentrations, vol /vol.   
Samples were spiral plated (limit of detection: 1.31 log10 CFU/mL, where <1.31 indicates 
no recoverable CFU on replicate plating), and logarithmic reductions in recoverable 
CFU/mL were considered significant.   Samples were plated at least in duplicate, and 
colony counts were averaged.   Data are representative of three independent 
experiments.    
 
Recoverable Log10 CFU/mL 
 
 P. gingivalis 
 
 F. nucleatum 
 
 S. aureus 
 
% Bleach  0 min 60 min  0 min 60 min  0 min 60 min 
0  4.64 4.6  4.4 4.16  4.51 4.46 
2 x 10-6  4.65 4.69  4.38 4.21  4.54 4.45 
2 x 10-5  4.6 4.62  4.37 4.18  4.52 4.47 
2 x 10-4  4.68 4.65  4.38 4.2  4.51 4.49 
2 x 10-3  <1.31 <1.31  <1.31 <1.31  <1.31 <1.31 
2 x 10-2  <1.31 <1.31  <1.31 <1.31  <1.31 <1.31 
2 x 10-1  <1.31 <1.31  <1.31 <1.31  <1.31 <1.31 
2 x 100  <1.31 <1.31  <1.31 <1.31  <1.31 <1.31 
 
 
Recoverable Log10 CFU/mL 
 
 P. gingivalis 
 
 S. aureus 
 
 S. pyogenes 
 
% Bleach  0 min 60 min  0 min 60 min  0 min 60 min 
0  4.79 4.7  4.51 4.41  4.47 4.44 
3.13 x 10-4  4.74 4.75  4.51 4.39  4.48 4.48 
6.25 x 10-4  4.77 4.68  4.63 4.5  4.53 4.52 
1.25 x 10-3  2.76 <1.31  2.42 <1.31  2.35 <1.31 
2.5 x 10-3  <1.31 <1.31  <1.31 <1.31  <1.31 <1.31 
5 x 10-3  <1.31 <1.31  <1.31 <1.31  <1.31 <1.31 
1 x 10-2  <1.31 <1.31  <1.31 <1.31  <1.31 <1.31 
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Table 4.3.  Effects of Varying Bacterial Density on Hydrogen Peroxide- vs. Sodium 
Hypochlorite- Mediated Killing of P. gingivalis and S. aureus at 37oC at 0 and 60 
min.    Results are expressed as recoverable log10 CFU/mL.   H2O2 concentrations are 
expressed as FC in µM, and sodium hypochlorite (bleach) concentrations are expressed 
as % FC, vol /vol.  P. gingivalis and S. aureus were titered 10-fold, so that starting 
inoculums varied logarithmically per sample, from 108 – 103 log10 CFU/mL, final 
concentration.   Limit of detection was 2.0 log10 CFU/mL; <2 indicates no recoverable 
CFU on replicate plating.   Samples were plated at least in duplicate, and colony counts 
were averaged.   Data are representative of three independent experiments.    
 
 
0 min 
P. gingivalis 
Recoverable Log10 CFU/mL 
 
0 min 
P. gingivalis 
Recoverable Log10 CFU/mL 
[H2O2] in 
µM 103 104 105 106 107 108 % Bleach 103 104 105 106 107 108 
0 3 4 5 6 7 8 0 3 4 5 6 7 8 
6.25 3 4 5 6 7 8 10-4 3 4 5 6 7 8 
12.5 3 4 5 6 7 8 10-3 <2 <2 3 6 7 8 
25 3 4 5 6 7 8 10-2 <2 <2 <2 <2 7 8 
50 3 4 5 6 7 8 10-1 <2 <2 <2 <2 <2 <2 
100 3 4 5 6 7 8 1 <2 <2 <2 <2 <2 <2 
 
60 min  
  
60 min 
 [H2O2]  103 104 105 106 107 108 % Bleach 103 104 105 106 107 108 
0 3 4 5 6 7 8 0 3 4 5 6 7 8 
6.25 3 4 5 6 7 8 10-4 3 4 5 6 7 8 
12.5 2 3 4 5 6 7 10-3 <2 <2 <2 6 7 8 
25 <2 2 3 4 5 6 10-2 <2 <2 <2 <2 4 8 
50 <2 <2 2 3 4 5 10-1 <2 <2 <2 <2 <2 <2 
100 <2 <2 <2 2 3 3 1 <2 <2 <2 <2 <2 <2 
 
 
0 min 
S. aureus 
Recoverable Log10 CFU/mL 
 
0 min 
S. aureus 
Recoverable Log10 CFU/mL 
[H2O2]  103 104 105 106 107 108 % Bleach 103 104 105 106 107 108 
0 3 4 5 6 7 8 
0 3 4 5 6 7 8 
10-4 3 4 5 6 7 8 
600 3 4 5 6 7 8 10-3 <2 <2 <2 6 7 8 
2000 3 4 5 6 7 8 10-2 <2 <2 <2 <2 7 8 
6000 3 4 5 6 7 8 10-1 <2 <2 <2 <2 <2 <2 
 
1 <2 <2 <2 <2 <2 <2 
 
60 min  
  
60 min 
 [H2O2]  103 104 105 106 107 108 % Bleach 103 104 105 106 107 108 
0 3 4 5 6 7 8 
0 3 4 5 6 7 8 
10-4 3 4 5 6 7 8 
600 3 4 5 6 7 8 10-3 <2 <2 <2 6 7 8 
2000 2 3 4 5 6 7 10-2 <2 <2 <2 <2 4 8 
6000 <2 2 3 4 4 5 10-1 <2 <2 <2 <2 <2 <2 
 
1 <2 <2 <2 <2 <2 <2 
200 
 
Figure 4.2.  Effects of DMSO on H2O2- Mediated Killing of P. gingivalis,  
F. nucleatum, A. actinomycetemcomitans, and S. aureus at 60 min and 37oC.  
Results are expressed as recoverable log10 CFU/mL.  Samples were spiral plated (limit 
of detection: 1.31 log10 CFU/mL), and logarithmic protection from killing (≥1 log 
increases in recoverable CFU/mL compared to killing by H2O2 in the absence of DMSO) 
was considered significant as indicated by asterisks.   Samples were plated at least in 
duplicate, and colony counts were averaged.   Data are representative of three or more 
independent experiments. 
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CHAPTER 5 
GENERAL DISCUSSION 
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AFTERWORD 
 
It is well-known that neutrophils are indispensable to periodontal health, 
supported by the fact that individuals with impaired neutrophil functions have a high 
prevalence of an early onset of aggressive periodontitis (1) (2) (3) (4) (5) (6) (7) (8) (9) 
(10).   The health of periodontal tissues is therefore highly dependent on proper  
neutrophil function (e.g. chemotaxis, phagocytosis, bactericidal mechanisms), as 
periodontitis, which is sometimes mislabeled or generalized by medical professionals 
(non-dentist) as severe gingivitis, stomatitis, or ulcerative oral lesions around the teeth, 
is frequently one of the first manifestations of a systemic breakdown in neutrophil 
function (11) (12).   While these periodontal infections may initially appear in these 
patients as severe gingivitis, they are not simply gingivitis, and the patient should be 
referred to a periodontist, for identification of specific periodontal pathogens and 
therapies appropriate to these microorganisms (8) (11).   Besides tooth loss, the 
importance of prompt treatment is implicated in the fact that periodontitis is linked to an 
increased risk of premature heart disease, stroke, lung infections, preterm low birth 
weight pregnancy outcomes, and septicemia, as well as to a variety of other chronic 
health issues (13). 
In this laboratory, plaque samples cultured from children and adolescents who 
present with periodontitis show unusually high levels of specific adult periodontal 
pathogens, which behave as opportunistic pathogens when there is a breakdown in 
periodontal defense.    While normally healthy children and adolescents are suspected to 
be exposed to adult periodontal pathogens by parents etc (14) (15) (16), the diagnosis of 
periodontitis in children and young adults is highly abnormal, and is suggestive of a 
serious underlying medical illness such as a neutrophil disorder (8) (11) (12).   The 
abnormal presentation of periodontitis in young individuals is also suggestive that the 
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periodontium is normally resistant to developing periodontal disease as long as the 
periodontal (i.e. neutrophil) defense mechanisms remain intact.     
Despite the importance of neutrophils in the maintenance of periodontal health, 
relatively few studies have examined the critical killing mechanisms used by neutrophils 
when periodontal tissues are exposed to particular pathogens.   While it is understood 
that the main method by which neutrophils handle potential periodontal pathogens is 
through phagocytosis and killing (6) (17) (18) (19) (20), the specific post-phagocytic 
bactericidal mechanism(s) essential to the defense against specific periodontal 
pathogens have yet to be defined.    While adult periodontitis is a mixed flora infectious 
and inflammatory disease, pathology is associated with a relatively small group of overt 
periodontal pathogens (21). 
The overall objective of this dissertation was therefore to elucidate the 
mechanism(s) used by neutrophils to kill Porphyromonas gingivalis, an overt periodontal 
pathogen that is the most associated with the etiology of both chronic and aggressive 
forms of severe adult periodontitis (14) (22) (23) (24) (25).   This dissertation project, 
which focused on defining the conditions and components essential for neutrophil-
mediated killing of this pathogen, as well as understanding the relative susceptibility of 
this species to these killing mechanisms compared to other relevant pathogens, have 
undoubtedly offered valuable insights into how normally healthy people are resistant to 
periodontitis and likewise how others are susceptible to periodontitis; as well as offered 
clues about therapies appropriate to this pathogen. 
Several studies have shown that different isolates of P. gingivalis express 
discrete virulence traits in animal models, which may reflect distinct clinical presentations 
(26) (27) (28) (29) (30) (31) (32).   Strain A7436 is a clinical isolate of P. gingivalis that 
was chosen for its expression of multiple virulence traits considered representative of 
this periodontopathic species, which include capsule and resistance to phagocytosis (27) 
210 
 
(33) (34) (35).   P. gingivalis A7436 was originally isolated from a patient with aggressive 
periodontitis, and has been characterized by the late V.R. Dowell (36), and by this 
laboratory (27) (28) (34) (35) (37), and others (29) (33) (38).    In the mouse 
subcutaneous chamber model, A7436 is remarkably resistant to neutrophil phagocytosis 
and is capable of spreading and dissemination, leading to septicemia and death of the 
mouse (27) (28) (29).    
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OVERALL SUMMARY, DISCUSSION, AND CONCLUSIONS 
 
It is widely held that the primary defense mechanism operative in the periodontal 
pocket involves the teamwork of neutrophils, antibody, and complement (19).   The 
importance of these components in periodontal defense seem to be supported by the 
prolific serous and cellular infiltrate in diseased pockets, which is dominated by antibody-
secreting plasma cells and neutrophils, which comprise at least 95% of the leukocyte 
influx (39) (40).   Previous studies have shown that P. gingivalis has a striking ability to 
recruit neutrophils into infected sites, as well as to induce a significant serum and local 
antibody response, which is predominantly IgG (27) (41) (42) (43).   While subjects with 
adult periodontitis have been shown to have elevated IgG antibody titers to many P. 
gingivalis antigens (41) (42) (43), serum samples isolated from many of these subjects, 
however, lack opsonic capability toward specific strains of P. gingivalis such as A7436 
(20), which suggests that the antibody response is not always protective in periodontitis.    
In the face of a large number of neutrophils, as well as antibody and complement, P. 
gingivalis has the potential to multiply and thrive in active periodontitis (44), as well as in 
the mouse subcutaneous chamber model, where certain strains including A7436 are 
remarkably adept at evading phagocytosis (27).   Low avidity IgG responses have been 
attributed to a lack of sufficient antibody specificity to opsonize and phagocytose 
infecting strains (20) (45), and have even been suggested to function as an immune 
decoy to divert the attentions of the immune response (19).   Some P. gingivalis 
infections appear unable to be resolved (refractory), and these studies elucidate many of 
the reasons why.     
The main objective of chapter 2 was to examine what is necessary in order for P. 
gingivalis to be killed by neutrophils, since the periodontium is resistant to infections with 
periodontal pathogens such as P. gingivalis, when the protective functions of neutrophils 
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are intact.   After neutrophil chemotaxis to an infection site, the first step in defense 
against P. gingivalis is phagocytosis.    In order to begin to define the specific 
components essential for neutrophil-mediated suppression of this pathogen, a dual-color 
fluorescence assay was used to investigate under what conditions the human neutrophil 
phagocytizes and then kills P. gingivalis A7436.   Differential interference contrast optics 
and the fluorescent dyes DAPI/PI were used to visualize the phagocytic and microbicidal 
activities, respectively, of neutrophils under epi-illumination UV microscopy.   This 
approach allows direct visualization of both phagocytosis and killing, enabling a clear 
and straightforward interpretation:  the bacteria are either within the confines of the 
neutrophil plasma membrane or not, and are either alive (blue) or dead (red).    Figure 
A.3 in the appendix accompanying chapter 2 presents examples of how the data in 
chapter 2 were obtained. 
Preliminary studies in this laboratory using DAPI/PI have shown that P. gingivalis 
is not killed in the absence of phagocytosis, though normally competent neutrophils are 
capable of killing P. gingivalis, once phagocytized (20).    Previous studies have also 
suggested that several strains of P. gingivalis including A7436 exhibit remarkable 
resistance to neutrophil phagocytosis due in part to the production of a capsule, and to 
the proteolytic degradation of serum opsonins and their receptors (26) (46) (47) (48) (49) 
(50) (51) (52) (53) (54).    However, phagocytosis-resistant strains of P. gingivalis 
including A7436 are readily phagocytized in optimum conditions, which include the 
presence of serum containing both complement and hyperimmune antiserum specific for 
P. gingivalis (37).   It has been shown that the addition of high titered specific antibody 
(IgG) to P. gingivalis can facilitate phagocytosis not only by specificity for capsule, but 
also through reducing and/or slowing the proteolytic destruction of the opsonins C3b, 
C3bi, and IgG, as well as the complement (CR1 and CR3) and Fc receptors on the 
neutrophil (20) (34) (55), enabling a window of time for phagocytosis to take place.   This 
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is speculated to occur by gingipain-specific antibodies binding to and temporarily 
inhibiting (masking) the discrete proteases of P. gingivalis, thereby enhancing 
opsonization by increasing surface deposition of opsonic complement and C3-IgG 
complexes (34) (45) (56).    
In chapter 2, we confirmed that neutrophil phagocytosis of P. gingivalis A7436 
requires opsonization with both complement and high titered specific antibody, as there 
was only a small subset (10%) of neutrophils capable of phagocytosis of A7436 in the 
presence of complement but not specific antibody (Table A.1), and essentially no 
neutrophils capable of phagocytosis of A7436 in the absence of both of these opsonins 
(data not shown), through the two hour test period.    This was in striking contrast to 
neutrophils in the presence of both complement and high titered specific antibody to P. 
gingivalis, which resulted in a rapid and significant involvement of neutrophils in 
phagocytosis of A7436 at initial sampling (>70% at 0 time) that progressed to effectively 
100% of neutrophils involved in phagocytosis by two hours (Table A.1).   It is possible 
that the small subset (10%) of neutrophils able to phagocytize P. gingivalis A7436 in the 
presence of complement but not specific antibody (Table A.1) was somehow different 
from the neutrophils (90%) unable to phagocytize A7436 in the absence of specific 
antibody.   Perhaps this small subset expressed different or a greater numbers of 
receptors for phagocytosis, or may simply reflect the percentage of neutrophils able to 
phagocytize P. gingivalis through the alternative pathway (34) (45), before complement 
and/or its receptors are degraded by P. gingivalis.   Likewise, 90% may reflect the 
percentage of neutrophils unable to phagocytize P. gingivalis in time.   This is in 
agreement with the concept proposed by Cutler et al (34) (45), suggesting that most of 
the opsonic activity of antibody for P. gingivalis A7436 occurs via antibody-dependent 
alternative pathway opsonization, though contributions are also made by the classical 
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pathway.   Additionally, phagocytosis was shown to occur independent of the availability 
of oxygen (Table A.1).  
From previous studies using electron microscopy, P. gingivalis A7436 is singly 
taken up into individual phagosomes (unpublished observations) for killing.    No studies 
to date clearly define the specific mechanism(s) used by neutrophils to kill P. gingivalis, 
once phagocytized.   The significant findings of chapter 2 were that in addition to 
phagocytosis, neutrophil killing of P. gingivalis A7436 absolutely requires a functional 
NADPH oxidase, which is absolutely dependent on the availability of oxygen.    There 
was essentially no killing of phagocytized P. gingivalis by normally competent 
neutrophils in anaerobic atmosphere (Table 2.1); by neutrophils from subjects with 
chronic granulomatous disease (CGD) in aerobic atmosphere (Table 2.2); or by normally 
competent neutrophils in aerobic atmosphere in the presence of the NADPH oxidase 
inhibitor, diphenyleneiodonium (DPI) (Table 2.3).    In all three cases, the NADPH 
oxidase was inhibited, superoxide was not generated (confirmed in Table A.3 and data 
not shown), and there was no killing of P. gingivalis A7436, despite normal 
phagocytosis, even after several hours.    This was in striking contrast to NADPH 
oxidase-functioning neutrophils from normally healthy donors in the presence of oxygen 
(Table A.3), where there was a significant involvement of phagocytic neutrophils in killing 
by one hour (>75%) that progressed to nearly 100% involved in killing by three hours 
(Table 2.3).     
Because even a small amount of oxygen introduced into the anaerobic chamber 
was enough oxygen to allow neutrophil killing of A7436 (unpublished observations), 
efforts were required to sufficiently reduce all reagents before use in anaerobic 
experiments, which required at least one hour.   Preliminary experiments attempted 
shorter and longer reduction times, though reducing reagents for less than one hour left 
enough oxygen to allow neutrophil killing of A7436, while going much longer started to 
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compromise the viability of neutrophils due to their short half-lives, and showed more 
apoptosis at later time points.    This provided further confirmation that normally 
competent neutrophils are capable of killing A7436 if even small amounts of oxygen are 
available.    
In order to determine whether the oxygen and NADPH oxidase requirements for 
killing P. gingivalis may be unique or common to other species associated with 
periodontitis, neutrophil killing of P. gingivalis was compared with that of Aggregatibacter 
actinomycetemcomitans and Fusobacterium nucleatum, under aerobic vs. anaerobic 
atmosphere, and in the presence and absence of DPI.    Untreated normal neutrophils 
under aerobic atmosphere were capable of rapid cell-association and killing of all three 
periodontal pathogens, with progressions of each through 180 min (Table 2.8).    In 
contrast to P. gingivalis, normal neutrophils under anaerobiosis (Table 2.7) or DPI (Table 
2.8) were capable of near normal killing of A. actinomycetemcomitans; and substantial, 
though significantly reduced, killing of F. nucleatum.    Compared to these species 
associated with periodontitis, P. gingivalis A7436 was remarkably, totally resistant to the 
non-oxidative killing mechanisms of the neutrophil, which by definition, should still be 
operational under anaerobiosis, in the presence of DPI, and in CGD; and was instead 
completely dependent on an NADPH oxidase-dependent mechanism for killing.    In 
contrast, A. actinomycetemcomitans was highly susceptible to non-oxidative killing 
mechanisms, as well as to DPI-insensitive mechanisms; while F. nucleatum was 
relatively more sensitive to non-oxidative killing mechanisms, as well as to DPI-
insensitive mechanisms, than was P. gingivalis, which was totally resistant to both.     
There was absolutely no evidence of oxygen-independent killing of A7436, 
including that of serum-mediated, extracellular killing in the absence of phagocytosis.    
Like its mechanism of resistance to phagocytosis (34), the resistance of P. gingivalis to 
the bactericidal activity of serum is also attributed to both the production of capsule and 
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to the proteolytic degradation of complement in serum, which together prevent the 
membrane attack complex from assembling on and penetrating its surface (54) (57) (58).   
In addition to capsule, P. gingivalis produces and releases large quantities of 
broad-spectrum, as well as specific and discrete proteases, which undoubtedly 
contribute to its pathogenicity and ability to evade many of the host defenses.   Of the 
many proteases identified in P. gingivalis, the three gingipains, encoded by the genes 
rgpA, rgpB, and kgp, are generally considered the major virulence factors of this 
periodontal pathogen (46) (59), and are reported to be responsible for at least 85% of its 
overall proteolytic activity (60) (61).   Demonstrating ‘trypsin-like’ activities, the arginine 
gingipains (HRgpA and RgpB) specifically cleave after arginine residues; whereas, the 
lysine gingipains (Kgp) specifically cleave after lysine residues (22) (62).   Both cell-
associated and released, the gingipains are hypothesized to at least partially account for 
the remarkable resistance of P. gingivalis to the non-oxidative killing mechanisms of the 
neutrophil.    Afterall, since many of the proteins and peptides contributing to the non-
oxidative killing mechanisms of the neutrophil are highly cationic and rich in arginine and 
lysine residues, they seem highly susceptible to digestion by the arginine and lysine 
gingipains of P. gingivalis.   Consistent with this, the robust proteolytic activities of P. 
gingivalis both in culture supernatants and by whole cells of P. gingivalis have been 
shown to digest and inactivate a multitude of oxygen-independent, antimicrobial 
peptides, proteins, and enzymes found in neutrophil granules, including lactoferrin, the 
cathelicidin LL-37, β-defensins, cathepsin G, elastase, bacterial-permeability increasing 
factor, etc (50) (63) (64) (65) (66) (67) (68) (69) (70) (71).   Interestingly, Bachrach et al 
(72) suggested that the resistance of P. gingivalis strain ATCC 33277 (a non-
encapsulated, non-disseminating strain) to direct killing by select antimicrobial peptides, 
including the neutrophil peptide LL-37, can be attributed more to the low affinity of these 
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antimicrobial peptides to P. gingivalis, rather than to the proteolytic activities of P. 
gingivalis.     
The studies thus far have suggested that once phagocytized, the mechanism 
used by neutrophils to kill P. gingivalis A7436 is entirely phagocyte oxidase (phox) 
activity- dependent.    Requiring specific (or secondary) granule fusion with the 
phagosome, the five NADPH oxidase subunits (gp91phox, p22phox, p47phox, p67phox, and 
p40phox), which are referred to by their molecular weight (kDa) and have been given the 
designation phox for phagocyte oxidase (73), are delivered to the phagosome upon 
activation, at which time they assemble on the interior surface of the phagosome 
membrane to form the NADPH oxidase complex (74) (75).   In what is known as the 
respiratory burst, large amounts of oxygen are consumed by the NADPH-dependent 
oxidase complex, in the enzymatic generation of superoxide anion:  NADPH + 2O2 → 
NADP+ + 2O2.- + H+ (17) (76) (77) (78) (79).   The genetic deficiency in phagocytes of 
either gp91phox, p22phox, p47phox, or p67phox results in the vast majority of CGD cases 
(>99%), and neutrophils from subjects with CGD are consequently unable to produce 
superoxide or any downstream reactive oxygen species (ROS), and are considered 
respiratory burst-deficient (73) (78) (80) (81) (82) (83) (84) (85) (86).    In normal, 
NADPH oxidase-functional neutrophils, superoxide, the direct product of the respiratory 
burst, is subsequently dismutated to hydrogen peroxide (O2.- + 2H+ → H2O2), and from 
these two initial products, other more reactive oxidants are generated, either by reacting 
with iron or with enzyme systems such as myeloperoxidase (MPO), or by the products of 
these systems reacting with O2.- and/or H2O2, or with each other (75) (87) (88) (89) (90) 
(91).    In CGD, both MPO-catalyzed and MPO-independent oxidative killing 
mechanisms are absent (92), which explains its severity.   This translates to the inability 
of phagocytes to generate O2.-  and every downstream ROS dependent on O2.- 
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generation, including H2O2, HOCl, OH., ONOO.-, 1O2 etc; compared to MPO-deficiency, 
where presumably only HOCl is absent.     
Still unknown at this point, was whether the NADPH oxidase-dependent killing of 
P. gingivalis is dependent or independent of additional contributions by MPO.    Heme-
based MPO is the most abundant enzyme in neutrophils (93) (94), and is localized in the 
azurophilic (or primary) granules.   By azurophilic granule fusion with the phagosome, 
MPO is delivered in high concentration and in close proximity to microbial targets, 
following the initiation of the respiratory burst by specific granule fusion with the 
phagosome (75) (95) (96).    Once present, MPO is proposed to utilize H2O2, already 
available in potentially large concentrations, to generate the strong oxidant, weak acid, 
hypochlorous acid (H+ -OCl or HOCl), also known as bleach:  MPO + Cl- + H2O2 → H+ -
OCl (97) (98).    MPO-generated HOCl displays potent microbicidal activities against a 
broad range of microorganisms, by chlorinating or otherwise modifying a wide range of 
microbial targets, including enzymes, proteins, lipids, cell walls, membranes, RNA, and 
DNA, etc (75) (93) (94) (95) (96) (97) (98) (99) (100) (101).   Since most of the oxygen 
consumed by an activated neutrophil is converted to H2O2 from O2.- (102) (103), and 
since
 
the vast majority of the H2O2 generated in the neutrophil is reported to be 
converted to HOCl by MPO (76) (91) (95) (104) (105), MPO is believed to play a 
dominant role in oxygen-dependent killing in the phagosome.     
Despite its abundance and perceived importance, however, subjects with MPO-
deficiency are remarkably healthy and do not experience an increased frequency of 
infections (106) (107).   In fact, MPO-deficiency is generally considered innocuous and 
was recently removed as a primary immune deficiency disease (108) (109).   While their 
phagocytes show an impaired ability to kill certain targets ex vivo, such as 
Staphylococcus aureus and Candida albicans (97) (110) (111), the only clinical 
complication that has been reported in these patients is a predisposition to infections 
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with Candida spp. in MPO-deficient subjects who also happen to be diabetic (S. aureus 
is not a problem) (85) (112).   Interestingly though, even the frequency of Candida 
infections is very low in these subjects (reported in less than 5%) (107), raising doubts 
about the true importance of MPO in host defense (113) (114) (115).   This led to the 
question as to whether MPO had any importance in neutrophil killing of P. gingivalis 
A7436. 
In initial experiments, MPO was found to be completely dispensable in the killing 
of P. gingivalis A7436, because subjects with MPO-deficiency (Figure A.1B) were fully 
capable of killing A7436, comparable to MPO-sufficient (Figure A.1A) neutrophils from 
normally healthy donors (Table 2.4).   Since P. gingivalis was killed normally in the 
absence of MPO in neutrophils, MPO was not suggested to be a necessary or important 
component for neutrophil-mediated killing of P. gingivalis.    For comparison, the killing of 
P. gingivalis was next examined by neutrophils treated with the classic MPO inhibitors, 
sodium azide and 4-aminobenzoic acid hydrazide (4-ABH).     
The addition of azide blocked the killing of P. gingivalis A7436 by both MPO-
sufficient and MPO-deficient neutrophils, despite normal phagocytosis (Table 2.5).   
These data are consistent with the probability that azide is blocking a mechanism, other 
than MPO, which is essential to the killing of P. gingivalis by normal and MPO-deficient 
neutrophils.    In comparison, MPO-competent neutrophils treated with the more specific 
MPO inhibitor, 4-ABH, were capable of effective, though delayed, killing of P. gingivalis, 
despite normal phagocytosis (Table 2.6).    For instance, while the number of neutrophils 
involved in phagocytosis of A7436 did not vary in the presence of 4-ABH, fewer 4-ABH 
treated phagocytic neutrophils were involved in killing at each time point; and the 
number of 4-ABH-treated phagocytic neutrophils that killed at two hours was comparable 
to the number of untreated phagocytic neutrophils that killed at 30 min (Table 2.6).    
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Similar to P. gingivalis, normal neutrophils treated with 4-ABH were also capable 
of effective, though delayed, killing of both F. nucleatum and A. actinomycetemcomitans, 
with no effects on phagocytosis (Figure 2.1); however, the data demonstrate a greater 
effect of 4-ABH on neutrophil killing of F. nucleatum than on neutrophil killing of P. 
gingivalis, and the least effect on neutrophil killing of A. actinomycetemcomitans.    For 
P. gingivalis and F. nucleatum, the effect of 4-ABH was significant at all time points 
between 30 min and three hours; while the 4-ABH effect on A. actinomycetemcomitans 
only reached significance at the 30 min time point, consistent with its greater 
susceptibility to non-oxidative and DPI-insensitive killing mechanisms compared with F. 
nucleatum and P. gingivalis (Tables 2.7 and 2.8).    Additionally, A. 
actinomycetemcomitans was killed equivalently by neutrophils treated with either DPI or 
4-ABH, suggesting that 100% of its oxidative killing is attributable to MPO.    
Taken together, these data suggest that MPO or some other yet-to-be-identified 
4-ABH-sensitive mechanism contributes to the killing of all three periodontopathogens, 
but that there are highly effective MPO-independent mechanisms utilized by the 
neutrophil for the killing of all three species.   Because neither azide nor 4-ABH affects 
the respiratory burst or degranulation in stimulated neutrophils (116) (117), these data 
also suggest that P. gingivalis A7436 is killed by a mechanism subsequent to the initial 
generation of superoxide by the NADPH oxidase.    Furthermore, these data suggest 
that the dominant mechanism that normal and MPO-deficient neutrophils use to kill P. 
gingivalis is an MPO-independent, but an azide-sensitive mechanism.     
While sodium azide is a highly potent inhibitor of MPO enzymatic activity 
(confirmed in Figure A.2), by directly attaching to the coordinate position of the iron in 
the heme moiety (118), it is unclear what azide was blocking (i.e. what unidentified co-
factor) in neutrophil killing of P. gingivalis.    Important to the interpretation of the azide 
data is the fact that azide is not a specific inhibitor of MPO and is also reported to inhibit 
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the activity of other metalloenzymes in the neutrophil and have other effects as well 
(119) (120) (121) (122).    For instance, besides inhibiting other heme-based enzymes, 
azide is also reported to function as a hydroxyl radical (OH.) and singlet oxygen (1O2) 
scavenger (123), as well as a potent inhibitor of redox reactions (124) and reactions 
involving the transition of metals (125).   Therefore, azide may have protected A7436 by 
functioning as a radical scavenger or by preventing toxicity attributable to H2O2.   By 
binding and bridging transition metals (125), azide may have prevented H2O2 from 
participating in a Fenton reaction (Fe2+ + H2O2 → Fe3+ + H2O + OH.), in the absence of 
competition with MPO for H2O2.    It is also conceivable that azide may have protected 
A7436 by shutting down its metabolism, since azide has been used in a number of 
studies to inhibit the metabolism of P. gingivalis (126) (127) (128) (129).   This is 
consistent with the concept presented by Imlay et al (130), who suggested that an active 
bacterial metabolism is required for killing by H2O2.    
It is also important to note that while 4-ABH is also a highly potent inhibitor of 
MPO enzymatic activity (confirmed in Figure A.2), and is reported to be a more specific 
inhibitor of MPO than is sodium azide with no effects on other neutrophil enzymes (116) 
(131) (132) (133); it is also possible that 4-ABH may have had additional effects on the 
neutrophil to account for the discrepancy in MPO-deficient vs. 4-ABH-treated neutrophil 
killing of P. gingivalis.   Another possibility is that MPO-deficient neutrophils may have 
compensatory or alternative killing mechanisms in place in the absence of MPO, which 
is not inconsistent with our data that MPO may actually afford protection to bacteria 
against H2O2-mediated killing.   In the absence of MPO, H2O2 may build up and be more 
available to kill directly or participate in OH. generation
 
(91) (97) (134).   This is 
consistent with the findings of Winterbourn (135), which suggested that OH. generation 
is more favorable in MPO-deficient neutrophils due to the absence of competition with 
MPO for H2O2.   In addition, attributed to a lack of inactivation of the respiratory burst 
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due to the absence of MPO (91) (119), MPO-deficient subjects consume more oxygen in 
the respiratory burst than normal (119) (136), and have extended superoxide and 
hydrogen peroxide production compared to individuals with MPO-sufficiency (98) (137).   
Alternative or upregulated MPO-independent killing mechanisms such as these may 
therefore account for greater (normal) killing of P. gingivalis by MPO-deficient 
neutrophils, compared to neutrophils treated with 4-ABH, and may explain the low 
(normal) morbidity in subjects with MPO-deficiency.    
The conclusions from chapter 2 are that P. gingivalis A7436 is remarkably 
resistant to the non-oxidative killing mechanisms of the neutrophil, in comparison to 
other periodontal pathogens tested; and is instead completely dependent on a functional 
NADPH oxidase, which requires the presence of oxygen, in order to be killed by 
neutrophils.    Additionally, this phox-dependent killing is consistent with a mechanism 
subsequent to the initial generation of superoxide by the NADPH oxidase, though the 
role and contributions of MPO in this killing remain unclear.   Which NADPH oxidase-
dependent ROS proved most important in neutrophil-mediated killing of P. gingivalis was 
therefore the subject of chapter 3.    
Since the NADPH oxidase is central to killing P. gingivalis, it was important to 
examine the susceptibility of P. gingivalis to the three principal products of the NADPH 
oxidase:  O2.-, H2O2, and MPO-generated HOCl.    To begin to address this, it was first 
examined whether the killing of P. gingivalis can be duplicated in a cell-free system 
using phosphate buffered saline (PBS); and if so, whether either or both of the two initial 
products of the NADPH oxidase (O2.- and H2O2) are capable of killing P. gingivalis alone 
and in the absence of other neutrophil co-factors such as MPO.   The killing potentials of 
the two initial products of the NADPH oxidase system, O2.- and H2O2, were examined 
using the xanthine (X) – xanthine oxidase (XO) system.    The X-XO system was chosen 
because it emulates the NADPH oxidase by enzymatically generating exogenous O2.- , 
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which subsequently dismutates to H2O2.   In order to determine the individual 
contributions of these ROS, superoxide dismutase (SOD) was used to eliminate O2.- in 
the X-XO system, and catalase was used to eliminate H2O2 in the X-XO system. 
P. gingivalis was indeed killed by the X-XO system (Figure 3.1), confirming that 
P. gingivalis can be killed in a cell-free system by O2.- and/or H2O2, in the absence of 
other neutrophil co-factors such as MPO.    Killing of P. gingivalis by the X-XO system 
was completely blocked by catalase, but SOD offered no protection through the two 
hours tested (Figure 3.1).    Under X-XO plus catalase, superoxide was generated as 
determined by cytochrome c reduction (data not shown), and there was no discernible 
killing of A7436 (Figure 3.1).   In contrast, when challenged with X-XO plus SOD, 
hydrogen peroxide was generated as determined by cytochrome c oxidation (data not 
shown), and A7436 killing was equivalent to that of X-XO alone (Figure 3.1).   Because 
superoxide under the conditions of these experiments had no effect on P. gingivalis 
A7436, the direct product of the NADPH oxidase (O2.- ) was not suggested to be 
bactericidal to P. gingivalis.    Killing consistent with H2O2 was demonstrated to account 
for 100% of the killing in the X-XO system, which suggested that H2O2 but not O2.- is 
important to the killing of P. gingivalis.    P. gingivalis sensitivity to H2O2 but not to O2.-  is 
consistent with P. gingivalis possessing SOD (MnSOD and FeSOD), but not catalase or 
peroxidase enzymes (138).   Toxicity to H2O2 but not to O2.-  is also consistent with the 
fact that H2O2 is membrane-permeable, while O2.-  is not (139). 
Since these data indicate that H2O2 alone can kill A7436, the sensitivity of P. 
gingivalis to H2O2 free of O2.-  was the next center of focus.   The glucose (G) – glucose 
oxidase (GO) system was chosen because it enzymatically generates H2O2 directly in a 
sustained fashion, allowing the susceptibility of P. gingivalis to H2O2 to be assessed 
when generated at various rates.   P. gingivalis was killed by the G-GO system (Figure 
3.2), which confirmed the X-XO data that H2O2 is indeed effective in killing P. gingivalis 
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when generated at a sufficient rate, which increased with GO concentration.    
Additionally, this time- and rate- dependent killing of A7436 by the G-GO system was 
completely blocked by the addition of catalase (data not shown), further implicating a 
direct toxicity of H2O2.    Furthermore, the temporal effect of GO titration suggests there 
is a threshold concentration of H2O2 necessary to kill P. gingivalis.   In order to validate 
the H2O2-sensitivity of P. gingivalis and to address the killing kinetic of P. gingivalis by 
H2O2, the bactericidal activity of H2O2, delivered non-enzymatically as a bolus, was next 
examined. 
Boluses of H2O2 were titrated and challenged with P. gingivalis, in order to 
determine the approximate sensitivity of P. gingivalis to H2O2 in a pure system, and to 
determine the killing kinetic of P. gingivalis with H2O2 over time.   H2O2 delivered as a 
bolus killed P. gingivalis in a time- and dose-dependent fashion (Figure 3.3), which 
suggested that H2O2-mediated killing of P. gingivalis does not occur instantly, but that P. 
gingivalis and H2O2 (generated enzymatically at a sufficient rate or delivered as a bolus 
at a sufficient concentration) need time together in order for H2O2 to be lethal to P. 
gingivalis.   Killing did not occur at initial time with H2O2, though significant killing 
occurred by 30 min, with additional killing occurring at each subsequent time point.    
Specifically, there was a concentration-dependent, logarithmic killing progression over 
the three hour test period with all H2O2 concentrations tested, including as low as 6.25µM 
H2O2 (Figure 3.3).   Furthermore, since there was no reduction in recoverable CFU/mL 
upon initial plating, despite concentrations of H2O2 as high as 10mM (data not shown), 
the process of plating was suggested to neutralize any additional bactericidal activity of 
H2O2, further suggesting that the killing events occur in the reaction volume only.   
These data indicate that low, micromolar concentrations of H2O2 are capable of 
killing P. gingivalis in the absence of exogenous co-factors.     The purpose of the next 
series of experiments was to determine how the susceptibility of P. gingivalis to H2O2 
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compares on a grand scheme relative to other bacteria with relevant features.    Other 
pathogens, with and without catalase, and with different relationships with oxygen, that 
are either associated with periodontitis, CGD, and/or neutropenia were selected for 
comparison.     
The relative susceptibility of P. gingivalis A7436 (an encapsulated strain of P. 
gingivalis) to H2O2 was first compared with other well-studied, non-encapsulated strains 
of P. gingivalis, including ATCC 33277, 381, and HG405, in order to determine if the 
sensitivity of A7436 to H2O2 is a feature shared by the species and is independent of 
capsule production.    It was hypothesized that encapsulated strains like A7436 may 
show greater resistance to H2O2 than non-encapsulated strains due to protection 
afforded by the extracellular polysaccharide capsular layer.    All strains of P. gingivalis 
independent of capsule production or virulence type, however, showed nearly identical 
sensitivities to H2O2 (Figure 3.4B).   Therefore, the susceptibility of A7436 to very low 
concentrations of H2O2 (Figures 3.3 and 3.4A-B) does not appear to be a feature unique 
to strain A7436, but appears to be a unique feature representative of P. gingivalis as a 
species.   
The sensitivity of P. gingivalis to H2O2 was next compared to Prevotella 
intermedia, a catalase-negative, strictly anaerobic periodontal pathogen, similar in 
ancestry to P. gingivalis.    Not surprisingly, P. intermedia (which like P. gingivalis, also 
requires heme and Vitamin K for growth, readily forms black-pigmentation on blood-
based agars due to the production of protoporphyrin, and is a strict anaerobe) was the 
most similar to P. gingivalis in sensitivity to H2O2 (Figure 3.4B).    
The sensitivity of P. gingivalis to H2O2 was also compared to F. nucleatum and A. 
actinomycetemcomitans, two periodontal pathogens that were consistently more 
sensitive to neutrophil killing than was P. gingivalis (Tables 2.7 and 2.8).   F. nucleatum 
is a catalase-negative, periodontal pathogen like is P. gingivalis; while A. 
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actinomycetemcomitans, in contrast, is a catalase-positive, periodontal pathogen.     
Both are capable of growing in microaerophilic conditions, though A. 
actinomycetemcomitans has a greater ability to grow in the presence of oxygen than 
does F. nucleatum, in stark contrast to P. gingivalis, which requires anaerobiosis for 
growth.    Based on the anaerobic (Table 2.7) and DPI (Table 2.8) data, it was possible 
that both F. nucleatum and A. actinomycetemcomitans were more sensitive to H2O2 in 
the neutrophil than was P. gingivalis, if minute levels of oxygen were present in the 
anaerobic chamber which contributed to H2O2 production.   This did not seem to be the 
case, however, as even F. nucleatum (which was more dependent on oxygen and a 
DPI-sensitive mechanism for neutrophil-mediated killing than was A. 
actinomycetemcomitans) was approximately 15- to 25- fold more resistant to H2O2 than 
was P. gingivalis (Figures 3.4A and B).   The even greater resistance of A. 
actinomycetemcomitans to H2O2, in comparison to F. nucleatum (Figures 3.4A and B), is 
likely associated with its ability to produce catalase, and perhaps other antioxidant 
defense mechanisms, which allow A. actinomycetemcomitans to grow in the presence of 
oxygen. 
The relative susceptibility of P. gingivalis to H2O2 was also compared with the 
catalase-positive Staphylococcus aureus, a pathogen in CGD and in neutropenia, which 
is capable of growing in the presence of oxygen; and to the catalase-negative 
Streptococcus pyogenes, a pathogen in neutropenia but not in CGD, which is also 
capable of growing in the presence of oxygen.    While the various test bacteria showed 
a wide range of sensitivities to H2O2, P. gingivalis was consistently much more 
susceptible to low concentrations of H2O2 than all other test bacteria (Figure 3.4B).     
The three aerotolerant pathogens (S. aureus, S. pyogenes, and A. 
actinomycetemcomitans) independent of catalase production were the most resistant to 
H2O2 (Figures 3.4A and B).   Interestingly, S. pyogenes (catalase-negative) was more 
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resistant to H2O2 than was S. aureus (catalase-positive), which is consistent with the 
findings of Wilson et al (140), who attributed greater H2O2 resistance not to catalase 
production, but to the more prolific production of peroxidases in streptococci, compared 
to S. aureus.   Additionally, the requirement of time in order for H2O2 to kill was common 
with all bacteria that were tested (data not shown).   
Since MPO is a principal constituent of the phagosome environment and is 
suggested to be the major consumer of H2O2 in the phagosome (95), the in vitro 
influences of MPO activity on the interactions of H2O2 with P. gingivalis were also 
examined.    While P. gingivalis was remarkably sensitive to low concentrations of H2O2 
in the absence of other neutrophil co-factors such as MPO, which suggests that H2O2 
alone is a highly effective mechanism of killing P. gingivalis; the MPO-H2O2 system was 
next examined in order to determine what role MPO plays in the interaction of H2O2 with 
P. gingivalis, and specifically, whether MPO has any effect on H2O2-mediated killing of 
P. gingivalis.   Previous studies suggested that MPO is not essential in the killing of P. 
gingivalis or in the killing of either of the other two bacteria that were tested, F. 
nucleatum and A. actinomycetemcomitans.    Subjects with MPO-deficiency were fully 
capable of killing P. gingivalis A7436, comparable to MPO-sufficient controls (Table 2.4); 
while 4-ABH similarly did not block neutrophil-mediated killing of either P. gingivalis, F. 
nucleatum, or A. actinomycetemcomitans (Figure 2.1).    It was suggested, however, that 
MPO may play a greater role in the killing of F. nucleatum than P. gingivalis, and the 
least role in the killing of A. actinomycetemcomitans (Figure 2.1).    
F. nucleatum was initially chosen for comparison with P. gingivalis, because like 
P. gingivalis, F. nucleatum is a catalase-negative, anaerobic periodontal pathogen, but in 
contrast to P. gingivalis, requires approximately 15-fold higher concentrations of H2O2 to 
achieve logarithmic reductions (Figures 3.4A and B).   Interestingly, despite both 
bacteria having very different sensitivities to H2O2, the addition of MPO protected both F. 
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nucleatum and P. gingivalis against bactericidal concentrations of H2O2, and surprisingly, 
there was no killing of either P. gingivalis or F. nucleatum in the presence of MPO with 
concentrations of H2O2 exceeding that necessary for MPO-independent bactericidal 
activity (Figures 3.5A and B).    Additionally, while the mechanism of protection by MPO 
against bactericidal concentrations of H2O2 is unknown (e.g. whether MPO scavenges 
H2O2, and whether it is an enzymatic process or not), it has previously been suggested 
that ≥100µM H2O2 inhibits the peroxidatic activity of MPO (141), or transitions it to that of 
catalatic activity (142).   To our knowledge, however, this is the first evidence that MPO 
interaction with H2O2 protects bacteria from killing and/or that MPO neutralizes 
bactericidal concentrations of H2O2.   The total block of H2O2-mediated killing of P. 
gingivalis and F. nucleatum with the addition of MPO is not inconsistent with our earlier 
data which suggested that MPO is not essential to the killing of either P. gingivalis or F. 
nucleatum.     
While the addition of MPO offered protection against higher, bactericidal 
concentrations of H2O2; MPO was also shown to enhance the killing of P. gingivalis 
(Figure 3.5B) and F. nucleatum (Figure 3.5C), but only within a very narrow range of 
sub-lethal concentrations of H2O2, which gave little or no killing alone.   Therefore, while 
P. gingivalis was already remarkably sensitive to very low concentrations of H2O2 (10µM 
or greater H2O2 directly kills P. gingivalis at one hour); P. gingivalis was sensitive to even 
lower concentrations of H2O2 at one hour, in the presence of MPO (Figure 3.5B).     
Additionally, while MPO-dependent killing was only evident within a very narrow 
range of H2O2 concentrations, MPO was shown to lower the amount of H2O2 required to 
kill every one of the six test bacteria, including P. gingivalis (Figure 3.6A), P. intermedia 
(Figure 3.6B), F. nucleatum (Figure 3.6C), A. actinomycetemcomitans (Figure 3.6D), S. 
aureus (Figure 3.6E), and S. pyogenes (Figure 3.6F), at one hour.   The addition of MPO 
enhanced the killing of all six test bacteria, specifically, at concentrations between 0.6 
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and 10µM H2O2, with an optimum at 5µM.   This bactericidal activity was best interpreted 
to be due to the conversion of H2O2 to HOCl, since the MPO peroxidatic inhibitor 4-ABH 
completely protected all test bacteria against this killing at sub-optimal and optimal MPO 
concentrations (Figures 3.6A-F).    
Interestingly, while all six test bacteria showed major differences in their range of 
sensitivities to H2O2 in terms of the concentrations of H2O2 that were required to kill 
(Figure 3.4B), all six test bacteria surprisingly had comparable susceptibilities to the 
MPO-H2O2 system; and unlike with H2O2, there was no differential susceptibility of test 
bacteria to the product of the MPO-H2O2 system (HOCl), as long as there was sufficient 
MPO available (Figures 3.6A-F).   While the addition of MPO enhanced the killing of all 
test bacteria at an optimum of 5µM H2O2, there were two- to four- fold differences 
between species in the concentration of MPO required to function with 5µM H2O2.   This 
was likely a reflection of catalase possession by S. aureus and A. 
actinomycetemcomitans, causing these two bacteria to require more MPO (24mU/mL for 
optimal activity), in order to exceed the ability of their catalase to scavenge H2O2; as well 
as a reflection of some level of H2O2 scavenging, by protoporphyrin perhaps, possessed 
by the two black-pigmenting bacteroides, P. gingivalis (143) (144) and P. intermedia 
(145); and due to the possession of peroxidases by S. pyogenes, which like catalase, 
may compete with MPO for H2O2 (the later three species required 12mU/mL for optimal 
activity).   The non-black-pigmenting, non-catalase and non-peroxidase -producer, F. 
nucleatum, in contrast, required the least MPO (6mU/mL) activity to function optimally 
with 5µM H2O2 (Figures 3.6C), which suggested that F. nucleatum is the least efficient at 
scavenging H2O2 compared to the other species, and is the most sensitive to MPO since 
it required the least MPO activity for killing.   These data are also interesting in the 
context of the differential effects of 4-ABH on neutrophil-mediated killing of F. nucleatum 
and A. actinomycetemcomitans compared to P. gingivalis (Figure 2.1), which showed 
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the greatest reduction in the number of phagocytic neutrophils capable of killing F. 
nucleatum in the presence of 4-ABH, in contrast to A. actinomycetemcomitans. 
Because it would appear likely that MPO would be neutralized in the phagosome 
by the copious amounts of H2O2 produced there, it is unclear whether MPO plays an 
important role in killing in the phagosome if antagonistic interactions between MPO and 
H2O2 occur in the phagosome.   The data in chapter 3 suggest that P. gingivalis and 
possibly other H2O2-sensitive bacteria may be killed in the phagosome by H2O2 alone, in 
the period of time before MPO gets delivered; and that phagosomal concentrations of 
H2O2 must be tightly regulated for MPO to function as a bactericidal constituent, once 
MPO is delivered.   As proposed by Reeves et al (115), it is possible that MPO has an 
alternative role in the phagosome such as H2O2 scavenging, which may serve to 
dampen the toxicity of the neutrophil; not only by “mopping up” excess H2O2, but by 
limiting the activities of cytotoxic and degradative enzymes.    This is consistent with the 
observation that the majority (94%) of chlorinated proteins in the phagosome are of host 
origin (146).    This may also occur outside the ‘frustrated’ neutrophil, which releases 
MPO to its exterior, into the gingival crevice. 
Our data suggest that killing by H2O2 would be an effective mechanism of killing 
P. gingivalis within the phagosome, especially before MPO gets delivered, and possibly 
even after MPO gets delivered, if even low micromolar concentrations of H2O2 are 
present and left unscavenged by MPO, due to this bacterium’s unusually high 
susceptibility to low micromolar concentrations of H2O2.    This is consistent with the 
neutrophil phagosome model of Winterbourn et al (95), which suggested that low 
micromolar concentrations of H2O2 are steady state in the phagosome, despite robust 
HOCl generation.    This sustained low level H2O2 concentration could potentially be all 
that is required to kill P. gingivalis. 
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H2O2 is hypothesized to kill by diffusion inside the bacterial cell, where it reacts 
with bacterial-associated iron, mediating a Fenton reaction, where ferrous iron (Fe2+) 
reduces H2O2 to the most reactive (i.e. non-specific and diffusion-limited) radical known, 
hydroxyl radical (OH.) (89) (130) (147) (148) (149) (150) (151) (152) (153) (154) (155) 
(156).   This scenario appears consistent with the fact that H2O2-mediated killing of P. 
gingivalis does not occur instantly, but that P. gingivalis and H2O2 (generated 
enzymatically at a sufficient rate or delivered as a bolus at a sufficient concentration) 
need time together in order for H2O2 to become lethal – a mechanism consistent with 
requiring time in order for H2O2 to enter the bacteria, find and react with bacterial-
associated iron, generate something more toxic (e.g. OH.), and cause a lethal, 
irreparable hit (e.g. damage to DNA).    It is therefore suggested from these studies that 
in order to kill P. gingivalis, MPO is an unnecessary co-factor.    Because H2O2 alone at 
very low concentrations is a highly effective mechanism of killing P. gingivalis, 
compounded with the observation that H2O2 must be tightly regulated for MPO to 
function as a bactericidal constituent (i.e. the MPO-H2O2 system works only within a very 
narrow range of H2O2 concentrations and MPO is highly susceptible to neutralization by 
H2O2), and perhaps most importantly, due to the order of delivery to the phagosome (i.e. 
H2O2 is present before MPO gets delivered) – makes H2O2 a highly desirable candidate 
as the effector mechanism of killing P. gingivalis.    For instance, H2O2 may have a front-
end ability to kill P. gingivalis, before MPO even gets delivered.  
In conclusion from chapter 3, the MPO-independent bactericidal activity of H2O2, 
effective against P. gingivalis and all other species tested, was demonstrated to be both 
time- and dose- dependent; though a significant range of susceptibilities to H2O2 was 
demonstrated among the various species tested.    Of all the species tested, all strains of 
the strictly anaerobic, catalase- and peroxidase-negative, periodontal pathogen P. 
gingivalis were consistently more susceptible to low concentrations of H2O2; and at 60 
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min, there were nearly identical logarithmic reductions in recoverable CFU/mL of all four 
P. gingivalis strains with 20µM H2O2 (Figures 3.4A and B).   In comparison, other 
catalase- and peroxidase-negative, anaerobic periodontal pathogens, P. intermedia and 
F. nucleatum required, respectively, 100µM H2O2 (Figure 3.4B) and >300µM H2O2 
(Figure 3.4A) for logarithmic reductions.   In contrast, the three species that are capable 
of growing in an aerobic environment, A. actinomycetemcomitans, S. aureus, and S. 
pyogenes, required >1,250µM, >2,500µM, and >5,000µM H2O2, respectively, for 
logarithmic reductions (Figures 3.4A and B).    Interestingly, however, while there were 
major differences in the susceptibilities of these bacteria to MPO-independent H2O2, 
there were no differences in the susceptibilities of these bacteria to the H2O2 required for 
MPO-dependent killing.    As long as there was optimum MPO activity available, there 
was no difference in the amount of H2O2 required to kill with MPO.    This seemed to 
suggest that these test bacteria were not different in their susceptibility to the product of 
the MPO-H2O2 system (HOCl), despite having very different susceptibilities to H2O2.    
The objective of chapter 4 was therefore to investigate the differential killing 
mechanisms of H2O2 vs. bleach, in an attempt to better understand how these oxidative 
killing mechanisms may operate in the neutrophil with various bacteria.   To begin to 
address this, select bacteria that were revealed to have very different susceptibilities to 
H2O2 were challenged with a bolus of sodium hypochlorite (Na+ -OCl, which is the salt 
form of H+  -OCl generated by the MPO-H2O2 system in the neutrophil), in order to 
compare susceptibilities to H2O2 vs. bleach.    Despite requiring logarithmically different 
concentrations of H2O2 in order to be killed (Figures 3.4A and B), these bacteria showed 
identical susceptibilities to bleach (Table 4.2).   When titered in 10-fold increments, 
sodium hypochlorite killed all bacteria (shown with P. gingivalis, F. nucleatum, and S. 
aureus) completely and instantly with the same lethal dose of 0.002% Na+ OCl- v/v 
(Table 4.2).   Identical susceptibilities to bleach were also observed with other tested 
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bacteria, including P. intermedia and A. actinomycetemcomitans (data not shown).    
Upon refinement of the titration using 2-fold dilutions, again sodium hypochlorite killed all 
the tested bacteria (shown with P. gingivalis, S. aureus, and S. pyogenes) with the same 
concentration of between 0.00125 - 0.0025% Na+ OCl- v/v (Table 4.2).    
In contrast to H2O2, which killed all test bacteria with a concentration-dependent, 
kinetic killing progression over time; bleach killing occurred in an all-or-none fashion, 
instantly, and with no definable killing progression over time (Tables 4.1 and 4.2).   If 
delivered at a sufficient concentration (≥0.001% Na+ OCl- v/v), bleach killed instantly (at 
0 time, without much additional killing with 0.001% Na+ OCl- v/v after this initial time 
point) (Table 4.1).   Conversely, if challenged with an insufficient dose (≤0.0001% Na+ 
OCl- v/v), bleach did not kill P. gingivalis at all, even through two hours.   These data 
suggest that bleach either kills completely and instantly with a sufficient dose – or as 
quickly as it finds its target, because by one hour, nothing was recovered with 0.001% 
Na+ OCl- v/v, while the dose higher (0.01%) killed everything at 0 time – or kills nothing, 
even after two hours, if administered too low a dose.     
Additionally, because P. gingivalis was capable of being killed by a bolus of 
bleach immediately (at 0 time), this suggests that it takes time for the MPO- H2O2 system 
to generate HOCl; but once available at a sufficient (lethal) concentration, bleach does 
not require time in order to kill, and kills on contact.   This is in contrast with a bolus of 
H2O2, which does not kill on contact, but instead requires time with the bacteria in order 
to kill.   Unlike with bleach, there is a clear killing progression with H2O2, with additional 
killing at each subsequent time point with decreasing H2O2 concentrations.    
The effects of varying temperature on H2O2- vs. bleach- mediated killing were 
also assessed.    H2O2, delivered as a bolus, killed P. gingivalis better at 37oC than at 
room temperature, and was completely blocked when treatment was placed on ice (1oC) 
(Figure 4.1).   The temperature effects on H2O2 killing were not limited to P. gingivalis 
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and was also tested and observed with S. aureus (data not shown).    In striking contrast 
to H2O2, which showed a lag time for killing that was directly temperature-dependent 
(37oC), and a killing progression over time with lower and lower concentrations; bleach 
required a critical concentration in order to kill, and killing occurred equivalently at 37oC 
and on ice, and at 0 and 60 min (i.e. same endpoints over time) (Table 4.1).    
The effects of varying bacterial density on H2O2- vs. bleach- mediated killing were 
also assessed.    When administered to logarithmically-varied bacterial densities, H2O2 
logarithmically killed every bacterial density with the same H2O2 concentration(s); while 
bleach killed the lower bacterial densities completely, while the higher bacterial densities 
were not killed at all – consistent with all-or-none killing by bleach, and decreased 
effectiveness of bleach as the target density was increased (Table 4.3).    Whereas H2O2 
had a clearly titratable effect at 60 min, showing dose-dependent increases in killing at 
every bacterial density; bleach did not show a clear titration at any bacterial density, but 
an all-or-none effect at 0 and 60 min.   For instance, 108 P. gingivalis went from no killing 
(8 log10 CFU/mL) to complete killing (<2 log10 CFU/mL) with 0.1% Na+ OCl- v/v.    These 
data are consistent with the hypothesis that bleach is contact-lethal with a critical 
concentration, whereas H2O2 must be converted to something else in order to become 
lethal. 
The possible nature of this product was next examined with the highly specific, 
hydroxyl radical scavenger, DMSO (157), with H2O2-mediated killing of P. gingivalis, F. 
nucleatum, A. actinomycetemcomitans, and S. aureus (Figure 4.2).    Any protection by 
DMSO is used as a direct indicator of OH. generation (130) (148) (149) (157) (158).    
DMSO similarly protected all four species from H2O2-mediated killing, in a dose-
dependent manner:  100mM DMSO protected best, followed by 10mM DMSO.   At a 
minimum concentration of H2O2 which gave 100% killing (no recoverable CFU on 
replicate plating), 100mM DMSO gave >99% protection of P. gingivalis, >95% protection 
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of F. nucleatum, >90% protection of A. actinomycetemcomitans, and 99.9% protection of 
S. aureus.   These data support hydroxyl radical as the effector mechanism of H2O2-
mediated killing of P. gingivalis, F. nucleatum, A. actinomycetemcomitans, and S. 
aureus.   
The killing kinetics, temperature requirement differences, and the effects of 
bacterial density on the bactericidal activities of H2O2 vs. bleach, are consistent with the 
hypothesis that bleach is directly toxic; whereas H2O2 requires conversion to something 
else, likely by the bacteria itself (e.g. intracellular bacterial iron), in order to kill.   This 
time-dependent event is consistent with the conversion of H2O2 to the toxic product of 
OH..    Additionally, OH. is so reactive that it has been defined as diffusion-limited (89) 
(91).    Its immediacy of reaction with DNA (130), before DMSO could make contact with 
OH., could therefore explain why even 100mM DMSO could not protect from H2O2-
mediated toxicity entirely.    In addition, DMSO may not have protected completely 
because even minute amounts of OH.  is highly effective in bacterial killing, as proposed 
by Repine et al (148).   However, others have suggested that DMSO may not protect 
completely because the immediate product of the Fenton reaction is a ferryl radical 
(FeO2+), rather than a free hydroxyl radical (130) (149).   
Due to the requirement of temperature (37oC) for killing, and due to the total 
block of killing with H2O2 on ice (Figure 4.1), which is suggested to inhibit bacterial 
metabolism, as well as energy-dependent activities independent of metabolism (159) 
(160); these data are also consistent with the hypothesis that conversion of H2O2 to OH. 
requires an active bacterial metabolism or is energy-dependent, and that the bacteria 
themselves contribute to their own demise.    Imlay et al (130) (161) also suggested that 
an active bacterial metabolism is required for killing by H2O2.   Specifically, an active 
bacterial metabolism is suggested to be necessary to provide the reductive cellular 
environment to reduce ferric iron to ferrous iron, the form of which is required for 
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participation in the Fenton reaction:  Fe2+ + H2O2 → Fe3+ + H2O + OH.  (158) (159) (160) 
(161) (162) (163).    These data also support the hypotheses that azide-treated 
neutrophils are unable to kill P. gingivalis either due to OH. scavenging (123), or by 
preventing H2O2 toxicity by shutting down bacterial metabolism or by inhibiting energy-
dependent redox reactions (126) (127) (128) (129), required for OH. production by the 
Fenton reaction (124) (125).     
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SPECULATION AND FUTURE STUDIES 
 
Over one hundred years ago, Elie Metchnikoff recognized the importance of 
phagocytes in host defense against invading microorganisms, but noted that “what 
substances within the phagocyte that harm and destroy the microbes are quite 
undecided” (164).    One hundred years later, much is known about the principal ROS 
associated with neutrophil-mediated killing, though knowledge of the killing biochemistry 
within the phagosome remains limited by the specificity of inhibitors; the inaccessibility of 
probes, detectors, and scavengers; and the variations which exist between individuals, 
infecting organisms, and infection-host dynamics which are too complex to study– 
leaving much open to speculation.   While the studies described here have begun to 
elucidate the components required for neutrophil-mediated killing of P. gingivalis, many 
questions remain unanswered.    While studying the antimicrobial activities of the 
neutrophil in isolation with a pure bacterial culture of P. gingivalis in PBS may be an 
inaccurate representation in light of the polymicrobial and complexity of infection 
conditions in vivo; taking such a reductionist approach is a prerequisite to understanding 
the specific killing mechanisms that may be of importance to this organism.    While 
understanding how P. gingivalis is killed has offered clues about potential treatments for 
this pathogen, as well as insights into the neutrophil-pathogen interactions that may 
contribute to the pathogenesis of periodontitis; many things remain unclear, such as how 
exactly this relates to neutrophils and to the gingival pocket in situ, in periodontitis.    A 
few of the speculations and unanswered questions derived from these studies are 
outlined below. 
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Because P. gingivalis showed an absolute dependence on phagocytosis and a 
functional NADPH oxidase in order to be killed, and was completely resistant to the 
oxygen-independent killing mechanisms of the neutrophil when oxygen was unavailable; 
it is likely that the success of P. gingivalis as a periodontal pathogen is not only linked 
with its exceptional resistance to phagocytosis and to extracellular and serum-mediated 
killing, but to its specific requirements for high titered specific antibody in order to be 
phagocytosed, and the availability of oxygen (for the production of a respiratory burst) in 
order to be killed in the phagosome.    
One hypothesis as to why P. gingivalis infections can present as refractory in 
subjects with severe periodontitis is that deep pockets are anoxic.    Despite a large 
number of neutrophils; reduced oxygen conditions, which prevail in the periodontal 
pocket (165), likely explain the ability of this pathogen to resist killing, as well as to 
persist and multiply in active periodontitis.    In the anoxic conditions of severe 
periodontitis, P. gingivalis would not be killed by gingival crevicular neutrophils due to the 
inability of these neutrophils to mount a respiratory burst in the absence of oxygen (166).   
It is further hypothesized that P. gingivalis may even benefit from the presence of 
neutrophils, which would make major contributions by consuming available oxygen in the 
periodontal pocket (anaerobiosis is required for the growth of this strictly anaerobic 
bacterium); while contributing to tissue destruction, necessary to provide this fastidious 
assacharolytic bacterium with a source of peptides and amino acids for growth and 
nutrition.    
It is also hypothesized that the neutrophil may be of more importance in the 
prevention of the initiation of periodontal disease, when the pockets are shallow and 
more oxygenated, allowing the function of the NADPH oxidase; than in progressive and 
severe disease states, where the pockets are deep and anoxic.    The massive influx of 
neutrophils in periodontitis has been shown to form a leukocyte wall that becomes 
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interposed between plaque and the junctional epithelium and sulcus (3), which likely 
consumes all available oxygen along the interface into the periodontal pocket, leaving 
the center of the pocket anaerobic.    In conjunction, fibroblasts are known to wall off the 
area, sequestering infection and inflammation, while limiting the re-introduction of 
oxygen into the area, as a consequence.   Re-introducing oxygen into the pocket via 
scaling and debridement, and especially periodontal surgery, so that the neutrophil 
NADPH oxidase can function again, would likely be an excellent treatment for 
periodontal infections with P. gingivalis.    
Immunizing with specific virulence determinants of P. gingivalis, including both 
capsule and gingipains, may also facilitate clearance by increasing the subset (10% in 
these studies) of neutrophils capable of phagocytosis in the absence of specific 
antibody.    In addition, since the majority of the proteins and peptides contributing to the 
non-oxidative killing mechanisms of the neutrophil are arginine- and lysine- rich, they 
appear incredibly susceptible to cleavage and inactivation by the arginine and lysine 
gingipains of P. gingivalis.   Introducing gingipain-specific antibody or protease inhibitors 
specific to gingipains into infection sites known to have P. gingivalis may also serve as 
an effective treatment by neutralizing these activities, and may increase the ability of 
neutrophils to kill this pathogen by non-oxidative mechanisms when oxygen is 
unavailable.   
Another potential treatment of periodontitis would be to target pro-inflammatory 
pathways, since disease progression is due in large part to the consequences of 
inflammation.   It is hypothesized that neutrophil function is altered in periodontitis in the 
presence of pro-inflammatory cytokines, the influence of which may enhance 
phagocytosis at the expense of effective killing.   Despite an abundance of neutrophils, 
P. gingivalis flourishes in periodontitis, and it is important to understand why.   For 
example, it would be important to understand why in situ neutrophils, under the influence 
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of P. gingivalis and/or pro-inflammatory cytokines do not kill as effectively, and whether 
they are still capable of delivering granule components for killing; furthermore, if oxygen 
were reintroduced, would effective killing resume, and why not, if not?    For instance, it 
has been suggested in the studies of Abe et al (167) that P. gingivalis may be capable of 
altering or shutting down the oxidative killing mechanisms of the neutrophil, which is an 
interesting concept that warrants further study.   It is also unknown whether P. gingivalis 
and/or pro-inflammatory cytokines are capable of inhibiting neutrophil degranulation after 
phagocytosis, which can be determined by electron microscopy of phagolysosomal 
fusion events using histochemical staining of MPO-containing granules and immunogold 
labeling of lactoferrin-containing granules, as well as cytochrome c reduction assays of 
neutrophils for the determination of respiratory burst capacity. 
Furthermore, it is interesting that P. gingivalis absolutely requires phagocytosis in 
order to be killed, which requires the presence of serum containing both complement 
and high titered specific antibody.    It is possible that P. gingivalis interferes with the 
respiratory burst in the absence of antibody, explaining why P. gingivalis is not killed on 
the surface of neutrophils, despite the purported production of superoxide and hydrogen 
peroxide proximal to a bacterial surface and on the outside of the neutrophil before 
phagocytosis occurs (an estimated 10% of specific granules are exocytosed while the 
remainder are delivered to the phagosome after phagocytosis).   Potential experiments 
could be to measure the cytochrome c reduction capacity of neutrophils in the presence 
of P. gingivalis and in the presence and absence of antibody and complement, after the 
addition of cytochalasin B/ PMA vs. fMLP, with and without SOD and/or catalase; and 
how well this correlates with the ability of P. gingivalis to be killed on the surface of 
neutrophils under these conditions.   While the use of PMA would allow us to 
differentiate the effects of the respiratory burst independent of MPO release due to the 
selective release of specific granules, fMLP would allow us to examine the influence of 
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both granule populations (specific and azurophilic).   Additionally, anaerobiosis and DPI 
could also be used to differentiate the contributions of oxygen- and NADPH oxidase- 
dependent killing pathways, respectively, in extracellular neutrophil-mediated killing of P. 
gingivalis in the presence of cytochalasin B/ PMA vs. fMLP. 
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Bacterial virulence has been suggested to be connected with the ability of 
bacteria to synthesize specific antioxidant enzymes that help to neutralize the oxidative 
killing mechanisms of the neutrophil.    Many bacteria synthesize antioxidant enzymes 
such as SOD, catalase, and peroxidases, which may contribute to their resistance to 
killing by neutrophils.   SOD is thought to protect Nocardia asteroides (168) (169), 
Listeria monocytogenes (170), and Shigella flexneri (171) (172) from phagocytic killing; 
whereas, catalase activity has been suggested to protect S. aureus (173) and Neisseria 
gonorrhea (174) from phagocytic killing.   While SOD in P. gingivalis has not been 
associated with resistance to neutrophil killing, it has been found to contribute to its 
remarkable ability to survive during transient exposure to oxygen (175).   As suggested 
by Lynch et al (175), initial colonization events may pose the most crucial oxidative 
stresses to P. gingivalis, and given the varying oxygen tension in periodontal pockets, 
aerotolerance in the absence of growth may be as significant a virulence trait of P. 
gingivalis as any other.    SOD in P. gingivalis may therefore contribute not only to its 
ability to successfully colonize, but in protection against oxygen exposure during 
periodontal procedures (e.g. scaling, planing, and surgery).       
While P. gingivalis does not make catalase or peroxidase enzymes to degrade 
H2O2 (138) (176), it does make a protoporphyrin layer from hemoglobin, which is 
proposed to serve as an antioxidant barrier (143) (144), as well as rubrerythrin (177), 
Dps (DNA binding protein from starved cells) (178), an alkyl hydroperoxide reductase 
(AhpFC) (179) (180), and OxyR (181), which have all been shown to potentially protect 
P. gingivalis against H2O2.    P. gingivalis, however, is remarkably sensitive to low 
micromolar concentrations of H2O2, so it is apparent that these antioxidant mechanisms 
against H2O2 are not very effective against H2O2-mediated killing, at least in the 
conditions (PBS) tested.     
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Since H2O2-mediated lethality in bacteria is associated with the possession of 
intrinsic iron (88) (148), and is due to overwhelming DNA damage due to inefficient 
repair (130) (159) (161); the exceptional susceptibility of P. gingivalis to H2O2 may be 
due to several things.   For instance, P. gingivalis may possess 1- fewer scavenging 
enzymes or 2- fewer DNA repair mechanisms; 3- a greater number or 4- a greater 
accessibility of lethal targets; or 4- a greater amount of intrinsic iron (e.g. iron-sulfur 
clusters) available to generate OH..   These are unknown variables which warrant future 
study.   It is also unknown whether heme iron in protoporphyrin is capable of 
participating in Fenton chemistry, which could account for the relatively greater 
sensitivity of both P. gingivalis and P. intermedia to H2O2, compared to the other test 
species that do not make protoporphyrin.   It is possible that the iron abundant within the 
protoporphyrin layer that covers the surfaces of these bacteria provide additional iron 
sources for the generation of OH., close to vital targets such as DNA. 
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Preliminary studies in this laboratory, which compared H2O2-mediated killing of P. 
gingivalis in PBS vs. in various complex media (e.g. in Wilkins-Chalgren broth (WC) as 
well as in trypticase soy broth (TSB)), suggested that P. gingivalis has an advantage 
over other organisms in WC because of how resistant it became to killing in WC; i.e. P. 
gingivalis required approximately 100-fold more H2O2 in WC, in order to achieve 
equivalent killing in WC and PBS (unpublished observations).   WC, which contains 
haemin, afforded a protection to P. gingivalis against H2O2-mediated killing not evident in 
TSB, which does not contain haemin.    In contrast to P. gingivalis, S. aureus showed 
very similar killing in PBS and WC, suggesting that haemin is what was protecting P. 
gingivalis against H2O2-mediated killing in WC.   It is therefore possible that P. gingivalis 
in growth-conditions in situ, where red blood cells and thus haemin are available, may 
enhance the resistance of P. gingivalis by permitting the up-regulation or accretion of 
potential defense mechanisms such as protoporphyrin, which is dependent on haemin 
derived from hemoglobin.    As suggested by others (156) (182), it is also possible, 
though unlikely given the negligible effect on S. aureus susceptibility, that the rich 
medium of WC (which contains buffer salts, proteins, etc) accounts for the reduced 
bactericidal activity of H2O2, by its components scavenging H2O2.   All of these 
observations warrant further study.     
Experiments could include examining P. gingivalis sensitivity to H2O2 under the 
influence of different growth phases (i.e. lag, exponential, and stationary) and examining 
what defense mechanisms are up-regulated or accreted (e.g. protoporphyrin) at the 
different growth phases and under the growth conditions of WC vs. the non-growth 
conditions of PBS, to possibly account for its greater sensitivity to H2O2 in PBS 
compared to WC.    Additional experiments could examine P. gingivalis (and P. 
intermedia) sensitivity to H2O2 when protoporphyrin is promoted (e.g. when grown on 
blood-based medias which allow protoporphyrin to be accreted vs. on non blood-based 
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medias such as WC), in comparison to non-black pigmenting mutants that make little or 
no protoporphyrin (99) (143) (144) (145); and if there are differences in the effectiveness 
of heme-derived vs. hemoglobin-derived protoporphyrin.    For instance, growth on 
media containing hemoglobin but not heme/haemin is necessary for black-pigmentation 
(99), a result of modification of protoporphyrin.   PBS and TSB could also be enriched 
with heme/ haemin (vs. hemoglobin) in order to confirm the influence of haemin in WC, 
and to evaluate the potential effects of metabolism, in the increased resistance of P. 
gingivalis in WC compared to PBS. 
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Despite the protective role of neutrophils in the periodontium, neutrophils are the 
main cell type associated with the pathogenesis of periodontitis, and are responsible for 
a significant amount of damage accompanying disease activity.    Host tissue damage 
most likely occurs unintentionally by ‘frustrated’ neutrophils, unable to clear 
phagocytosis-resistant bacteria, or when confronted by high concentrations of bacteria 
which they are unable to handle, such in the absence of oxygen (183).   In the presence 
of pro-inflammatory cytokines, neutrophils become hyper-responsive, and are believed 
to deliver more of their granule contents extracellularly, which in these special 
circumstances include MPO.    It is highly plausible that the primary strategy of P. 
gingivalis in the periodontium may be to minimize the presence of oxygen, which would 
minimize the production of H2O2, and may do so by utilizing host elements.     
If P. gingivalis is as sensitive to H2O2 in the gingival crevice as it is in PBS, it may 
even benefit from the presence of MPO, which may function as a H2O2 scavenger or a 
catalase in high concentrations of H2O2 (115) (142) (and Figure 3.5B).   By consuming 
H2O2, the catalase-like activity of MPO in the gingival crevice would convert H2O2 to 
oxygen and water, thereby protecting H2O2-sensitive bacteria such as P. gingivalis 
against H2O2.    In the presence of red blood cells in the gingival crevice due to bleeding 
gums, hemoglobin would not only be available to provide haemin to P. gingivalis, but 
could also serve to “mop up” excess oxygen from these catalatic activities of both 
catalase and MPO.   It is also likely that extra-phagosomal H2O2 either released by 
neutrophils into the gingival pocket or provided as a clinical treatment, would not be 
effective in periodontitis due to the abundance of catalase from red blood cells, which 
would readily rid H2O2 in periodontal tissues. 
While it is hypothesized from our studies that MPO protects enzymatically (e.g. 
functions as a catalase) in the presence of high H2O2 concentrations, this also warrants 
confirmation, which can be achieved with 4-ABH under these conditions; the alternative 
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possibility, though unlikely given the negligible protein contribution, was that it was a 
protein effect.     
In future studies, it would be of upmost importance to better understand the 
function of MPO in the context of what is actually happening in the phagosome.   For 
instance, at a pH of 7.4, MPO was highly effective at blocking killing by ≥10µM H2O2 
(Figure 3.5), and thus it remains unclear whether MPO can play an important role in 
killing in the phagosome, if antagonistic interactions between MPO and H2O2 occur in 
the phagosome, as they were shown to occur in these studies.   Furthermore, it would 
be important to better understand what shifts the function of MPO (e.g. whether pH is 
involved or if purely dependent on substrate availability such as H2O2 concentration) – 
from being bactericidal, to host protective, and potentially protective of bacteria, 
depending on H2O2 concentration. 
In future studies, it would also be important to understand the influence of order 
of addition.   For instance, in these studies, MPO was combined with H2O2 for several 
seconds before bacteria were added, which was designed to favor HOCl generation.    It 
would be interesting to determine whether exposure of bacteria first with H2O2, at various 
concentrations and for various lengths of time, followed by the addition of MPO, would 
have a different effect.    For instance, the H2O2 to MPO ratios required for killing may be 
different if the order of addition is altered, due to additional H2O2 scavenging 
opportunities by bacteria, if exposed to H2O2 for a period of time before MPO.   
Additionally, the pre-treatment of bacteria with H2O2, followed by the addition of MPO, 
would presumably also be comparable to the order of addition which occurs within the 
phagosome, and may allow H2O2 to enter the bacteria and initiate MPO-independent 
killing events before MPO gets delivered.   In these circumstances, the subsequent 
addition of MPO may not show as much protection against H2O2-mediated killing as 
previously seen, or may show no protection at all, if H2O2 has already entered the cell at 
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the site of delivery, and has already reached lethal concentrations within the bacterial 
cell.    A lethal, intracellular build-up of H2O2 may likely occur before MPO is delivered 
via an azurophilic granule, which would fuse at a separate and distinct site of the 
phagosome.    
H2O2, which is generated proximal to a bacterial surface and is rapidly 
membrane- diffusible, would also be less available to react with MPO when it is 
delivered later, at a separate site of the phagosome, for the subsequent generation of 
HOCl.    In contrast, the Winterbourn model (95) assumes that all of the H2O2 in the 
phagosome will be consumed immediately by MPO, and that H2O2 is unavailable for 
purposes other than the generation of bleach.   In context of this model and our own, it 
would be extremely important to better understand the timing of azurophilic granule 
fusion with the phagosome and the timing of MPO release, subsequent to the initiation of 
the respiratory burst, as previous studies in this laboratory using electron microscopy 
have suggested that H2O2 generation subsequent to specific granule fusion with the 
phagosome is initiated tens of minutes before MPO-containing azurophilic granules are 
seen to be delivered (unpublished observations).   Additionally, it would be important to 
take into account the effect of antioxidant defenses of bacteria into this model, as 
suggested in Figures 3.4 and 3.6 and in the discussions of chapters 3 and 4. 
In addition, in future studies, it would also be important to understand the 
influence of pH on killing.    The studies here employed a pH of 7.4, which is the 
presumed pH when MPO is delivered and bacterial killing occurs (95).    However, 
earlier in the phagosome, when the respiratory burst has just begun, the pH is believed 
to be transiently lower (97).   It is hypothesized that the lower pH would favor the 
conversion of O2.- and/or H2O2 to more toxic products such as OH. prior to the delivery of 
MPO (184). 
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Since the mechanism of azide protection of P. gingivalis against neutrophil-
mediated killing remains unknown, future studies are also warranted to determine the 
specific mechanism by which azide protects (e.g. whether by OH. scavenging or by 
inhibiting OH. generation).     
It is also a question what effect azide has on MPO-independent, H2O2-mediated 
killing of P. gingivalis, in comparison to treatment with other potent OH. scavengers or 
inhibitors (e.g. DMSO and thiourea, etc).   It is hypothesized that azide would also inhibit 
in vitro H2O2-mediated killing of this pathogen, by inhibiting toxicity by H2O2 by the 
mechanisms previously discussed.    
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The question also still remains as to why subjects with CGD, whose neutrophils 
are incapable of killing P. gingivalis, rarely present with periodontal or other anaerobic 
infections.   It is possible that the answer lies in the absence of the respiratory burst 
itself.   For instance, the inability to reduce the microenvironment (i.e. rid oxygen) in 
CGD, despite its inability to kill, may prevent this strict anaerobe from growing and thus 
establishing an infection in healthy, aerated periodontal tissues.    
It is also well-supported that ROS from the respiratory burst are the major 
contributors to the severe periodontal tissue destruction associated with aggressive 
periodontitis (185), so the absence of a respiratory burst in CGD may explain the 
absence of characteristic periodontal tissue damage.   This is consistent with the 
findings of Gronert et al (186), which associated locally inflamed sites in subjects with 
localized aggressive periodontitis with excessive superoxide production.    Additionally, 
this concept is consistent with the findings of Mydel et al (187), which suggested that the 
host respiratory burst paradoxically improved the survival of P. gingivalis in the mouse 
subcutaneous chamber model by enhancing local and systemic inflammation.   
Conversely, mice without a respiratory burst survived and were resistant to P. gingivalis 
infection, while mice with an intact NADPH oxidase succumbed to P. gingivalis 
challenge.    Excessive neutrophil-generated inflammation in wild type mice, which was 
shown to be completely responsible for the morbidity and mortality associated with P. 
gingivalis infection, may not only have provided reduced oxygen conditions, but a source 
of nutrients for the growth of this anaerobic and assacharolytic bacterium.    
Another explanation which may partially account for the lack of predisposition to 
periodontitis in subjects with CGD is long-term antibiotic use after diagnosis with CGD.   
This seems a less likely explanation, however, as subjects with other neutrophil 
disorders appear highly predisposed to developing severe periodontitis, despite 
aggressive antibiotic regimens (188).    
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It is also conceivable that the strict anaerobic metabolism of P. gingivalis may 
safeguard P. gingivalis in CGD, and that it is not killed by CGD neutrophils because it 
does not generate H2O2.   It would be valuable to investigate whether this in fact is true.    
Furthermore, impaired bactericidal activity in CGD neutrophils, which are incapable of 
producing their own O2.- and H2O2, has been restored in the laboratory by the addition of 
a H2O2-generating system (189) (190) (191) (192) (193) (194).   It would also be of 
interest to know whether a H2O2-generating system, such as 6-formylpterin (189), would 
restore bactericidal activity against P. gingivalis in CGD neutrophils.    
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Supplemental Table A.1.   Neutrophil Phagocytosis of P. gingivalis is Antibody-
Dependent and Oxygen-Independent 
% Phagocytosis, with Ab % Phagocytosis, without Ab 
 Time (min) Aerobic Anaerobic Aerobic 
0 71 (5) 72 (6) *1 (1) 
10 79 (9) 80 (10) *1 (3) 
30 94 (6) 90 (10) *10 (1) 
60 97 (5) 96 (4) *10 (1) 
120 98 (3) 98 (3) *10 (1) 
Results are expressed as the % of total neutrophils involved in phagocytosis (three or 
more bacteria per neutrophil).  Samples contained the presence of human complement, 
and either the presence or absence of hyperimmune rabbit antiserum (Ab).    
Experiments were performed at 37oC under aerobic vs. anaerobic atmosphere, using 
normally competent neutrophils purified from the peripheral blood of healthy donors.   
Values are the means from three or more independent experiments, and values in 
parentheses are the standard deviations of those means.   Asterisks indicate that the 
difference, compared to antibody-containing controls, is statistically significant (p<0.05). 
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Supplemental Table A.2.  Description of CGD Subjects 
Subject Age Gender Genotype 
CGD 1 10 mo M gp91phox 
CGD 2 12 yr F p47phox 
CGD 3 13 yr M p47phox 
CGD 4 10 yr F p47phox 
CGD 5 38 yr F p47phox 
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Supplemental Table A.3.   Neutrophil Oxidative Index by Flow Cytometry, and 
Vmax and Change in Optical Density over 30 min by Cytochrome C Reduction, 
Comparing CGD vs. Normal Neutrophils 
Flow cytometry PMAb fMLPe/cytochalasin bf 
Subject NOIa Vmaxc ∆mOD30mind Vmaxc ∆mOD30mind 
 
CGD 1 
 
1 0 70 0 0 
 
CGD 2 
 
2 0 0 0 0 
 
CGD 3 
 
4 0 0 0 0 
 
CGD 4 
 
6 NT NT NT NT 
 
CGD 5 
 
1 0 0 0 0 
 
Controls 
 
249 (95) 
 
47 (20) 473 (335) 17 (2) 151 (28) 
 
Control values are the means from normally competent neutrophils purified from the 
peripheral blood of four different healthy donors, and values in parentheses are the 
standard deviations of those means.   Values for CGD Subjects 1-5 represent data 
obtained from a single sample.    NT:  not tested.   Experiments were performed under 
aerobic atmosphere. 
 
a
 NOI:  neutrophil oxidative index (>30 defined as normal). 
b
 PMA:  phorbol myristate acetate (final concentration:  1x10-7M/5x106 neutrophils). 
c
 Vmax:  maximal velocity of superoxide production (mOD/min) calculated by 
SOFTMAX® software. 
d
 ∆mOD30min:  change in optical density over 30 minutes (from time 0 to time 30 min). 
e
 fMLP:  N-formyl-methionyl-leucyl-phenylalanine (final concentration:  5x10-8M/5x106 
neutrophils). 
f
 Cytochalasin b (final concentration:  5µg mL-1/5x106 neutrophils). 
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Supplemental Figure A.1A.   MPO-Positive Neutrophils from a Normally Healthy 
Human Donor.   Transmission electron micrograph, representative of normal 
neutrophils from a healthy donor, showing histochemical staining for peroxidase-positive 
granules (original magnification x7500).   Note the distribution and dark staining 
character of the peroxidase-positive granules.    All neutrophils from donor controls 
demonstrated normal distributions of peroxidase-positive granules. 
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Supplemental Figure A.1B.  Transmission Electron Micrographs of Representative 
Neutrophils from the Peripheral Blood of Subject MPO-PDM (left panel) Compared 
to MPO-DS (right panel).    Right panel:  Note the absence of peroxidase-positive 
granules in the neutrophils from MPO-DS, compared to that of MPO-PDM (arrows, left 
panel) and to that of normal neutrophils in Supplemental Figure A.1A.   None of the 
neutrophils examined from subjects MPO-DS (right panel), MPO-DB or MPO-DF (not 
shown) contained peroxidase-positive granules.    However, all subjects had dense 
distributions of granules and all contained granules that were positive for lactoferrin as 
determined by immunogold (Supplemental Figure A.1C and data not shown).   
Approximately 90% of the neutrophils from MPO-PDM (left panel) showed normal 
distributions of peroxidase-positive granule types; the remaining 10% of neutrophils had 
no discernible peroxidase-positive granule types.  
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Supplemental Figure A.1C.   Transmission Electron Micrographs of 
Representative Neutrophils from MPO-PDG, Histochemically Stained for 
Peroxidase and Immunogold-Labeled for Lactoferrin (arrows).   Approximately 50% 
of neutrophils from MPO-PDG were peroxidase-negative (right panel), with the 
remainder having normal distributions of peroxidase-positive granules (left panel).   All of 
the neutrophils from MPO-PDG contained lactoferrin-positive granules (arrows, right and 
left panels). 
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Supplemental Figure A.2.   MPO Enzymatic Assay Testing Various Potential MPO 
Inhibitors.   The following final concentrations were used:  DPI: 20µM in less than 
0.3mM or 0.1% (v/v) DMSO; DMSO: less than 0.3mM; sodium azide: 20µM; 4-ABH: 
4mM. 
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DAPI/PI Fluorescence Microscopy of Neutrophil 
P. gingivalis and F. nucleatum 
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MATERIALS AND METHODS 
Patient Selection  
 Chronic Granulomatous Disease (CGD) Subjects:   Five CGD subjects were 
included in this study and are characterized in Supplemental Table A.2.   CGD1 was a 
ten month old male, who presented to UNC Hospital with a history of recurrent bacterial 
infections, most notably staphylococcal skin abscesses.   CGD1 died two months later of 
a disseminating Aspergillus infection.   CGD2, CGD3, and CGD4 were juveniles ranging 
between 10-13 years of age.   All three reported a prior history of recurrent skin 
infections, abscesses, sore mouth, and sore gums.   Oral examination revealed mild 
gingivitis in CGD3 and CGD4 (brother and sister), while CGD2 appeared to have 
excellent gingival health.  CGD2, CGD3, and CGD4 had no tooth loss and no 
radiographic evidence of bone loss.   CGD5 was a 38 year old female with a history of 
periodontal surgery.   CGD5 was on a periodontal maintenance program and had a 
stable periodontal condition (2-5mm probing depths), little clinical inflammation, and 
excellent oral hygiene.   CGD5 did not report a history of frequent intraoral ulcerations.   
Her periodontal condition rapidly deteriorated with highly inflamed gingival tissues with 
excessive bleeding and exudate, and probing depths of 6-9mm.   This patient did not 
respond to antibiotics or to local irrigation treatments.   Radiography showed moderate 
to severe generalized horizontal bone loss, but no missing teeth.   Her purified 
neutrophils were determined incapable of reducing cytochrome c following either PMA or 
fMLP stimulation.   She was subsequently diagnosed genetically as heterozygous 
p47phox deficient. 
 MPO- Deficient Subjects:   Five MPO-deficient subjects were included in this 
study, and were members of one family previously identified with MPO-deficiency.   
MPO-DS was a five year old Caucasian female, who presented with a history since 
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infancy of recurrent sinusitis (documented by sinus radiographs), bronchitis (associated 
with fever), and asthma.   MPO-DS had frequent respiratory exacerbations, which were 
treated with both antibiotics and asthma therapy.   She also had chronic headaches, 
treated with valproic acid and restoril.   Her initial workup at UNC (age specific normal 
values for UNC laboratories shown parenthetically) included a hemoglobin of 11.3 g/dl 
(normal: 12.3-15.7 g/dl), hematocrit of 32.5% (normal: 38-47%), white blood count of 8.6 
x109 cells/l (normal: 4-12 x109 cells/l), monocyte count of 0.5 x109 cells/l (0.7-1.5 x109 
cells/l), and an eosinophil count of 0.2 x109 cells/l (0.3-0.8 x 109 cells/l).   Serum 
immunoglobulins included IgA of 25 mg/dl (normal: 40-320 mg/dl), IgM of 26 mg/dl 
(normal: 25-210 mg/dl), and an IgG of 319 mg/dl (normal: 400-1400 mg/dl) and an IgG4 
of 11 mg/dL (normal: 0-138 mg/dL).   IgE was <10 IU and her skin test negative.   Her 
oxidative burst index was 151 (>30 considered normal).   Delayed type sensitivity skin 
tests were normal, as were lymphocytic marker studies for CD3, CD4, CD8, CD19, and 
CD56.   Pneumococcal vaccine was administered and her pre- and post- immunization 
titers (performed at Scripps) obtained on the day of immunization and four weeks post- 
immunization for each serotype (protective considered >2.0) were:  serotype 4: <0.1 and 
<0.1, serotype 6b: <0.1 and <0.1, serotype 14: <0.2 and <0.2, serotype 18c: <0.1 and 
0.1, serotype 19f: <0.3 and <0.3 and serotype 23b: <0.1 and <0.1.   She then underwent 
a course of IVIG (0.4 g/kg monthly), with gradual improvement in her sinopulmonary 
status, such that she had no hospitalizations for the 12 months following initiation of 
IVIG.   After one year, she was taken off IVIG therapy for six weeks and immunized 
again with diphtheria, tetanus, and pneumococcal vaccines.   Post- immunization titers 
to diphtheria were 1:19,683, tetanus 1:59,049, and pneumococcal titers were:  serotype 
4: 0.5, serotype 6b: 0.6, serotype 14: 2.2, serotype 18c: 0.9, serotype 19f: 1.1 and 
serotype 23b: 0.7.  During the time she was off IVIG, she began having respiratory 
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episodes with temperature of 38.2 or less, which were treated with antibiotics.   IVIG 
treatment was reinitiated. 
MPO-DB, the brother of MPO-DS, presented to UNC Hospital at age two with a 
history of chronic sinusitis (documented by sinus radiographs), which did not resolve 
with an initial 21-day treatment with amoxicillin and clavulanic acid.   He then underwent 
treatment with clindamycin for 14 days without improvement and eventually required 
concurrent treatment with clindamycin and amoxicillin + clavulanic acid.   He had 
recurrent episodes of sinusitis.  His initial workup at UNC (age specific normal values for 
UNC laboratories shown parenthetically) included a hemoglobin of 12.8 g/dl (12.3-15.7 
g/dl), hematocrit of 34.9% (38-47%), white blood count of 7.6 x109 cells/l (4-12 x 109 
cells/l), neutrophil count of 2.6 x109 cells/l (2-6 x 109 cells/l), lymphocyte count of 4.2 x109 
cells/l (2-5 x 109 cells/l), monocyte count of 0.2 x109 cells/l (0.3-1.1 x 109 cells/l), and an 
eosinophil count of 0.3 x109 cells/l (0.2-2.0 x 109 cells/l).   Serum immunoglobulins 
included an IgA of 30 mg/dl (25-240 mg/dl), IgM of 48 mg/dl (25-210 mg/dl), and an IgG 
of 532 mg/dl (325-1300 mg/dl), with an IgG1 level of 353 mg/dl (290-1065 mg/dl), IgG2 
of 59 mg/dl, IgG3 of 38 mg/dl (4-71 mg/dl), and an IgG4 of 23 mg/dl (0-90 mg/dl).   IgE 
was <10 IU and he was skin test negative for allergy.   His oxidative burst index was 151 
(>30 considered normal).  Delayed type sensitivity skin tests were normal, as were 
lymphocyte marker studies for CD3, CD4, CD8, CD19, and CD56.  Pneumococcal 
vaccine was administered and titers obtained four weeks later to each serotype were:  
serotype 4: 0.8, serotype 6b: 0.1, serotype 14: <0.2, serotype 18c: 2.1, serotype 19f: 
<0.3 and serotype 23b: 0.2.   IVIG treatment was started and the need for antibiotic 
treatment for sinusitis subsided.   After four months of treatment, IVIG was stopped and 
pre- and post- pneumococcal immunization titers for each serotype were found to be:  
serotype 4: 0.1 and 0.1, serotype 6b: <0.1 and <0.1, serotype14:  <0.2 and <0.2, 
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serotype18c: 0.6 and 0.5, serotype19f: <0.3 and <0.3 and serotype 23b: <0.1 and <0.4.   
MPO-DB is now receiving IVIG.    
The mother (MPO-PDM) and maternal grandmother (MPO-PDG) to MPO-DS 
and MPO-DB both reported problems with sinopulmonary infections, especially sinusitis.   
They did not choose to undergo treatment.   The father (MPO-DF) had a normal health 
history, despite complete MPO-deficiency.   Five gender- and race-matched normally 
healthy donors were included as controls for the determination of neutrophil MPO- and 
lactoferrin-granule profiles.   Purified neutrophils (buffy coat from MPO-DB) from 
peripheral blood from each of these subjects were examined by transmission electron 
microscopy for peroxidase-positive and lactoferrin-positive granule staining (see 
methods below).    
 
Transmission Electron Microscopy 
Purified neutrophils or buffy coat from selected MPO-deficient subjects and 
controls were examined simultaneously by histochemistry for peroxidase-positive 
granule content and by immunogold-labeling for lactoferrin-containing granules.   Cell 
preparations were fixed in 3% paraformaldehyde, 0.5% glutaraldehyde in 0.1M 
cacodylate buffer (pH 7.4) for three hours, then rinsed in the 0.1M cacodylate buffer 
overnight.   Histochemical staining for MPO was performed according to the methods of 
Pelliniemi (1) and Castaneda (2) et al.   Briefly, cells were incubated in 5mg 
diaminobenzidine (DAB) contained in 10mL 0.05M Tris-HCl buffer and 0.1mL 1% H2O2 
for 30 min, rinsed and amplified with 2% OsO4 for one hour.   Cell suspensions were 
dehydrated in 50% and 70% ethanol for five min each, and then transferred to a 2:1 
mixture of LR White resin and 70% ethanol for four hours.   The samples were then 
infiltrated in LR White resin overnight at room temperature, transferred to gelatin 
281 
 
capsules and cured for three days at 45oC.   Sections were cut on an ultramicrotome 
(60-90nm) and placed on nickel grids. 
Post-embedding immunolocalization of lactoferrin was performed based on a 
procedure described by Esaguy et al (3).   All washing, incubation, and fixation 
procedures were accomplished by immersing the grids face down in drops of the 
different solutions.   Briefly, the grids were washed with water for 10 min, rinsed with 
PBS/1% BSA x 2 for five min at room temperature or 37oC, washed with PBS/BSA x 3 
for five min, and incubated with 10nm gold conjugated Protein A/antibody (affinity-
purified rabbit anti-human lactoferrin IgG prepared in this laboratory) in PBS/BSA (1:20, 
v/v) for 45 min.   The grids were then rinsed with PBS/BSA x 3 for five min, PBS x 2 for 
five min, fixed with 2% glutaraldehyde in 0.1M phosphate buffer for 10 min, rinsed with 
water x 3 for five min, and post-stained in uranyl acetate and lead citrate.  Sections were 
viewed with a Philips CM12 transmission electron microscope operating at 80kV 
accelerating voltage. 
 
Flow Cytometry Assay 
The intracellular production of hydrogen peroxide was measured in individual 
stimulated neutrophils by flow cytometry using the procedures reported by Rothe et al 
(4) (5).   An Oxidative Burst Kit was purchased from New Concept Scientific Ltd 
(Burlington, Ontario).   One ml of blood was collected in EDTA from the five CGD 
subjects and controls.   100µL of whole blood was suspended in a microcentrifuge tube 
containing 900µL of phosphate buffered saline (PBS) and dihydrorhodamine 123 (DHR 
123, final concentration 2.5 µg/ml).   The suspension was incubated in a shaking water 
bath for 15 min at 37°C.  10µL of phorbol myristate acetate (PMA, final concentration 
100ng/mL) was added and the neutrophils were incubated for another 15 min at 37oC.   
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Control samples containing no DHR123 or no PMA were run in parallel.   The 
neutrophils were collected after centrifugation (300xg, five min), red blood cells were 
lysed with lysing buffer, and the remaining neutrophils were washed again with wash 
buffer and fixed in 0.5mL of 1% paraformaldehyde.   Flow cytometric analysis was 
performed on 5,000 neutrophils using a Becton Dickinson FACScan flow cytometer.    
Neutrophil Oxidative Index (NOI) was calculated by dividing the mean fluorescence of 
the sample with both DHR123 and PMA, by the mean fluorescence of the sample 
without PMA.    An NOI > 30 was considered to be normal, and an NOI < 30 was 
considered an absence of respiratory burst, and suggested CGD. 
 
Neutrophil Superoxide Production Assay 
 The extracellular release of superoxide anions by neutrophils upon stimulation 
with fMLP (N-formyl-methionyl-leucyl-phenylalanine) in the presence of cytochalasin b or 
with PMA was measured using a microtiter spectrophotometric assay based on the 
superoxide dismutase (SOD)-inhibitable reduction of cytochrome c (6).   A continuous 
rate-determination (Vmax or maximal velocity) and total superoxide production assay 
(∆OD30min) were employed to examine neutrophil oxidative burst functions.   Briefly, stock 
solutions of SOD (Boehringer Mannheim, GmbH, Germany) and cytochrome c (Sigma 
Chemical Co., St. Louis, MO) were made using HBSS buffer without metals.   fMLP and 
PMA (Sigma Chemical Co., St. Louis, MO) were made in 100% DMSO (dimethyl 
sulfoxide, Sigma Chemical Co.) and diluted to the appropriate working concentration just 
before use.   The final concentration of DMSO in the assay mixture was <0.1% (v/v).    
All experiments were carried out at least in triplicate.   Each test well contained 5x106 
neutrophils, 0.11µM cytochrome c, 0.6 mM CaCl2, 0.5 mM MgCl2, and either fMLP (5x10-
8M) + cytochalasin b (5µg/ml), or PMA (1x10-7M).   Control wells additionally contained 
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100µg SOD.   HBSS without metals was added to adjust the final volume to 100µL.  
Superoxide production by neutrophils after stimulation with either fMLP/cyt b or PMA 
was assessed by measuring the change in absorption at Aλ550nm every 10 seconds for 30 
min in a Vmax kinetic microplate reader (Molecular Devices, Menlo Park, CA) at room 
temperature.   Agitation was applied before each reading using an auto vibrating plate 
holder.   The microplate reader was connected to a PC with Softmax software (Molecular 
Devices, Menlo Park, CA) allowing Vmax estimates, OD (optical density) change 
measurement, and curve fittings.    An absence of cytochrome c reduction, as 
demonstrated by a Vmax of zero, and a negligible OD change over 30 min, was 
considered an absence of respiratory burst (inability to produce superoxide), and 
suggested CGD. 
 
MPO Assay 
 MPO enzymatic activity was tested using a microtiter spectrophotometric assay 
on titered human neutrophil MPO (Athens Research and Technology Inc, Athens, GA) 
(frozen as 30µL aliquots of 20U/mL stock in 50mM sodium acetate pH 6 + 100mM 
NaCl), using a substrate kit from Kirkegaard & Perry Laboratories (#50-76-00), in the 
presence and absence of various inhibitors (azide at 20µM FC, 4-ABH at 4mM FC, DPI 
at 20µM FC, and DMSO at 0.03% (v/v) or 0.28mM FC).   Briefly, 50µL of substrate, 
mixed in equal parts (25µL of 1.7mM 3,3’5,5’-tetramethyl benzidine (FW 240.35), in 
N,N’,dimethylforamide phosphate buffer (Kirkegaard & Perry Labs) + 25µL of 0.02% 
(v/v) H2O2 in citric acid buffer) was added per well, in triplicate.  On a 15 s interval, 10µL 
of MPO (serially diluted two-fold) with or without inhibitor (pre-incubated for one min) 
were added to microtiter dish wells; 10µL of 0.05M KH2PO4 (pH 7) was used as the 
blank.   The reaction was allowed to proceed for 15 min.   Adhering to the 15 s interval, 
the reaction was stopped after 15 min by adding 50µL of 1M phosphoric acid per well.   
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Endpoints were read at Aλ450nm and were plotted as a function of OD at Aλ450nm, (y axis) 
and MPO concentration (x axis), in the presence and absence of the various potential 
MPO inhibitors.   Positive values indicated MPO enzymatic activity. 
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Supplemental Table A.4.   Staphylococcus aureus Sensitivity to Propidium Iodide 
at 1 hr.   Results are expressed as the number of log10 reductions in recoverable 
CFU/mL.   Propidium iodide (PI) concentrations are expressed in µg/mL FC.   Samples 
contained a starting inoculum of ~106 CFU/mL.   Since the limit of detection was 2.0 
log10 CFU/mL, a maximum of four log reductions could be detected; >4 indicates no 
recoverable CFU on replicate plating.   
 
PI Concentration 
(µg/mL) 
Log10 Reductions in CFU/mL 
Strain 25923 
Strain 
29213 
Strain 
14154 Strain 27659 
0 0 0 0 0 
1.88 0 2 0 1 
3.75 1 3 1 2 
7.5 2 4 2 3 
15 3 >4 3 4 
30 4 >4 4 >4 
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RESULTS AND DISCUSSION 
 Because subjects with CGD are characteristically susceptible to Staphylococcus 
aureus infections, we ideally wanted to include S. aureus in our neutrophil killing studies 
along with P. gingivalis.   It was hypothesized that like P. gingivalis, neutrophil-mediated 
killing of S. aureus is dependent on the function of the NADPH oxidase.    Because 
absolutely no killing of P. gingivalis occurred by CGD neutrophils or by normal 
neutrophils in the presence of DPI or under anaerobiosis (as detected by the complete 
absence of PI uptake), it was of interest to see how S. aureus compared.    However, in 
preliminary experiments, it was discovered that optimal and sub-optimal PI 
concentrations killed S. aureus, as detected by immediate PI uptake under fluorescence 
microscopy and logarithmic reductions in CFU/mL by plating.   Therefore, it was not 
possible to include S. aureus in our phagocytosis and killing studies using DAPI/PI. 
 It is important to note that the current understanding is that PI, a small cationic 
dye, is excluded by the cytoplasmic membranes of live bacteria, and enters bacteria 
upon loss of membrane integrity, associated with death.   As a result of membrane 
damage, PI enters cells with an increased membrane permeability to molecules ≥2nm in 
diameter, and binds to double-stranded nucleic acids and fluoresces red at an 
excitation/emission maxima of 535/617nm (7) (8).   Two common applications of PI 
permeability by bacteria involve quantification by flow cytometry as an indicator of 
membrane damage and associated lethality, and the detection of intracellular bacterial 
killing by phagocytes using dual-color fluorescence microscopy.   Used both ways, PI 
permeability (PI uptake) is thought to be a reliable indicator of bacterial killing, as 
confirmed by plating (9) (10) (11) (12).   However, as suggested by Williams et al (13), PI 
staining has not been extensively tested on bacteria, and was developed for small 
eukaryotic cells.     
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 Four strains of S. aureus (strains 25923, 29213, 14154, and 27659) were tested 
(Supplemental Table A.4), as well as other Staphylococcus species including S. 
epidermidis and S. saprolyticus (data not shown), with a variety of PI concentrations.   
All Staphylococcus species and strains tested were killed by sub-optimal PI 
concentrations; i.e. concentrations below which were optimal for distinguishing live from 
dead bacteria using DAPI/PI fluorescence microscopy.    In our hands, ~7.5µg/mL PI 
(FC) was optimal based on color intensity and complete staining of heat-killed S. aureus, 
P. gingivalis, F. nucleatum, and A. actinomycetemcomitans alike (at 106 bacteria/mL) 
under both DAPI and PI filtrations.    Furthermore, this concentration of PI had no effect 
on the viability of live P. gingivalis, F. nucleatum, or A. actinomycetemcomitans, as 
detected by plating and the absence of PI uptake (data not shown).     
 Williams et al (13) determined a similar concentration (5µg/mL PI) to be optimal 
for the fluorescence of E. coli, B. subtilis, and Pseudomonas species, based on PI 
staining of heat-killed bacteria and no effect on viability; but suggested that several 
factors, including the PI concentration used and inherent membrane permeabilities of 
viable bacteria, can impact PI staining and lead to false conclusions.   For instance, this 
study suggested that too high of PI concentrations can falsely stain viable but “leaky” 
bacteria; while too low of PI concentrations can give heat-killed bacteria, confirmed to be 
non-viable by plating, the appearance of being unstained, unevenly stained, or weakly 
stained (13).    The comparison of PI permeability with plating, as observed by this group 
(13) and others (14), therefore indicate the two are not always consistent with each 
other.   It has thus been suggested that leakiness of cells, when too high of PI 
concentrations are used, is artifactual and does not necessarily indicate death (13).     
Hilliard et al (14) also observed that the uptake of PI due to membrane damage 
occurs rapidly and may precede the event of death in bacteria.   This may be consistent 
with our observations, as logarithmic reductions in CFU/mL were not immediately 
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detected upon plating S. aureus in the presence of ≤120µg/mL PI at 0 time (data not 
shown), though S. aureus was immediately fluorescent with as low as 0.12µg/mL PI, 
under PI filtration (data not shown).    Though <7.5µg/mL PI was not enough PI present 
to penetrate all S. aureus cells (at 106 bacteria/mL) at 0 time, a certain percentage were 
detected with bright red intensity at 0 time with as low as 0.12µg/mL PI, under PI 
filtration.   Therefore, PI permeability by fluorescence was a more sensitive indicator of a 
moribund-state than was plating.  
Our results suggest that with as low as 3.75µg/mL PI, all S. aureus strains tested 
experience one or more logarithmic reductions (which correspond to a ≥90% reduction in 
viability) in recoverable CFU/mL at one hour (Supplemental Table A.4), and are highly 
permeable to PI at this concentration at 0 time (all were various shades of red under PI 
filtration).     At concentrations of ≥7.5µg/mL PI, all Staphylococcus tested fluoresced 
bright red in entirety at 0 time under both DAPI and PI filtrations.   Furthermore, in our 
hands, no other genuses have shown sensitivity like this to PI, which appears unique for 
Staphylococcus species.    Yet, to our knowledge, there are no reports that have 
described a hypersensitivity of Staphylococcus to PI.   This is particularly confounding 
because PI has been used as a tool in multiple studies to investigate the killing of S. 
aureus– some of which have used the same strains as reported here, and all of which 
have used PI concentrations (e.g. 2 - 100µg/mL PI) which are reported here to be lethal 
to S. aureus.   While this certainly warrants further investigation, we hope that killing 
studies using PI with S. aureus have not been misinterpreted due to a hypersensitivity of 
this bacterium to PI.      
Similar to the hypersensitivity of S. aureus to sub-optimal concentrations of PI, 
preliminary studies (data not shown) also found a hypersensitivity of Streptococcus 
pyogenes with DAPI, as confirmed by plating, at concentrations much below that which 
is required for optimal visualization of DAPI fluorescence (45µL of 7.5µg/mL).   To our 
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knowledge, this too has never before been reported, despite the common use of DAPI 
with this organism. 
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MATERIALS AND METHODS 
Bacterial Growth and Storage: 
 The aerotolerant anaerobe S. aureus was grown at 36oC under aerobic 
atmosphere, in 9mL volumes of non-reduced Wilkins-Chalgren (WC) Anaerobe Broth 
Medium (Oxoid Ltd, Basingstroke, Hampshire, England) in glass test tubes, without 
shaking.   WC was the standard medium used to grow all bacteria (for consistency), and 
worked well for the growth of strict anaerobes as well as aerotolerant anaerobes that are 
capable of growing in the presence of oxygen alike.    In order to minimize mutation, 
bacteria were freshly grown from minimally passaged, aliquoted frozen stocks each 
week before use in experiments.   Briefly, 100µL aliquots of S. aureus (grown in WC to 
mid-exponential phase or to ~0.5 optical density (OD) at Aλ660nm) were stored in 1mL 
glass vials containing 0.5mL sterilized skim milk (Sigma, St. Louis, MO), at -80oC until 
use.   Individual frozen aliquots were thawed at room temperature and recovered by 
inoculation into 9mL volumes of WC.   From this, 1 drop (using a sterile plastic transfer 
pipette) was inoculated into fresh 9mL volumes of WC, and from this, 3-5 drops were 
inoculated into a second 9mL volume of WC, and from that, 3-5 drops were inoculated 
into a third 9mL volume of WC, and placed into the aerobic incubator for growth.   These 
broth cultures took approximately 18-24 hr to initially recover from frozen stock in WC.   
Upon initial visible growth, broth cultures were serially diluted (1 drop and several 10-fold 
dilutions from that) into fresh 9mL volumes of WC.   Bacteria were harvested from 
overnight cultures (~18 hr) using the dilution that best fit early- to mid-exponential phase 
with an Aλ660nm of 0.2-0.6.   The starting inoculum also assured that the test bacteria 
used in all experiments had undergone a minimum of five doublings.   Individual frozen 
aliquots were checked for purity  by streaking for isolation on reducible Brucella blood 
agar plates (Anaerobe Systems, Morgan Hill, CA), incubated aerobically at 36oC.   A 
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morphologically pure, β-hemolytic culture on blood agar assured purity and was 
confirmed by Gram stain (agar and broth cultures).    
 
Bacterial Labeling with DAPI 
One 9mL overnight culture (~18 hr) of S. aureus in early- to mid-exponential 
phase (Aλ660nm of 0.2-0.6) was divided into six 1.7mL polypropylene centrifuge tubes 
(VWR International, West Chester, PA), and centrifuged for four min at 10,000xg.  
Supernatants were discarded, and bacteria were concentrated into one tube by 
resuspending pellets serially in one 1mL volume (q.s. to 1.5mL) of Hanks Balanced Salt 
Solution (HBSS) (GIBCO, Grand Island, NY) without metals (calcium or magnesium) or 
phenol red, followed by 4’, 6-diamidino-2-phenylindole (DAPI) (Sigma Chemical Co, St. 
Louis, MO) labeling (45µL of 7.5µg/mL) for ten min at room temperature, without motion 
in the dark.  This was followed by three washes (four min at 10,000xg) in 1.5mL of fresh 
HBSS without metals.   After the fourth and final spin, the pellet was resuspended in 
0.75mL of HBSS with calcium and magnesium (with metals), and adjusted with HBSS 
with metals to a final Aλ660nm =0.2 (approximately 108 CFU/mL), using a 
spectrophotometer (Beckman, Fullerton, CA). 
 
Dual-Color Fluorescence Killing Assay 
The dual-color fluorescence phagocytosis and killing assay using DAPI/PI first 
described by Kalmar et al (15) and modified by Cutler et al (16) (17) was intended to be 
used to assess neutrophil phagocytosis and killing of S. aureus, in comparison to P. 
gingivalis.   DAPI is a vital stain, which binds to A/T-rich regions of double-stranded 
DNA, and forms a highly fluorescent complex (blue color) when bacteria are alive (18).   
Propidium iodide (PI) is a red fluorescing viability dye, which is excluded by the 
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cytoplasmic membranes of live bacteria and enters the bacteria upon loss of membrane 
potential, associated with death (19). 
In summary, DAPI-labeled S. aureus (100µL at Aλ660nm =0.2) were opsonized with 
12.5µL of active human complement and 12.5µL of heat-inactivated (at 56oC for 30 min 
just prior to use) human complement (gently mixed), in a 1.7mL polypropylene centrifuge 
tube (VWR International) for 10 min in a 37oC Fisher Isotemp dry bath (Fisher Scientific 
Company, Fairlawn, NJ), with rocking.   DAPI-labeled P. gingivalis was included as a 
control, and opsonized with human complement (12.5µL) and hyperimmune rabbit 
antiserum (12.5µL), as previously described.    After opsonization, 10µL of PI, and 125µL 
of HBSS without metals (in place of neutrophils) were added and gently resuspended, 
initiating the start of the experiment (time 0).     In testing the sensitivity of S. aureus to a 
variety of PI concentrations, PI was titered using 2-fold dilutions (in deionized water, the 
diluent of PI from stock), from 120µg/mL through 0.12µg/mL FC.    The standard FC of 
PI normally used in this assay is 7.5µg/mL (10µL).   
At the prescribed time intervals, 30µL aliquots were removed (after gently 
resuspending) and cytospun (Shandon Inc., Sewickley, PA) for 3 min at 850rpm onto 
pre-cleaned microscope slides (VWR International).   Once dried (≤1 min after spin 
finished), glass cover slips (VWR) were mounted with cyanoacrylate (Krazy Glue™), and 
slides were examined by epi-illumination UV microscopy with oil immersion (63x) on a 
Zeiss Axioskop to access bacterial viability in the presence of DAPI/PI.   Approximate 
fluorescence excitation/ emission maxima for DAPI and PI, when bound to DNA, were 
358/461 and 535/617, respectively.  
At the prescribed time intervals, 10µL aliquots were also removed (after gently 
resuspending) and plated by delivering 10µL of sample (spot assayed) to the surface of 
non-reduced WC agar (Oxoid Ltd), for growth and bacterial enumeration.   To assess 
bacterial viability in the presence of DAPI/PI, compared to controls (no PI +/- DAPI), 
293 
 
detection of logarithmic differences in recoverable CFU was sufficient.   Logarithmic 
reductions in bacterial densities per spot were estimated by comparison to controls, 
which were serially diluted 10-fold.   Logarithmic reductions in recoverable CFU/mL were 
considered significant; i.e. ≥1 log reduction was considered significant and equated to a 
≥90% reduction in CFU/mL, while <1 log reduction was not considered significant.   After 
plating, agar surfaces were briefly allowed to dry in ambient air (dried within 5 min of 
plating), and were quickly placed into the aerobic incubator (for S. aureus) or anaerobic 
chamber incubator (for P. gingivalis) for growth.   Plates were incubated at 36oC, and 
recoverable CFU were countable after 4-6 days for P. gingivalis, and after 1 day for S. 
aureus. 
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